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Abstract
The expectation for continual improvements in the treatment of cancer has
brought quality assurance in radiotherapy under scrutiny in recent years.
After a cancer diagnosis a custom treatment plan is devised to meet the par-
ticular needs of the patient’s condition based on their prognosis. A cancer
treatment plan will typically comprise of several cancer treatment technolo-
gies combining to form a comprehensive programme to fight the malignant
growth. Inherent in each cancer treatment technology is a percentage error
in treatment accuracy. Quality assurance is the medical practice to minim-
ise the percentage error in treatment accuracy. Radiotherapy is one of the
several cancer treatment technologies a patient might receive as part of their
treatment plan, and in-vivo dosimetry is a quality assurance technology spe-
cifically designed to minimise the percentage error in the treatment accuracy
of radiotherapy.
This thesis outlines the work completed in the design of a next genera-
tion dosimeter for in-vivo dosimetry. The proposed dosimeter is intended to
modernise the process of measuring the absorbed dose of ionising radiation
received by the target volume during a radiotherapy session. To accomplish
this goal the new dosimeter will amalgamate specialist technologies from the
field of particle physics and reapply them to the field of medical physics.
This thesis describes the design of a new implantable in-vivo dosimeter, a
dosimeter comprising of several individual stages of electronics working to-
gether to modernise quality assurance in radiotherapy. Presented within this
thesis are the results demonstrating the performance of two critical stages
for this new dosimeter, including: the floating gate metal oxide field effective
transistor, a radiation sensitive electronic component measuring an absorbed
dose of radiation; and the micro antenna, a highly specialist wireless com-
munications device working to transmit a high frequency radio signal.
This was a collaborative project between Rutherford Appleton Laborat-
ory and Brunel University. The presented work in this thesis was completed
between March 2007 and January 2011.
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Chapter 1
Introduction
1.1 In-Vivo Dosimetry
Dosimetry refers to a device used to calculate the absorbed dose of ionising
radiation in matter or tissue resulting from its direct or indirect exposure
to a radiation source. The measurement of absorbed dose of ionising ra-
diation has many applications from space science, to health and safety, to
particle physics, to medicine. In-vivo is a latin phrase meaning, of processes
taking place in a living organism. Despite the literal interpretation of the
term seldom does in-vivo dosimetry (IVD) refer to the measurement of the
absorbed dose of ionising radiation from within a living thing. Instead the
nomenclature for the term comes from its medical application within radio-
therapy and is commonly used to describe the measurement of absorbed dose
of ionising radiation taken while a patient is receiving treatment.
If dosimetry is the measurement of the absorbed dose of ionising radiation
then the practical value of dosimetry to the field of radiotherapy has long
been recognised. The merits of a dosimeter in the calibration of a radiation
source has led to the development of a plethora of different types of commer-
cially available dosimeters, each with their own distinct attributes. However,
dosimeters developed to provide measurement of the absorbed dose of ion-
ising radiation while the patient is undergoing treatment has not been met
with the same ubiquitous support as dosimeters for linac (linear accelerator)
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calibration.
Historically the arguments against the routine use of IVD have to do
with the cost compared to perceived improvements to the patient’s quality
of care. Dosimetry alone is not a technology capable of directly changing the
probability of a patient overcoming cancer, it can only provide assurances
towards the accuracy of the treatment. The number of competing dosimetry
technologies available on the market today only add to the confusion facing
a physician’s incentive in favouring routine IVD.
Although the operational requirements of a dosimeter are unique to their
field of application the implementing technology behind each dosimeter can
sometimes be transferable. The substantial advance of scientific research in
the field of particle physics over the last couple of decades has culminated
in the launch of the LHC experiment at CERN, and it is in addressing the
challenges of radiation measurement faced by the engineers and physicists
of CERN that has, in a small way, contributed to the science of IVD in
medicine.
1.2 Research Goals
It is the objective of this project to develop an implantable submillimetre in-
vivo dosimeter based on floating-gate transistor technology. The attributes
that make the floating-gate transistor suitable in the design of an implantable
in-vivo dosimeter are presented in Section 3.4.4.
Such a complex technology can only be achieved by breaking down the
problem into sections and implementing solutions to each section in stages.
Only once each of the individual sections to the new dosimeter are designed
and proven to work can all stages be brought together to realise the intended
solution.
The work carried out for this thesis is comprised of two separate studies.
These two studies make two of the four sections deemed necessary before a
completely new and novel dosimeter for IVD can be realised. The aim of
the first study was to assess the potential of the floating-gate transistor as
an electronic component capable of measuring the absorbed dose of ionising
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radiation it has been exposed to. Other alternative transistor types can and
have been used to measure an absorbed dose of radiation however there are
particular attributes to the floating-gate transistor that enhance its suitab-
ility as a radiation measuring component. The aim of the first study was to
investigate these potentially advantageous characteristics of the floating-gate
transistor.
The aim of the second study was to address the necessary wireless com-
munication requirement of an implantable in-vivo dosimeter by evaluating
the performance difference between three alternative micro antenna designs.
The operational requirements of a micro antenna for an implantable medical
device are unique by comparison to the extensive list of designed antennas for
alternative applications. It was the lack of completed research available on
the performance of a micro antenna for an implantable medical device that
led the second study to assess the performance of three alternative designs
to determine which antenna design would offer the greatest efficiency when
used to communicate the dosimeter’s measured absorbed dose of ionising
radiation.
The work carried out for this thesis was funded by a Co-operative Award
in Science and Engineering (CASE) studentship from the Science and Tech-
nology Facilities Council (STFC) in collaboration with Rutherford Appleton
Laboratory (RAL) of the Harwell Science Park, Didcot, England.
1.3 Thesis Organisation
This is the first thesis on the design and performance of an implantable do-
simeter for radiotherapy from the Centre for Sensors and Instrumentation
(CSI) at Brunel University. The group has traditionally been involved in
the design of silicon based detectors for space science (Chandrayaan-1) and
particle physics (CMS and MICE) while supporting the computing infra-
structure to the LHC experiment through the GridPP framework. However,
with the increasing affordability of the cyclotron accelerator technology, it
has been recognised within the group that it is only a matter of time be-
fore the development of particle based radiation is used as commonly in the
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treatment of cancer as the more widespread γ based radiation treatments
seen today. It is with this thinking in mind that there is value to be had
by extending the group’s working knowledge of dosimeter design for medical
application. The higher energies used in particle based radiation treatment
will only further galvanise the call for routine IVD to improve quality assur-
ance (QA) in radiotherapy. With the use of higher energy radiation beams
the dangers of mistreatment are potentially more harmful if they occur. As
such with the introduction of improved QA, including routine use of IVD,
will mean the attractive properties of a particle based radiation beam can
be exploited whist minimising the risk. A particle based radiation beam is
superior to the conventional radiation beam γ by the nature of how energy
is deposited within the patient. This idea is explored further in Section 6.2.
The thesis is organised into seven chapters including:
• Chapter 1 - briefly outlining subject, research goals, and structure of
this thesis, as well as listing all accomplished peer reviewed publications
and conference presentations.
• Chapter 2 - a background chapter summarising all relevant aspects
of the field of radiotherapy, from cancer incidence rates in the UK to
the effects of ionising radiation on human cells, building an argument
justifying the need for routine IVD as a QA technology.
• Chapter 3 - a theory chapter exploring why the floating gate metal
oxide field effective transistor (FGMOSFET) is potentially a suitable
electronic component to measure the absorbed dose of ionising radi-
ation. Starting with the fundamental structure of doped silicon the
presented material works all the way through to the expected response
of the FGMOSFET when exposed to a radiation source.
• Chapter 4 - a theory chapter included as a brief review of electro-
magnetic theory as defined by Maxwell’s equations before delineating
the relevant theoretical and practical considerations of micro antenna
design.
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• Chapter 5 - a presentation of the results from an experiment where
the precise evaluation of the FGMOSFET as an electronic component
capable of measuring the absorbed dose of ionising radiation was com-
pleted. The radiation source used for this experiment is comparable to
a source used during radiotherapy.
• Chapter 6 - a results chapter presenting the findings of an experiment
that determined which of three custom designed micro antennas would
best perform in the field of IVD as part of an electronic circuit to be
used as a medical implant. The micro antenna was designed to com-
municate its measured absorbed dose of radiation via a strict wireless
specification.
• Chapter 7 - a brief conclusion that evaluates the accomplishments high-
lighted in this thesis and also offers a summary of the shortcomings of
the completed work. This chapter closes by identifying the next steps
that could follow from this thesis offering a platform from which future
work could begin in the pursuit of the next generation of dosimeters
for radiotherapy.
1.4 Publications and Presentations
The data presented in both results chapters included within this thesis were
presented at the below list of either international conferences and peer re-
viewed journals:
Peer Reviewed Publications
• R. Edgecock, J. Matheson, M. Weber, Giulio E. Villani, R. Bose, A.
Khan, D. R. Smith, I. Adil-Smith, and A. Gabrielli.
Evaluation of commercial programmable floating gate devices as radi-
ation dosimeters.
Journal of Instrumentation, 4(2):1-10, February 2009.
http://iopscience.iop.org/1748-0221/4/02/P02002
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• Giulio E. Villani, R. Bose, and A. Gabrielli.
Evaluation of on-chip micro antennas for in vivo dosimetry application.
Radiation Measurements, 46(12):1963-1966, 2011.
http://www.sciencedirect.com/science/article/pii/S1350448711002757
Peer Reviewed Presentations
• N54-7: Evaluation of on-chip Micro Antennas for In-Vivo Dosimetry
Applications
IEEE Nuclear Science Symposium and Medical Imaging Conference
30th October to 6th November, 2010
Knoxville, Tennessee
http://www.nss-mic.org/2010/
• Evaluation of On Chip Micro Antennas for In-Vivo Dosimetry Applic-
ations
16th Solid State Dosimetry Conference
19th September to 24th September, 2010
Sydney, Australia
http://www.uow.edu.au/conferences/SSD16/
• Evaluation of a Commercial Programmable Floating-Gate MOSFET
as a Radiation Dosimeter for In-Vivo Dosimetry
2nd Annual Student Research Conference
22nd June to 24th June, 2009
London, United Kingdom
http://www.brunel.ac.uk/sed/annual-conferences/1st-annual-student-research-
conference-2009
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Chapter 2
Background
2.1 Introduction
This is a background chapter setting the context for the thesis by building
an argument justifying the need for routine IVD as a QA technology. In the
medical context the use of dosimetry forms part of the QA practices used to
minimise errors within radiotherapy.
The chapter begins with a section presenting the latest statistics on the
prevalence of cancer in the UK. Following this brief review will be a discussion
of the biology of cancer and how it develops from a cellular level. That
section leads into an overview of radiotherapy as a treatment, the types of
radiotherapy treatment available, and how a typical treatment is conducted.
The following section reviews safety procedures in radiotherapy leading into
a discussion on the need for improved QA. This is an important discussion
as it explains how and why the demand for IVD in radiotherapy came about.
Section 2.6 is a more lengthy discussion about how ionising radiation kills
cells, the mechanism by which ionising radiation is used to treat cancer. The
discussion approaches the subject by looking at the physical, chemical, and
biological effects of ionising radiation on cells. The remaining three sections
describe the proposed dosimeter, its expected performance, and give an idea
of how it might operate.
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2.2 UK Cancer Incidence Rates
Cancer is a heterogeneous classification of more than 200 different diseases
characterised by the abnormal growth of a mutated cell. The symptoms of
cancer vary due to the variety of its forms. Naturally, the symptoms of breast
cancer differ to the symptoms of lung cancer but both are characterised by
the abnormal growth of human cells.
Each year more than 300,000 new cancer diagnoses are made in the UK
alone. With such high incidence rates, cancer is a disease that touches most
peoples lives, directly or indirectly, and is therefore a subject of global in-
terest. Organisations like the Cancer Research UK charity work hard to
educate the public on the facts about cancer. Cancer Research UK perform
a regular review of all published data from the Office for National Statistics
regarding both incidence rates and mortality rates caused by cancer. The
results are presented in an accessible form for the public.
The statistics of cancer in the UK are well documented. Unfortunately
there is some latency between the latest statistics on cancer and the date
when they are published. At the time of writing the following statistics are
widely accepted as accurate based on data no later than 2008 [1]:
• 1 in 3 people will be diagnosed with cancer in their lifetime.
• 1 in 4 deaths in the UK are cancer related deaths.
• In woman, breast cancer has the highest incidence rate. Just over 1 in
3 newly diagnosed cancer cases in women are breast cancer.
• In men, prostate cancer has the highest incidence rate. Just under 1 in
4 newly diagnosed cancer cases in men are prostate cancer.
• The four most common types of cancer account for more than half of all
cancer incidences in the UK. They include: breast, prostate, colorectal,
and lung.
A popular illustration to capture the above statistics is shown in Fig-
ure 2.1. This graphic from Cancer Research UK provides a clear snapshot
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of which cancers are most common by gender. This easy to read plot is a
helpful tool used to educate the British public on the facts about cancer.
Figure 2.1: Distribution of most common cancers by gender [1].
The likelihood of developing cancer is dependent on many factors includ-
ing age, lifestyle and genetic make-up. It has been estimated that almost half
of all cancers in the UK could be avoided with attention to diet, exercise,
bodyweight and sunlight exposure [2].
Tackling the growing concerns about the ever increasing unhealthy state
of the British population is a high priority for every new government. The
2010 UK coalition government published Healthy Lives, Healthy People: Our
strategy for public health in England [3]. This document outlines the im-
portance of healthy living to help reduce the number of cancer incidence
rates.
2.3 The Biology of Cancer
The growth of all healthy human cells in the body is conducted by a natural
process called the cell cycle. This cycle is broken into two distinct phases,
the interphase and the mitosis phase, as illustrated in Figure 2.2. During the
interphase the cells gathers sufficient nutrients to complete the mitosis phase.
Mitosis is the process whereby a mother cell splits and divides, making an
exact copy of itself, forming two daughter cells. The daughter cells contain
roughly half the cellular components of the mother cell.
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Figure 2.2: Illustration of the major stages to cell mitosis [4].
An important stage in the mitosis phase is the separation of the cell’s
chromosomes into two identical sets when the mother cell divides into two
daughter cells and one set of chromosomes is for either daughter cell. Within
a cell the deoxyribonucleic acid (DNA) is organised into long structures called
chromosomes. A cell’s DNA contains the instructions necessary for an or-
ganism to develop. The genetic information of the DNA is necessary for the
cell to build and maintain itself. Communication between neighbouring cells
is what regulates the rate at which cells undergo the cell cycle, this charac-
terises the expected behaviour of healthy human cells. Cancer cells, however,
are the result of an error in part of this communication process.
Cancer is defined as the unregulated growth of cells. A cancer cell is one
that has stopped communicating with its neighbouring cells and is reprodu-
cing at an uncontrolled rate. A cancerous daughter cell is physiologically
different to its mother cell in the composition of its DNA. All cancer cells
are cells carrying DNA that has undergone a mutation.
Within nature the background rate is a low rate of randomly occurring
DNA mutation. Mutation of a cell’s DNA can have one of several effects.
Only one of these effects is for the cell to become cancerous.
When a mutation occurs in a cell’s DNA there is no guarantee the muta-
tion will be persistent. That is, the mutation may not be persistent through
the process of mitosis. When DNA becomes damaged proteins within the
cell can sometimes correct the damage and repair the DNA. Failing that the
DNA mutation may instigate the process of programmed cell death (PCD)
and the cell will terminate. Should either of these two mechanisms occur
then the cell, although carrying mutated DNA, will not cause cancer.
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Should the DNA mutation be persistent through mitosis then there is
one of two possible outcomes. Paradoxically, DNA mutation can serve as an
advantage to an organism and this phenomenon is the first of two possible
outcomes for cells carrying persistent mutated DNA. As Charles Darwin fam-
ously postulated, an adaptive evolution caused by natural selection is only
possible with heritable genetic variation [5]. Persistent mutated DNA gives
an organism genetic variation, and should that genetic variation provide the
organism with an advantage in its natural habitat then that genetic vari-
ation facilitates adaptive evolution [6]. Unfortunately, persistent mutated
DNA that supports adaptive evolution is a seldom occurrence, thus making
evolution a slow process. The second possible outcome for cells carrying per-
sistent mutated DNA occurs if the mutation is not repaired by cell proteins,
or if the cell is not killed off by PCD, or if the persistent genetic variance is
not a facility to adaptive evolution, and if the cell stops communicating with
its neighbouring cells, then it will most likely be a cancerous cell. Over time,
from this single cell, under the natural process of the cell cycle, a tumorous
growth will develop. Only when symptoms resulting from this abnormality
develop can a diagnosis be made.
Having described the advantage of naturally occurring DNA mutation
there is one additional factor to be discussed, mutagens. A mutagen is an
agent that causes a change in the frequency of DNA mutation in a cell. That
is, separate to the cell’s own physiology, a mutagen is an external agent that
can raise the mutation rate in a cell’s DNA above the naturally occurring
background rate. It goes without saying that should the mutation rate of
a cell’s DNA increase then the probability of a mutation being a persistent
cancer causing mutation also increases.
Just as DNA mutation at the natural background rate can have a positive
implication to serve adaptive evolution, under certain circumstances, so too
can the controlled introduction of a known mutagen have positive ramifica-
tions. This seemingly contradictory suggestion is explained in Section 2.6.1.
There are many different mutagens that can cause irreversible damage to
DNA. Broadly speaking, mutagens are broken into two categories, physical
agents and chemical agents. Should the mutagenic agent cause damage to
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DNA that leads to cancer then that mutagen is referred to as a carcinogen.
It should be noted that not all mutagens are carcinogens as not all mutations
to DNA cause cancer. Carcinogens are mutagenic agents that damage DNA
in such a way it leads to the uncontrolled divisions of malignant cells that
ultimately causes the formation of tumours.
The original discovery of the effects of a mutagen was made by Hermann
Muller. Muller published the results of his research in 1928 and showed that
X-rays caused mutations in fruit flies [7]. In Muller’s experiment the X-ray
radiation was the mutagen being investigated, and only one parent fruit fly
was subjected to X-ray exposure. The mutations observed were in the off-
spring from irradiated and non-irradiated fruit flies breeding together. The
mutations observed manifested in both visible and lethal forms. Muller’s
work found the mutations caused by X-rays to a parent fruit fly were hered-
itary. This meant the mutagen must be causing mutation in the genetic
material of the fruit fly.
2.4 Radiotherapy
External beam radiation therapy (EBRT) is a medical procedure routinely
used in the treatment of cancer typically forming part of a patient’s holistic
treatment programme. An oncologist is a doctor who specialises in the treat-
ment of cancer and is responsible for choosing the treatment programme a
cancer patient will undergo. Radiotherapy is a procedure that is capable
of treating cancer of any part of the body. It does so by aiming a high-
energy beam of ionising radiation at a predetermined target volume where
the cancerous growth is within that volume. Prior to radiotherapy treatment
computed tomography (CT) [8] imaging is used to locate the patient’s can-
cerous growth. Radiotherapy treats cancer by attacking cancer on a cellular
level.
Once radiotherapy is prescribed as part of a patient’s cancer treatment
programme a timetable for treatment delivery is devised. Typically a pa-
tient’s radiotherapy treatment is broken into several delivery sessions, or
fractions as they are known. Between 10 and 15 fractions is common. Break-
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ing up the treatment in this way has two major advantages. First, the dose
per fraction is reduced which reduces the chance of harmful effects of the
ionising radiation on the patient. Second, breaking up the treatment into
several sessions allows healthy cells to recover from the ionising radiation.
After CT imaging two small dots are tattooed on the patient. The tattoo
markers are permanent and are placed at the vertical and horizontal axis
that traverse the centre point of the target volume. The tattooed markers
are used to align the patient into the correct position for each treatment
fraction. A treatment fraction will be booked into a 20 minute session and
the treatment itself is brief. The majority of time during the session is spent
ensuring the patient is positioned correctly. Correctly positioning the patient
is critical to ensure the target volume is what the dose of ionising radiation is
pointing at. The medical physicist is responsible for delivering the patient’s
treatment and will take great care to ensure the patient’s setup is correct
before proceeding with the treatment.
Figure 2.3: A patient receiving radiotherapy treatment from a linac with the
gantry rotating around the patient for precision dose delivery [9].
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Figure 2.3 shows a patient in position on a bed under the gantry of the
linac [9]. The linac produces the beam of ionising radiation and the gantry
shapes the high-energy beam before firing the beam at the patient’s target
volume. Typical of this type of delivery an X-ray source is used. The gantry is
not fixed and, under computer controlled automation, the gantry will rotate
around the patient whilst the treatment is underway. Thus, at the target
volume, the sum of the absorbed dose of radiation energy from the beam
is far greater than the absorbed dose of radiation energy by surrounding
healthy tissue.
Alternative technologies in the field of radiotherapy deliver their treat-
ment in different ways. Some of the competing systems of treatment include:
conventional external beam radiation therapy (2DXRT), 3-dimensional con-
formal radiation therapy (3DCRT) [10], intensity modulated radiation ther-
apy (IMRT) [11], and image-guided radiation therapy (IGRT) [12]. The
source of ionising radiation used in the treatment of cancer is not limited
to photon based (X-ray/γ-ray) linacs. Alternative radiation sources include;
electrons [13], protons [14], and carbon ions [15]. However, in the UK the
vast majority of oncology clinics only have access to photon based linacs.
The only exception to this being the Clatterbridge Centre for Oncology, a
cyclotron radiation source using a 62 MeV proton beam to treat choroidal
melanoma [14]. Despite the variety of treatment systems and types of ra-
diation beam available the one factor that is common between all form of
radiotherapy is the need for QA.
With more than half of all cancer patients undergoing a course of radio-
therapy at some point in their treatment programme [16, 17, 18, 19], and
with more than 40 % of all cancer patients who survive cancer being treated
with radiotherapy [20], radiotherapy has been an essential part in the treat-
ment of cancer for many years. In the UK around 200 linear accelerators
deliver 100,000 courses of radiotherapy in 1.5 million fractions annually [21],
that is 4.25 million doses of radiation for cancer treatment each year.
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2.5 Safety in Radiotherapy
As a treatment radiotherapy is a complex multi-stage procedure. Exposing
the target volume to ionising radiation forms only part of the entire process.
Before a single dose can be delivered a custom treatment plan must be devised
based on the individual patient’s diagnosis.
Figure 2.4: Stages of radiotherapy treatment in which high-profile errors
repeatedly occurred [22, 23].
Figure 2.4 is a high-level generalisation of the stages to radiotherapy
[22, 23]. Conceptualising treatment like this helps recognise the inherent
errors within each stage of the treatment programme. The overall error of
the treatment is the product of the error in each stage.
QA in radiotherapy is to include protocol within the treatment procedure
that recognises the potential cause of errors within each stage. The need
for QA in radiotherapy has long been established [24, 25, 26]. QA should
safeguard the patient from the harmful effects of ionising radiation once an
error has been recognised and instil confidence in the accuracy of treatment,
that the intended dose of ionising radiation has successfully been delivered
to the target volume.
Precision is a fundamental requirement in the delivery of ionising radi-
ation as ionising radiation is harmful to human tissue. When a high degree
of accuracy is adopted in radiotherapy patient duress and recovery time is
minimised whilst maintaining quality of treatment. As such, when deliver-
ing a dose of ionising radiation, the consideration of the dose energy is as
important as the consideration of dose location. The recommended accur-
acy requirements of ∼ 3.5 % in the absorbed dose at the target volume and
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< 5 mm in geometric accuracy from the position of the target volume have
been stipulated [27].
Meeting the increasing demand for greater accuracy in radiotherapy has
only been achievable with innovation within medical science. As the soph-
istication of radiotherapy technology has matured so too have the guidelines
advising the performance requirements of radiotherapy. It is the scope of
this project to design and build a technology to provide QA in only one of
the stages in the radiotherapy procedure: the treatment delivery stage. The
proposed QA technology is IVD and is capable of confirming the absorbed
dose and geometric accuracy of the delivered dose.
Despite the long standing need for improved QA within radiotherapy
[28, 29], including the recommended use of IVD to achieve that goal [30, 31],
UK hospitals still maintain poor adoption rates for the routine use of IVD
in the treatment of cancer [32], and there is little evidence to support that
trend improving [33]. The Robert Appleyard survey found that over half
(54 %) of the participating hospitals did not include routine IVD as part of
their treatment, and none of those hospitals had plans to introduce routine
IVD within the near future.
It was only after a number of high-profile accidents in radiotherapy [34,
35, 36] before a written mandate from Sir Liam Donaldson, the then acting
Chief Medical Officer (CMO), instructed the integration of routine IVD in
radiotherapy in UK hospitals [22]. Figure 2.4 highlights exactly where acci-
dents can occur in radiotherapy [22]. The recommendation by the CMO for
routine IVD as part of the radiotherapy treatment programme is to identify
errors at these stages of treatment. Identifying errors early in treatment
will safeguard patients against the harmful effects of ionising radiation and
potentially save lives.
This proposal by the CMO is not without controversy and triggered a
national debate regarding the motives of IVD in radiotherapy safety. Wil-
liams and McKenzie [37] justified the benefit to IVD with a cost related
argument, suggesting the cost related to treating overdosed and under-dosed
cancer patients is greater than the cost to implementing IVD (where IVD is
used only in the initial fraction of a patient’s treatment). However MacKay
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and Williams [38] challenged the proposed financial argument suggesting the
call for IVD is instead an effort to improve public confidence in radiotherapy,
a move necessary only because of high-profile errors. In either case, neither
paper discredited the merit of IVD to improve safety in radiotherapy, or the
potential of IVD to save lives.
As state in the the Chief Medical Officer’s 2006 Annual report the use
of in-vivo dosimetry radiation checks should be made routine in accordance
with a culture of incident reporting [22], small or serious, with computer
reporting that is easy to understand by all staff.
If used correctly, IVD not only identifies when an unintended overdose or
under-dose is being administered, but, if used through every fraction, IVD
can give the medical physicist the opportunity to correct the potential error
so as to prevent it from being a persistent error throughout the entire course
of treatment.
2.6 Ionising Radiation: The Effect on Cells
The relationship between the energy of a photon (E) and the frequency (f)
of its associated electromagnetic (EM) wave is given by the Planck-relation,
described by Equation 2.1 [39], where h is Planck’s constant. By describing
radiation in terms of its energy it then becomes more straightforward to
predict the expected behaviour of the radiation when it interacts with the
cells of human tissue.
E = hf (2.1)
In the practical context of a radiation source the distinction between
the two classifications of energies is made by referring to how the radiation
is produced. γ-ray radiation is, in the practical context of working with
a radiation source, referring to a naturally occurring energy source where
the EM waves are ejected from the nucleus of a radioisotope as the nucleus
decays from an unstable state to a stable state. This process is measured as
the radioisotope’s half-life. A typical example of a γ-ray source is Cobalt-
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60 (60Co). A 60Co source is a popular choice when replicating the medical
conditions of radiotherapy for laboratory experiments. This avoids the costly
overhead of an artificial radiation source at the trade off for accuracy. X-
ray radiation is, in the practical context of working with a radiation source,
referring to an artificially produced energy source where the EM waves are
ejected from the collision events of high velocity electrons with a tungsten
target.
Modern radiotherapy facilities in a hospital will use a powerful linac to
produce and deliver a concentrated beam of photons at a patient’s target
volume. The energy of the photons can be of the X-ray or γ-ray range
depending on the type and location of the cancer being treated. The shape
and intensity of the beam is controlled using collimators near where the beam
exits the linac. A collimator is a device that narrows a beam of particles and
this artificial process gives the medical physicist a greater accuracy when
delivering a radiation dose to the patient.
The principle by which radiotherapy is an effective treatment of cancer
is to exploit the effect of ionising radiation on human cells. Damage from
ionising radiation can range from superficial skin burns to internal organ
damage, however the most devastating effect of ionising radiation is caused
by the mutagenic effect of ionising radiation on human cells, causing mutation
within cell DNA. Indeed if a patient is mistreated the effect of radiotherapy
could be, more than failure to treat the illness, the potential risk of causing a
new incidence of cancer. It is for this reason there is such a widely accepted
need for systematic error checking and QA throughout the entire treatment
programme of radiotherapy.
2.6.1 Apoptosis - PCD for Multicellular Organisms
This section outlines the effect of ionising radiation on the cells of human
tissue. It is by this mechanism that radiotherapy is used to treat cancer.
Cell apoptosis triggers cell death as a response to a variety of different sig-
nals. This variety of triggers for cell apoptosis is best illustrated by Figure 2.5
[40], and includes; triggering a cell’s death receptors, exposure to certain viral
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Figure 2.5: Common signals that instigate apoptosis in a cell [40].
infections, cell stress like nutrient deprivation, T-cells recognising damage to
the cell, and ionising radiation damaging cell DNA. Apoptosis, otherwise
known as Type I PCD, is a normal process available to multicellular organ-
isms. The apoptotic process enables a cell to instigate its own death in a
controlled and regulated fashion [41]. The sensitivity of a cell to apoptotic
causing stimuli can vary depending on a number of factors, a characteristic
exploited by the medical physicist designing a patient’s treatment.
Ionising radiation can trigger PCD by acting as a mutagen and the expos-
ure of a cell to ionising radiation will result in the frequency of mutation in
the cell’s genetic material to become elevated above the natural background
rate. The damaging effects of radiation induced mutation in a cell’s DNA
can instigate the process of apoptosis in a cell.
The apoptotic effect of ionising radiation on living cells is characterised
by three distinct phases: the physical, the chemical, and the biological. Fig-
ure 2.6 illustrates this point [42]. For an individual cell these three phases
do not overlap, rather they are consecutive, where each subsequent phase is
instigated as a result of the previous phase. The importance of each phase
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Figure 2.6: The 3-stage effect of ionising radiation on cells [42].
occurring exclusive to the others is a contributing reason to why the treat-
ment of cancer with radiotherapy is broken into fractions. Apoptosis in a
cell only occurs once the biological phase is reached and not before. However
apoptosis is only one of three possible outcomes caused by cell exposure to
ionising radiation. To trigger the death of cancer cells enough time is needed
for the ionising radiation to have caused the eventual resulting biological
effect.
Apoptosis: The Physical Phase
In 1923 Arthur Holly Compton described the behaviour of high energy photons
as they interact with matter [43]. Compton scattering is the name given to
a phenomenon exhibited when high energy photons (∼ 25 KeV to 25 MeV)
interact with atoms. Compton scattering describes the inelastic collision
between a photon and an electron. Inelastic scattering is a fundamental
scattering process in which the kinetic energy of an incident particle is not
conserved. Compton observed that when an incoming photon is absorbed
by an orbital electron there is an exchange of energy. Part of the energy of
the incoming photon is transferred into the orbital electron giving it suffi-
cient energy to break from its orbit. The remaining energy is released as an
incident photon of a higher wavelength. Should the incident photon have suf-
ficient energy the process will reoccur on its next interaction with an orbital
electron.
Should the number of electrons orbiting an atom not equal the number
of protons in the nucleus of that atom then that atom will have an electric
charge. The magnitude and polarity of the charge on an atom is determined
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by the ratio of electrons orbiting the nucleus of the atom to the number of
protons within its nucleus of the atom. An atom with an electrical charge is
called an ion. Thus, radiation with sufficient energy interacting with orbital
electrons is referred to as ionising radiation when the energy of the radiation
is sufficient to make ions of the atoms it interacts with.
Compton scattering is the most probable effect expected from photons
produced by a clinical linac for radiotherapy as the energy of photons used
in this medical context range from 50 KeV to 25 MeV. To understand the
consequence of Compton scattering in radiotherapy a closer look at the effects
of Compton scattering amongst atoms within molecules is required.
Apoptosis: The Chemical Phase
A molecule is a group of atoms that share a strong chemical bond. A cova-
lent bond describes a type of strong chemical bond that forms when a pair
of outer-shell orbital electrons is shared between two atoms. When Compton
scattering occurs amongst the orbital electrons of the atoms forming a mo-
lecule then the result is the production of a free radical. A free radical is a
molecule with an atom that has an unpaired outer-shell electron and, there-
fore, a highly reactive molecule due to its chemical imbalance. If an ion is
made of an atom that was originally part of a covalent bond then the bond
those atoms once shared becomes broken.
The chemical effect of ionising radiation is broken into two. First, the
direct effect where the molecules of DNA are damaged directly. Second, the
indirect effect where ionising radiation causes an increase in the number of
highly reactive free radicals within the molecules of the cell. The production
of free radicals is by no means an area of research unexplored [44, 45, 46].
If these free radicals interact with the molecules in the cell’s DNA this can
cause irreversible damage to the cell’s DNA.
Apoptosis: The Biological Phase
The structure of the DNA double helix is shown in Figure 2.7 and highlights
the grouping of molecules in the DNA structure. The illustration of Figure 2.7
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Figure 2.7: Compton scattering in or around DNA molecules will cause
double strand breaks and eventual apoptosis [47].
also highlights ionising radiation as having both a direct and indirect effect
on a cell’s DNA [47].
The effect of free radicals on cell biology is an extensively researched
area of interest for the study of inflammatory diseases and the progression
of cancer [48]. Free radicals, known as reactive oxygen species (ROS) and
reactive nitrogen species (RNS), are known to occur naturally in the human
body. However, unnaturally high quantities of ROS and RNS free radicals
in the body can be a cause of cancer. Despite this fact in radiotherapy the
exploited biological effect of cell exposure to ionising radiation is the eventual
trigger of apoptosis.
The production of free radicals within the cell causes lesions to the mo-
lecules within the cell, and the production of molecular lesions within the
cell triggers an enzymatic response within the cell. The vast majority of
the damage to the integrity of a cell’s molecules (including a cell’s DNA
molecules), caused by ionising radiation, is successfully repaired by the en-
zymatic response of the cell. It is only when the molecular lesions of the cell
are beyond the repair of the cell’s enzymes that apoptosis is triggered within
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the cell. The biological phase is characterised by apoptosis being triggered
within the cell. Cell death is not an immediate response once apoptosis is
triggered. In fact a cell will undergo several more mitotic division before
PCD is achieved.
Figure 2.8: Timescale of apoptosis caused by ionising radiation [49].
For a 1 Gy of absorbed dose of ionising radiation there are in excess of 105
ions causing direct or indirect events that occur within the volume of every
cell of diameter 10 µm, and despite this rate of events occurring when a cell
is exposed to ionising radiation Figure 2.8 highlights just how long it takes
those ions to trigger PCD within a cell [49]. This timescale plot in Figure 2.8
helps to further explain the need for a recovery time between radiotherapy
fractions. Without a break between radiotherapy fractions the cells would
not have enough time to achieve the full intended biological effect of ionising
radiation exposure.
The time it takes for apoptotic cells to disappear in tissue varies depend-
ing on the type of cell being irradiated. The duration of apoptosis is around
three to twelve hours in the cease of the epithelial lining of the small intestine
[50]. It is therefore suggested that the duration of apoptosis is of the same
order of magnitude as the average time it takes to the cell’s DNA to replic-
ate [50]. By that measure the scale of time for a radiation induced apoptotic
response for stomach cancer is around 103 to 104 seconds, as measured on
the plot in Figure 2.8.
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2.6.2 Dose Response Curve
Knowing that apoptosis in cancer cells is the intended effect of exposing a
cancer patient to a source of ionising radiation, and that apoptosis in cancer
cells is a delayed response when cancer cells are exposed to a source of ionising
radiation, there still remains the calculation of the optimum radiation dose
in the treatment of a patient’s cancer.
The probability of ionising radiation triggering apoptosis in an individual
cell is reasonably unpredictable, however, when ionising radiation is target-
ing a cancerous growth/tumour/tissue, where there are several thousands of
malignant cells grouped together, then the outcome is more predictable.
When irradiating a patient’s cancer the response of the target volume
can be characterised by its dose threshold. Should the target volume be ir-
radiated below the dose threshold then the outcome of the treatment will
be no observable clinical effect. Conversely, treat the patient with a dose of
ionising radiation above the dose threshold and a measurable reduction in
tumour size will occur within the target volume. The dose threshold is there-
fore the minimum dose of ionising radiation the medical physicist will want
to expose the patient’s cancer to in order to achieve tumour reduction. The
maximum dose of ionising radiation the medical physicist will want to expose
the patient’s cancer to can be determined by considering the radiosensitivity
of the cancer cells. The radiosensitivity of a cell is a measure of the relative
absorbed dose of ionising radiation necessary to trigger PCD within that cell.
Thus the radiosensitivity is a measure of how sensitive the cells of the target
volume are to ionising radiation, where a greater radiosensitivity of tumour
tissue compared to surrounding healthy tissue is favourable. A greater ra-
diosensitivity of tumour cells will determine the maximum dose of ionising
radiation the medical physicist will want to expose the patient’s cancer to.
Refer to Figure 2.9 and consider again the point that the radiosensitivity
of a cell quantifies the apoptotic response of the cell. The most effective
tumour control achievable is when the dose response curve of the tumour is at
a lower level than the dose response curve of the healthy surrounding tissue.
In this way, a minimum chance of complications due to radiation in healthy
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Figure 2.9: The dose response curve plotting the relative radiosensitivity for
both the tumour cells and the surrounding healthy tissue. D0 is the intended
treatment dose [9].
tissue is observed. The greater the refinement in dose delivery technology
for radiotherapy the smaller the needed separation between the tumour dose
response curve and the healthy tissue response curve. Depending on the
accuracy of the beam of ionising radiation from the linac the greater the
need for separation of the two radiosensitivity plots in Figure 2.9 [51, 52].
Radiotherapeutic success is most probable when the two curves in Figure 2.9
are widely separated [9], in which case a higher dose of radiation can be
delivered to the target volume without damaging neighbouring healthy cells.
Due to the radiocurability of a particular cancer being related to radio-
sensitivity of cancer by comparison to the radiosensitivity of its surrounding
healthy tissue, understanding the reason why cancerous cells are more prone
to the harmful effects of ionising radiation is critical to the treatment techno-
logy. Counting mitotic figures by light microscopy is a commonly practiced
low cost method for estimating tumour proliferation [53], and, as a character-
istic of cancer is the accelerated rate of mitosis, counting the rate of mitosis is
a helpful tool when making a diagnosis. Cancer cells are more sensitive to the
harmful effects of radiation exposure because they are are dividing rapidly,
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and so cells with a lower rate of mitosis tend to have a lower radiosensitivity
threshold [54].
2.7 Dosimeter Technologies
An extensive review of the most popular options for dosimetry in radio-
therapy has been compiled elsewhere [55]. However, for completeness, this
section outlines what alternative types of commercial dosimeters for radio-
therapy are available today. By the end of this section a comparison between
all dosimeters introduced in this section will be included, as will a summary
highlighting where improvements can be made in presently available dosi-
metry technologies.
Broadly speaking dosimeters for radiotherapy can be broken into two
categories; linac calibration, and treatment dosimeters.
Linac calibration and x-y cross sectional profile of the beam are critical
routine system diagnostics made by the medical physicist before any patient
is treated. Typically the linac at an oncology clinic will have a diagnostics’
schedule that will make up part of the routine maintenance of the linac
machine. Like all industrialised precision equipment periodic calibration of
the linac and its beam provide confidence that the equipment will operate
correctly during patient treatment. Commercially available technologies that
are used for calibration of a linac include: the WP34 [56], Figure 2.10(a),
a 1-D water based phantom from IBA Dosimetry that is designed for dose
measurements of a radiation beam with horizontal beam incidence. The
water component of a water phantom will replicate a likeness of a patient’s
composition. Knowing the dimensions of the phantom, the position of the
dosimeter inside the phantom, and the distance the phantom is from the linac,
calibration of the absorbed dose is completed by comparing the measured
dose with the intended dose. The ArcCHECK [57], Figure 2.10(b), from Sun
Nuclear is another pre-treatment dosimeter used by a medical physicist to
calibrate the linac. The profile of the absorbed dose of radiation provided
by a cylindrical calibration unit will more accurately characterise the cross
sectional beam profile for the radiation source. Although the use of these
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(a) Water phantom. (b) Cylindrical detector.
(c) Diode detectors. (d) MOSFET detectors.
(e) Implantable dosimeter.
Figure 2.10: The above listed dosimeters are commercially available solu-
tions suitable for radiation measurement in radiotherapy, including; linac
calibration (Figure 2.10(a) and Figure 2.10(b)), and treatment measurements
(Figure 2.10(c), Figure 2.10(d), and Figure 2.10(e).
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calibration and cross sectional beam profiling dosimeters is necessary for the
upkeep and routine maintenance on a linac they have one major limitation.
This type of dosimeter is not designed to be present during patient treatment
and cannot be used when it comes to the verification of the dose delivered
to the patient under treatment.
The treatment dosimeter is a critical routine verification device used by
the medical physicist during patient treatment to approximate the absorbed
dose of radiation at the target volume. The treatment dosimeter refers to
the commercially available dosimeter used to measure the received dose at
the surface of the patient where the beam of ionising radiation will pass
through. The treatment dosimeter is therefore placed directly above the loc-
ation of the target volume and accurately measures the absorbed dose of
radiation directly above the location of the target volume. The result from
this measurement is then used to mathematically approximate the absorbed
dose of radiation at the target volume. Knowing that the linac gantry is
purposefully designed to rotate around the patient to evenly distribute the
collateral dose of ionising radiation to the surrounding healthy tissue, and
because the treatment dosimeter is positioned directly above the location of
the target volume, this type of dosimeter can only accurately measure the
absorbed dose of radiation when the linac beam passes through an axis in-
cluding the dosimeter. Commercially available treatment dosimeters used
during patient treatment to measure the absorbed dose of radiation directly
above the location of the target volume include: the QED diodes [58], Fig-
ure 2.10(c), developed by from Sun Nuclear. This is an example of a diode
based dosimeter that is taped to the surface of the patient and connected
by a cable to a readout box measuring the absorbed dose of radiation as the
radiation beam passes through it. Another example of a treatment dosimeter
is the mobileMOSFET solution [59], Figure 2.10(d), from Best Medical Ltd.,
a Canadian company that makes this dose verification system. This solu-
tion provides wireless communication between the FGMOSFET device that
is positioned on the body of the patient and the receiver module outside the
treatment room. The medical physicist delivering the treatment can mon-
itor the receiver module and ensure no unintended overdose occurs during
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the patient’s treatment. Although the use of these treatment dosimeters is
practiced in the verification of the dose delivered to the patient under treat-
ment they have one major limitation. This type of dosimeter is designed
to provide an approximation of the absorbed dose of ionising radiation at
the target volume. This type of dosimeter cannot be used to determine the
precise absorbed dose of ionising radiation at the target volume. The approx-
imated absorbed dose of ionising radiation at the target volume is calculated
using a mathematical model.
There is one final commercially available dosimeter that is worth mention-
ing as it embraces the literal meaning of IVD, it is the implantable dosimeter
[60] from Sicel Technologies, Inc. as seen in Figure 2.10(e). The device is
surgically implanted near the tumour, activated before treatment, and ir-
radiated along with the rest of the target volume during treatment. After
treatment, communication is reestablished with the device and the measured
dose at the target volume is reported back. This type of dosimeter provides a
measurement of the absorbed dose of ionising radiation at the target volume.
What’s more, because this dosimeter is implantable, it provides a measure-
ment of the absorbed dose of ionising radiation at the target volume for all
axis the linac gantry will rotate through whilst completing the treatment.
What’s more, if CT imaging is used in conjunction with this technology and
the location of the implanted dosimeter is known with respect to the tumour,
it will verify if the intended dose of ionising radiation has been delivered to
the intended location. This type of implantable wireless technology provides
improved QA in radiotherapy while accommodating the natural movement
of the body’s internal organs.
To provide additional clarity on the relative merits of commercially avail-
able dosimeters for radiotherapy Table 2.1 is included. Table 2.1 is a com-
parison of the different features to each of the established technologies. The
labels across the top of Table 2.1 refer to the different types of commercially
available dosimeters for radiotherapy, and the labels down the left hand side
of Table 2.1 refer to their features. A more complete summary of the list of
features includes:
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Phantom Cylinder Diode MOSFET Sicel
Linac Calibration 3 3
Real-Time 3 3
In Treatment 3 3 3
Wireless 3 3
No Approx. Dose 3
Local Measurement 3
Table 2.1: A comparison of the features between commercially available do-
simeters for radiotherapy.
• Linac Calibration - The dosimeter is used during routine calibration of
the linac.
• Read-Time - The dosimeter can provide measurement of absorbed does
as it is delivered.
• In Treatment - The dosimeter is used whilst the patient is undergoing
treatment and receiving a dose of ionising radiation.
• No Approx. Dose - The dosimeter measures the absorbed dose of ion-
ising radiation at the target volume, and therefore the measured ab-
sorbed dose is not an estimate based on a proximity measurement.
• Target Volume - The dosimeter can occupy a space next to the tumours
growth being treated.
Considering the work carried out for this thesis is towards building a next
generation dosimeter for IVD understanding the merits and short comings
of the established order of dosimeters for radiotherapy is a suitable starting
point when attempting to conceive a better future for QA in radiotherapy.
2.8 Dosimeter Requirements
IVD is a QA technology intended to improve safety in radiotherapy by meas-
uring the absorbed dose of ionising radiation the target volume is exposed to
during a treatment fraction. IVD provides independent verification of dose
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received by the target volume by comparing the intended dose and the meas-
ured absorbed dose. This comparison will confirm if the correct dose was
delivered to the correct location during treatment. Confirmation of intended
dose at the target volume is a QA measure for radiotherapy bringing confid-
ence to both patient and medical physicist that the treatment was successful
without unnecessary risk to the patient’s health.
The work carried out for this thesis is towards building a completely new
and novel dosimeter for IVD that improves on the present standard of QA
in radiotherapy. One of the critical problems with IVD today is that the
majority of dosimeter technologies available on the market do not accurately
measure the absorbed dose at the target volume. Instead an approximation of
the absorbed dose is calculated based on external dosimeters measurement.
To rectify this issue the proposed dosimeter for IVD should be implanted
within the patient’s target volume. In this way IVD will verify; the absorbed
dose of ionising radiation at the target volume, beam accuracy at the target
volume, and treatment accuracy for all fractions. The most popular argument
opposing routine implantable dosimeters for IVD is cost. Thus any new
implantable dosimeter should be cost effective. That means something small
enough that it does not require expensive surgery to be implanted.
A list of requirements for a dosimeter that improves the standards of QA
in radiotherapy includes:
• Extremely small size, ∼ 1 mm3.
• Implantable.
• Target volume proximity, act as seed marker.
• Wireless communication.
• Real-time dose measurement.
• Self powered.
• X-ray and Hadron sensitive.
• Multiple detectors for optimum measurement resolution.
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• Low cost.
A composite particle, like protons and neutrons, are classed as hadron
particles as they are held together by the strong force, whereas atoms and
molecules are held together by the electromagnetic force. As a relative meas-
ure of the difference between the strong force and the electromagnetic force,
at the atomic scale, the strong force is about 100 times greater than the
electromagnetic force.
2.9 Dosimeter Design
This thesis presents the work carried out in two separate studies where each
presented study is investigating one of the four technology areas necessary to
prototype a dosimeter for IVD. The work completed to produce this thesis is
building towards a new type of implantable micro dosimeter for routine use
during radiotherapy treatment and is intended to transform the standards
of QA in radiotherapy by providing a cost effective solution for accurate
measurement of absorbed dose of ionising radiation at the target volume
for each treatment fraction. This section will outline a proposed prototype
design to be used.
To better understand the possible structure of a new and novel implant-
able dosimeter for IVD a high-level block diagram, illustrated in Figure 2.11,
is used to highlight the four key technology areas necessary to prototype such
a device. Presented in Figure 2.11 are four expected components to the pro-
posed dosimeter: a power unit, an electronic unit, a sensing unit, and an RF
unit. The results presented in this thesis are an investigation into potential
technologies that could be used in the sensing unit and the RF unit from the
block diagram of Figure 2.11.
The power unit needs to be a self contained power supply capable of
providing sufficient current to drive the entire circuit for the duration of the
dosimeter’s operation. Some limited work has been completed to date to
address this requirement, namely collaboration with the Cleaner Electronics
Research Group at Brunel University, to include Lithographic Printed Vol-
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Figure 2.11: A high-level block diagram showing the technology areas neces-
sary for a new and novel implantable dosimeter.
taic Cells [61, 62]. An alternative technology of interest includes the thin film
micro-batteries [63, 64]. Given that the actual volume in which the battery
must reside is > 1 mm3 in volume (see Figure 2.12), the calculations pub-
lished by Dudney [63] are interesting. A limiting factor in this work seems
to be the thickness of the cathode film, approximately 5 µm presently. A
thicker cathode film could guarantee 30 µWmm2, a value close to the power
requirements of the micro antenna.
For the electronic unit some work has been completed to date, mainly
exploring VCO technology. Unfortunately work in this area only extends as
far as the characterisation of the commercially available voltage-controlled
oscillator (VCO) from Crystek Microwave [65], the CVCO33CL-0390-0410.
This VCO will produce an oscillating output signal shifting between 310 MHz
and 410 MHz based on the DC bias applied to the tuning voltage pin.
The two remaining units form the basis of the work completed to produce
the results presented in this thesis. The inspiration for the sensing unit tech-
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nology, characterised as part of the work completed and presented within this
thesis, is provided by the accomplishments of the Particle Physics Depart-
ment at RAL in their role to support the detector design for the Compact
Muon Solenoid (CMS) experiment at Large Hadron Collider (LHC), CERN,
and that was to exploit the sensitivity of silicon based detectors under ex-
posure to ionising radiation. For the sensing unit the evaluation of the FG-
MOSFET as a suitable electronic component to measure the absorbed dose
of ionising radiation it has been exposed has been characterised.
The RF unit is the other technology area that has been investigated and
the result from that work are presented later in this thesis. Extensive work
was completed to evaluate and characterise a custom design micro antenna
optimised for the application of implantable medical electronic devices. For
medical electronic devices providing biotelemetry a unique type of wireless
communication is required, a custom designed micro antenna for implant-
able medical electronics which operates with low power consumption, low
data transfer speeds, and over a short range. To complete the necessary
work to evaluate and characterise the optimum antenna for this unique ap-
plication the single-loop and multi-loop antenna design was investigated and
characterised.
Before considering how the proposed dosimeter for IVD will be integrated
into radiotherapy as a tool to modernise the standards of QA in radiotherapy
a quick look at how the block diagram of Figure 2.11 can be abstracted into an
integrated system on a single silicon based circuit is presented in Figure 2.12.
It is clearly shown how the overall design requirement of a 1 mm3 size for the
entire implantable dosimeter is broken into its four technology components
necessary to prototype the new dosimeter. The integrated solution, in the
top right of the image in Figure 2.12, is expanded into a much larger digram
illustrating how each of the four technology components for a new dosimeter
would occupy the proposed volume of no more than 1 mm3. The design
includes two important regions, the radiation sensitive region and the wireless
communication region. This thesis is the presentation of work completed
in both of these areas, the evaluation of the FGMOSFET as a radiation
detector, and the performance of the micro antenna as a communications
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Figure 2.12: An integrated silicon solution for a new implantable dosimeter
including all four technology areas of a functional prototype.
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medium.
For the dosimeter design presented above the antenna is illustrated as a
multi-loop design with a conductive wire trace in the top part first quarter
slice from the device. This graphic is only a guideline about how the device
may be constructed. In practice there may be fabrication issues that dictate
the antenna’s design and the electronics may all share the same layer on an
integrated circuit.
Figure 2.13: A rendering of the new dosimeter as it would be used to improve
QA in radiotherapy.
Figure 2.13 illustrates how this proposed dosimeter for IVD will operate as
part of the QA programme to improve confidence in radiotherapy treatment.
Returning back to the original image in Figrue 2.3 to help contextualise the
application of the proposed dosimeter, Figure 2.13 is a helpful illustration to
better understand the intended use of the implantable dosimeter. From this
image it is possible to understand the role of the dosimeter as a technology
inside the patient within the target volume and with close proximity of the
cancerous growth. The implanted dosimeter will measure the absorbed dose
of ionising radiation the patient is exposed to during treatment and provide
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that information in real-time to the medical physicist. This proposed do-
simeter is about improving QA in radiotherapy by building an implantable
dosimeter that exceeds the performance of the presently available commercial
technologies.
A reasonable consideration at this stage is to ask how any proposed dosi-
meter might be implanted within the patient before treatment. To date there
are a multitude of implantable technologies that are used as routine part of
patient treatment [66]. The mechanism by which they are implanted may
vary widely, from an innocuous injection [67], right through to surgery [68].
Indeed, in some instances, the implanted device can serve multiple purposes.
In the case of the implanted dosimeter the device can act as the radiation
measuring QA technology it is primarily designed for, but also act as a ra-
diographic fiducial marker to identify the location of soft tissue anatomy on
radiographic images used during both the planning and delivery of IGRT
treatment [60]. The precedence and range of implanted medical technology
gives confidence that a proposed dosimeter can be used as described, however
the details regarding how the implantation of the propose dosimeter would
be accomplished is a discussion best suited for when a fully tested prototype
has been demonstrated to work.
2.10 Summary
This chapter has summarised the debate for routine in-vivo dosimetry in
radiotherapy and found in favour of its use. From statistics on incidence
rates in the UK to the potential errors in the treatment procedure of ra-
diotherapy the merits of in-vivo dosimetry to improve quality assurance in
radiotherapy have been presented. Also presented is a comparison of dosi-
meter technologies presently available for radiotherapy and highlighted the
potential benefits from a new enhanced dosimeter, a dosimeter that could
incorporate the best features from each of the established dosimeter tech-
nologies whilst integrating the very latest in detector design to optimise its
performance.
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Chapter 3
Transistor Theory
3.1 Introduction
The work completed for this thesis is towards building a new dosimeter for
IVD, an instrument that needs to be capable of measuring a typical dose of
ionising radiation a cancer patient is exposed to while undergoing a course
of radiotherapy. To do this the new dosimeter will need to be sensitive to
ionising radiation, respond reliably when exposed to ionising radiation, and
be capable of electronically communicating the amount of ionising radiation
it has been exposed to. This chapter presents a detailed explanation of what
type of electronic component can be used as a radiation sensitive compon-
ent and how that component is capable of measuring the absorbed dose of
ionising radiation it is exposed to. However, before this practical application
for an electronic dosimeter can be understood an overview of the supporting
theory is necessary.
This chapter will begin with an overview of the chemistry of silicon and
its structure. Following this is an explanation on the manipulation of pure
silicon to favourably alter its chemical properties and fabricate doped silicon.
Depending on the arrangement of this altered silicon it will form a variety of
different electronic components all with their own unique applications and
varying levels of complexity in behaviour. This theory forms the necessary
fundamental working knowledge required to understand how a silicon based
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electronic component can be used to predictably measure its exposure to
ionising radiation.
The theory content of this chapter is well established and extensively
documented elsewhere [69, 70].
3.2 Silicon
Silicon is the 14th element on the periodic table. It is a semiconductor with
an atomic number of 14, an atomic weight of 28.09, and the symbol Si.
Figure 3.1 provides an expression for this information. Silicon is the second
most abundant element in the Earth’s crust and in the form of silica it is
used in glasses, cements, and ceramics.
(a) Element. (b) Bohr diagram. (c) Lattice structure.
Figure 3.1: Silicon, the scientific description. Figure 3.1(a) as it appears
on the periodic table. Figure 3.1(b) the Bohr diagram of the element. Fig-
ure 3.1(c) the lattice structure for intrinsic silicon.
Niels Bohr was a Nobel prize winning Danish physicist who history re-
cognises for his contributions to, amongst other things, the understanding
of atomic structure. In 1913 Bohr introduced an improved model for the
structure of an atom that better describes the composition of the atom in-
cluding the relationship between the nucleus and orbital electrons of an atom
[71, 72, 73]. This model has become known as the Bohr model and will be
used throughout this chapter. From Figure 3.1(b) the Bohr diagram illus-
trates the arrangement of orbital electrons around the nucleus of the sil-
icon atom. From this illustration it becomes clear how the silicon element
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is an electrically neutral atom with 14 negatively charged orbital electrons
equalling the 14 positively charged protons within its nucleus. However in
this configuration the silicon atom still requires a further four additional
orbital electrons to make the atom a chemically neutral atom.
The element silicon, being without a full compliment of outer shell or-
bital electrons, is a reactive element on its own. But, in nature, silicon is
commonly found bound to other silicon atoms and not bound with other
elements through strong chemical bonds. To understand how silicon atoms
bind with other silicon atoms so readily in nature a closer look is needed at
the predicted behaviour of a single silicon atom as it neighbours other silicon
atoms. The arrangement is illustrated in detail in Figure 3.1(c).
Figure 3.2: A 3-D illustration of the silicon lattice and is described to have
a diamond cubic crystal structure [74].
Consider again the Bohr diagram from Figure 3.1(b) [74]. For the silicon
atom to become chemically neutral it requires a full compliment of electrons
to occupy its outer shell, a total of eight orbital electrons in all. A cova-
lent bond is a bond between two atoms by sharing an outer orbital electron
between the atoms. A covalent double bond is a bond between two atoms
where each atom shares an outer orbital electron and, as a result, each atom
gains an additional orbital electron for its outer shell while forming a strong
chemical bond between each another.
The valency of the silicon atom is four and as such a single silicon atom
requires an additional four orbital electrons to become chemically neutral.
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If a single silicon atom has four neighbouring silicon atoms that each share
one of their outer electrons in a covalent bond then the original silicon atom
will have a full compliment of outer shell electrons. If this arrangement is
maintained throughout the lattice all atoms form a diamond cubic crystal
structure through strong chemical bonds. Depicted in Figure 3.2 this regular
tetrahedral structure is both chemically and electrically neutral.
The electrical neutrality of a silicon lattice with four covalent double
bonds is a point that should be explained fully. The overall number of orbital
electrons in the outer shell of any single silicon atom has changed from four
to eight. However for each of the additional orbital electrons a single silicon
atom gains so too does it gain a strong chemical bond with a neighbouring
silicon atom. That neighbouring silicon atom has its own protons in its
own nucleus. As such the total number of electrons and protons within the
intrinsic silicon lattice has remained equal. Thus the potential difference
charge across the silicon lattice is 0. So the four covalent double bonds bring
a single silicon atom four additional shared orbital electrons for its outer shell
granting the silicon atom chemical neutrality whilst also leaving the electrical
potential of the atom unchanged.
When silicon forms a pure lattice, i.e. without any impurities, it is referred
to as intrinsic silicon. Since all the orbital electrons of intrinsic silicon are
firmly held in strong chemical bonds there are no electrons free to conduct
electricity at temperatures close to absolute zero. Thus intrinsic silicon at
absolute zero acts as a perfect insulator.
3.2.1 Holes and Free-Electrons
The energy band gap is the minimum energy an electron needs to move from
the valence band to the conduction band. The valence band refers to the
highest energy electrons still bound to an atom at temperatures approaching
absolute zero. The conduction band is the level required for an electron to
escape its binding with its parent atom. An electron in the conduction band
is free to conduct electricity.
The energy band gap is given by the symbol Eg. Should an outer shell
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electron of an atom acquire this energy it will move from its orbit about the
nucleus and become a mobile charge carrier able to move freely within the
material. The magnitude of energy to cross the band gap is therefore a factor
that determines the electrical conductivity of a material. Insulators typically
have a large energy band gap. Conduction of charge carriers in a conductive
material depends on partly filled bonds [74]. For silicon Eg = 1.12 eV at
302 K.
If an outer shell orbital electron of a silicon atom is able to move from the
valence band to the conduction band it will become free to move within the
lattice. The direction of movement of this electron is unpredictable unless it
is under the influence of an electric field. An electron free to move in this way
is called a free-electron. For the parent atom the free-electron has migrated
away resulting in a vacancy to re-complete the outer shell valency. This
absence in the parent atom’s outer shell is known as a hole. The process
where an outer shell orbital electron migrates away from its parent atom
after acquiring the necessary energy to cross the band gap threshold is known
as electron-hole pair generation. Electrons can fall spontaneously from the
conduction band into the valence band, and should this happen it is referred
to as recombination. The period during which both holes and free-electrons
can conduct electricity independently is limited by the rate of recombination.
Electron density is the measure of the probability of an electron being
present at a specific location. Free-electron density is the number of free-
electrons per unit volume and given the symbol n. Hole density is the num-
ber of holes per unit volume and is given the symbol p. Within intrinsic
silicon the process of electron-hole pair generation and recombination oc-
cur continuously such that there is an equilibrium between the number of
holes and the number of free-electrons within the lattice. A semiconductor
is therefore under equilibrium conditions when the rate of electron-hole pair
generation is equal to the rate of recombination. The free-electron dens-
ity under equilibrium conditions is denoted by n0, and hole density under
equilibrium conditions is denoted by p0.
n0 = p0 (3.1)
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If the condition for Equation 3.1 is met it is referred to as the intrinsic
carrier density of a material and is given the symbol ni. Equation 3.2 is a
mathematical description of the intrinsic carrier density.
n0p0 = n
2
i = NcNve
−Eg
kT (3.2)
The terms of Equation 3.2 include; k for Boltzmann’s constant, T is the
absolute temperature in Kelvin, and Nc and Nv are the effective density of
states for the conduction and valency band respectively. From Equation 3.2
it can be seen the expression e
−Eg
kT describes the electron-hole generation rate
(Rgen), ignoring the necessary material dependent constant:
Rgen ∝ e
−Eg
kT (3.3)
The intrinsic carrier density is the product of hole density and free-
electron density because the probability of recombination, where a free-
electron falls into a hole, depends on the density of holes available and the
density of the free-electrons available. The net average recombination rate is
defined by:
Rrec ∝ p0n0 (3.4)
The assumption of intrinsic silicon is that the electron-hole generation
rate is equal to the recombination rate (Rrec), and is the product of thermal
agitation, i.e. Rrec = Rgen. Thus the intrinsic carrier density can be charac-
terised as:
n2i ∝ e
−Eg
kT (3.5)
3.2.2 Diffusion and Drift
With intrinsic silicon there are two mechanisms by which hole and free-
electrons can move through silicon.
Diffusion is the name given to the movement of either holes or free-
electrons within a silicon crystal. There are two possible reasons for diffusion
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within a silicon lattice. Thermal diffusion, as the name suggests, is an effect
that does not occur when the silicon lattice is at temperatures close to ab-
solute zero, only at temperatures above 0 K. As the temperature of a silicon
lattice increases so too does the probability of an orbital electron escaping its
parent silicon atom. The vacancy left behind by the migrating free-electron
is a hole. Within intrinsic silicon the electron-hole formation due to thermal
diffusion results in no net flow of charge. This is because electron-hole pairs
formed by thermal energy do not change the potential difference across the
silicon lattice despite it changing the local charge of a particular silicon atom.
However consider the situation where the concentration of free-electrons
within a silicon lattice is particularly high compared to the surrounding re-
gion. If there are no other forces influencing the charge on the silicon lattice
as a whole then the region of highly concentrated free-electrons will naturally
diffuse into the regions of lower free-electron concentration. The result will
be for the concentration of free-electrons to become as uniform as possible
throughout the silicon lattice. The same is true for a concentration of holes
within the silicon structure. The movement of charge in this manner is know
as diffusion current.
Jp = −qDp dp
dx
(3.6)
Jn = qDn
dn
dx
(3.7)
Equation 3.6 and Equation 3.7 describe the diffusion current within a
silicon crystal where: J is the current density, q is the charge of an electron,
D is the diffusion constant, and x is the direction of the diffusion current. p
and n denote holes and free-electrons concentrations respectively. The sign
in each equation shows the direction of movement of the charge.
Drift is the other mechanism by which charge moves within a silicon
lattice. Carrier drift refers to the movement of charge under the influence
of an electric field. The drift velocity of free-electrons and holes in a silicon
crystal is a function of the electric field strength and given by Equation 3.8
and Equation 3.9.
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vdrift = µpE (3.8)
vdrift = −µnE (3.9)
E is the electric field strength and µp is the mobility of holes. For the drift
velocity of free-electrons Equation 3.9 has µn in place of µp, and the direction
of travel is opposite to that for Equation 3.8 . The mobility of free-electrons
in the conduction band is greater than the mobility of holes in the valence
band by a factor of 10. The velocity of these charge carriers is determined
by the electric field strength. Mobility is the constant of proportionality
between the velocity of the charge carrier and the electric field strength, and
is given the symbol µ.
If there is a higher concentration of either holes or free-electrons within a
silicon lattice the region of high concentration will naturally drift to the region
of low concentration to form an even concentration of charge throughout the
silicon lattice.
An electron requires less energy to fill the hole of a neighbouring atom
compared to the energy band gap an orbital electron needs to move from the
valance band to the conduction band. As such, although free-electrons are
free to conduct electricity in the space between atoms, the holes are free to
conduct electricity quite independently within the lattice.
Holes carry a positive charge equal in magnitude to the negative charge
of an electron. The electric current flow of free-electrons is within the con-
duction band and the electric current flow of holes is within the valence
band. Effectively within a semiconductor there are two clouds of charge, one
through the conduction band and the other through the valence band.
The mobility of free-electrons in silicon is considerably greater than the
mobility of free-electrons in a good metallic conductor. The mobility of free-
electrons in copper is 0.0035 m2V−1s−1, and the mobility of free-electrons in
silicon is 0.15 m2V−1s−1, making free-electrons in silicon more than 40 times
more mobile than free-electrons in copper. It would be easy to assume, there-
fore, that silicon would be a far more effective conductor of electricity. How-
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ever, at room temperature, the number of free-electrons in copper is many
times more than that of silicon, making copper a far better conductor. At
room temperature the number of charge carriers within a metallic conductor
like copper is at least equal to the number of atoms within that material.
The number of atoms per unit volume between silicon and copper is about
the same. For intrinsic silicon fewer than one free charge carrier per million
atoms is expected.
3.2.3 Doping Silicon with Impurities
Intrinsic silicon, as discussed in Section 3.2, is a chemically and electrically
neutral compound. Doping is the process of intentionally introducing im-
purity atoms to extremely pure silicon. The introduction of these impurities
is intended to alter the chemical behaviour of intrinsic silicon and change it
from a semiconductor to a doped semicondcutor.
The impurity elements are deliberately chosen as elements that will fit
the lattice structure the silicon without changing the chemical structure of
the lattice. Therefore the silicon lattice retains its diamond cubic crystal
structure and, more importantly, it remains a stable compound.
The level of doping is also deliberate. The quantity of impurity atoms will
be chosen depending on the required number of additional majority carriers.
Heavily doped and lightly doped silicon are necessary depending on their
intended application. Light and moderately doped silicon are referred to as
extrinsic. Silicon doped to such high levels that it acts more like a conductor
than a semiconductor is referred to as degenerate.
Silicon is doped always to alter the density of charge carriers within the
silicon. The charge carriers are either holes or free-electrons. Doping silicon
to introduce an increased density of holes is to create a p-type material, and
doping silicon to introduce an increased density of free-electrons is to create
a n-type material. p-type for positively charged doped silicon and n-type for
negatively charged doped silicon.
Where intrinsic silicon has an equal number of charge carriers doped
silicon has majority carriers and minority carriers. For a p-type material
46
the addition of a higher concentration of holes makes the holes the majority
carriers and the free-electrons minority carriers. The opposite is true for
n-type material, with the free-electrons of the n-type material being the
majority carriers and the holes being the minority carriers.
p-type silicon
(a) Element. (b) Bohr diagram. (c) Lattice structure.
Figure 3.3: Boron, the scientific description. Figure 3.3(a) as it appears on
the periodic table. Figure 3.3(b) the Bohr diagram of the element. Fig-
ure 3.3(b) the lattice structure for p-type doped silicon.
Every trivalent impurity atom added to a silicon lattice introduces a hole
to the crystalline structure. To create p-type material a uniform distribution
of trivalent impurity atoms are added throughout intrinsic silicon. The level
of doping achieved is determined by the concentration of trivalent impurity
atoms added to the intrinsic silicon. A trivalent atom is one that has three
orbital electrons in its outer shell.
Boron is a typical trivalent impurity atom used for the p-type doping
of intrinsic silicon. Figure 3.3(c) depicts how the trivalent impurity atom
fits into the silicon lattice without dramatically altering the structure of the
lattice. The greater the concentration of trivalent atoms throughout the
intrinsic silicon the more additional holes become available within the p-
type material. This addition of holes is independent of the holes created by
thermal agitation. The trivalent impurity atom is called an acceptor atom
and is given the symbol NA.
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n-type silicon
(a) Element. (b) Bohr diagram. (c) Lattice structure.
Figure 3.4: Phosphorus, the scientific description. Figure 3.4(a) as it ap-
pears on the periodic table. Figure 3.4(b) the Bohr diagram of the element.
Figure 3.4(c) the lattice structure for n-type doped silicon.
Every pentavalent impurity atom added to a silicon lattice introduces a
free-electron to the crystalline structure. To create n-type material a uniform
distribution of pentavalent impurity atoms are added throughout intrinsic
silicon. The level of doping achieved is determined by the concentration of
pentavalent impurity atoms added to the intrinsic silicon. A pentavalent
atom is one that has five orbital electrons in its outer shell.
Phosphorus is a typical pentavalent impurity atom used for the n-type
doping of intrinsic silicon. Figure 3.4(c) depicts how the pentavalent impurity
atom fits into the silicon lattice without dramatically altering the structure of
the lattice. The greater the concentration of pentavalent atoms throughout
the intrinsic silicon the more additional holes become available within the
n-type material. This addition of free-electrons is independent of the free-
electrons created by thermal agitation. The pentavalent impurity atom is
called donor atom and is given the symbol ND.
Properties of doped silicon
An alteration to the charge carrier mobility within the silicon lattice will only
occur in heavily doped silicon, transforming intrinsic silicon into a p-type or
an n-type material. The heavier the doping of the silicon the greater the
48
reduction of mobility to the charge carriers of the lattice. However just as
copper is known as a good conductor of electricity by virtue of its available
charge carriers so too does the semiconductor become an improved conductor
of electricity by the introduction of charge carriers in greater densities. The
greater the doping the closer to a pure conductor the semiconductor becomes.
For the doping of intrinsic silicon to transform the silicon into a useful
semiconductor the number of introduced majority carriers should roughly
make up all the majority carriers at thermal equilibrium such that, n0 ≈ ND
or p0 ≈ NA.
A point worth noting at this stage is the electrical neutrality of the doped
silicon remains unchanged.
Boron, acting as a trivalent impurity atom, is used to create excess holes
within the p-type material. A majority of holes within the doped silicon
makes holes the majority carriers of that doped silicon. The boron atom,
in isolation, has 5 protons in its nucleus and 5 orbital electrons around its
nucleus. With the introduction of a boron atom as an impurity atom into a
silicon lattice the boron atom will form a covalent double bond between each
of its outermost orbital electrons, three in total, and the outermost orbital
electrons of neighbouring silicon atoms. As the introduced impurity atom,
boron, forms a covalent double bond with only 3 of its orbital electrons a
neighbouring silicon atom is short of an orbital electron to form a covalent
double bond with. This deficit of 1 orbital electron within the lattice is
referred to as the ‘hole’ within the p-type material.
Phosphors, acting as a pentavalent impurity atom, is used to create excess
free-electrons within the n-type material. A majority of free-electrons within
the doped silicon makes free-electrons the majority carriers of that doped
silicon. The phosphors atom, in isolation, has 15 protons in its nucleus, and
15 orbital electrons around its nucleus. With the introduction of a phosphors
atom as an impurity atom into a silicon lattice the phosphors atom will from a
covalent double bond between four of its outermost orbital electrons and the
outermost orbital electrons of neighbouring silicon atoms. As the introduced
impurity atom, phosphors, forms a covalent double bond with only 4 of its 5
outermost orbital electrons there is an excess of one orbital electron without
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a neighbouring silicon lattice to form a covalent double bond. This addition
of 1 extra electron within the lattice is referred to as the ‘free-electron’ within
the n-type material.
The total number of protons and electrons across the doped silicon re-
mains equal. The potential difference across the doped lattice remains at 0.
This electrical neutrality of the doped silicon lattice shall prove to be a crit-
ical point when it comes to understanding the behaviour of the p-n junction,
where the p-type and the n-type material are arranged side by side.
3.3 Diode
When p-type and n-type doped silicon are brought together it makes for a
passive electronic component called a diode. A schematic showing the elec-
trical symbol of the diode is illustrated in Figure 3.5(a) and the p-n junction
is given in Figure 3.5(b). To better understand the electrical characteristics
of the diode it helps to consider the behaviour of the junction between the
p-type and n-type material when forming a p-n junction.
(a) Electrical symbol. (b) p-n junction.
Figure 3.5: The diode. Figure 3.5(a) is the symbol for the diode as it appears
in a circuit diagram. Figure 3.5(b) shows the p-n junction of the component.
3.3.1 Electrostatic p-n Junction
Remember for both the p-type and n-type doped silicon the electrical neut-
rality characteristic of the intrinsic silicon lattice is preserved. Although the
p-type material has been doped to have a higher concentration of holes to act
as majority carriers, the overall ratio of electrons to protons is the same. Just
as it is with the n-type material, despite the free-electron doping, the ratio
of electrons to protons is approximately equal. The consequence is electrical
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neutrality across doped silicon. Additionally, assuming no electric field and
the uniform distribution of thermal energy, the distribution of any holes or
free-electrons is uniform. It is important to keep both these ideas in mind
when inspecting the boundary between the p-type and the n-type material
in a p-n junction as depicted in Figure 3.6.
When the p-type and the n-type doped silicon are brought together there
is suddenly an uneven concentration of majority carriers along the boundary
of the two materials. The high concentration of holes from the p-type ma-
terial defuse across into the n-type material, and the high concentration of
free-electrons from the n-type material defuse across into the p-type matieral.
As such the free electrons of the n-type doped silicon diffuse across the
junction border into the p-type region. Once there the free-electrons will be
absorbed into the trivalent atom’s outer shell and recombination will occur.
The movement of the majority carriers from the n-type material is through
the conduction band.
Equally the holes from the p-type region diffuse across the junction bor-
der into the n-type region. Once there the holes will be absorbed into the
pentavalent atom’s outer shell and recombination will occur. The movement
of the majority carriers from the p-type material is through the valence band.
The consequence of this electrostatic movement is two fold. Firstly, the
region of the doped silicon nearest the junction border will suddenly become
depleted of its majority carriers. Secondly, the movement of holes away from
the trivalent acceptor atoms of the p-type material will leave the acceptor
atoms electrically unbalanced. Suddenly the acceptor atoms have had their
holes filled in their valence band and thus become negatively charged. Just
as the movement of free-electrons away from the pentavalent donor atoms
of the n-type material will leave the donor atoms electorally unbalanced.
Suddenly the donor atoms have had their free-electrons removed in their
conduction band and thus become positively charged. The region surround-
ing the junction border that has consequently become charged is referred to
as the depletion region.
This process of majority carrier diffusion will continue until the depletion
region of uncovered charge becomes a potential barrier too great for the
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Figure 3.6: The diode’s p-n junction under electrostatic conditions. The top
image is an illustration of the electrostatic charge distribution for the p-n
junction of the diode. The three lower plots describe across the space charge
region: the charge, electric field, and potential difference.
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migration of the majority carriers. The mobility of free-electrons is greater
than the mobility of holes. As such more free-electrons diffuse from the n-
type into the p-type than holes diffuse from the p-type into the n-type. This
is illustrated in Figure 3.6 by the size of either region of uncovered charge.
The formation of the depletion region is a lending insight when the char-
acteristics of the diode are studied with an applied electric field.
3.3.2 p-n Junction Capacitance
When a p-n junction is reverse biased the depletion region acts as a dielectric.
The conducting p-type and n-type outside the depletion region act as the
electrodes of a capacitor. In this way a reverse biased p-n junction has a
capacitance.
The capacitance of the p-n junction is maximum when the applied reverse
voltage is zero because this is when the width of depletion region is minimum.
As the reverse bias voltage is increased the depletion region increases and the
capacitance decreases.
Cj =
εsA
xd
(3.10)
The junction capacitance is modelled using the expression for the parallel
plate capacitor. εs is the permittivity of silicon for the junction, A is the
surface area of either side to the boundary of the depletion region, and xd
is the depletion layer width. The last term in the equation indicates that
the expression of a parallel plate capacitor still applies. Any variation of the
charge within a p-n junction of the diode that has an applied voltage across
it causes a capacitance which should be included in any circuit model of a
p-n junction.
The diode itself is a useful electronic component in its own right. However
the use of the p-n junction only begins with diodes. The electrostatic analysis
of a p-n junction helps to obtain the capacitance-voltage characteristic of the
diode and this understanding builds the foundation of information necessary
to understand the floating-gate metal oxide field effective transistor. By this
comment, consider the structure of a more complex complement, the n-p-n
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junction transistor. In this formation an outer n-type and the middle p-
type form p-n junction, and the opposite outer n-type and the same shared
middle p-type form a second p-n junction. The entire structure forms an
active component, the transistor, and the FGMOSFET is a n-p-n junction
transistor. Within the n-p-n transistor there are p-n junction capacitances
that must always be considered when designing circuits with these silicon
devices.
3.4 Floating-Gate MOSFET
The presented theory thus far in this chapter has explained how doped silicon
can be used to form a two terminal electronic component, the diode. The
next stage is to explore how doped silicon can be used to form a three terminal
device, the transistor.
The FGMOSFET is a type of three terminal transistor device, and is ul-
timately the recommended electronic component that should be used when
working towards an implantable electronic dosimeter for IVD. The attributes
that make the floating-gate transistor suitable in the design of an implant-
able in-vivo dosimeter are presented in Section 3.4.4. However, before the
FGMOSFET can be understood as an electronic component, it is best to
begin by studying the MOSFET device.
3.4.1 MOSFET
This section will start with an overview of the physical structure to the
MOSFET device, and continue by explaining just how the different voltages
applied to the MOSFET can manipulate the behaviour of the MOSFET.
To understand how the MOSFET works consider the MOSFET as a three
terminal device where the current through the device is regulated by a voltage
across the device.
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Figure 3.7: The silicon structure of the MOSFET device.
MOSFET Structure
The MOSFET is an electronic component made from doped silicon. Two
regions of n-type heavily doped silicon are embedded at either end of a sub-
strate of p-type doped silicon. This configuration makes the MOSFET a
three terminal device but it does not describe the entire structure of the
component. Having two regions of n-type heavily doped silicon between a
region of p-type doped silicon makes the three terminal MOSFET two back-
to-back diodes. As much is illustrated in Figure 3.7 where the ‘+’ of the n+
symbol denotes a heavily doped material.
Under electrostatic conditions the border of the p-n junction will have
a depletion region devoid of majority carriers and, as with any electrostatic
p-n junction, each depletion region will act as a dielectric of its own adding
unwanted, but unavoidable, capacitances between the junctions of the device.
Regarding the remaining structure of the MOSFET a layer of silicon
dioxide (SiO2) is grown atop of the transistor covering part of either n
+
region and all of the p-type region between. Silicon dioxide is an insulator.
Four electrodes are added to the device to interact with the transistor. The
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source and drain electrodes are metallic nodes at either n+, and, for now,
which side is which does not matter. However the source should always be at
lower electrical potential than the drain for the device to operate correctly.
A third electrode is placed above the silicon dioxide region with a conductive
plate covering the region. This metallic electrode is known as the gate. The
remaining electrode is the bulk and it is located beneath the p-type substrate.
MOSFET Gate Voltage
Figure 3.8: How a potential applied to VGS effects the MOSFET.
The DC bias voltage at the gate is abbreviated to VGS as it is the potential
between the gate and the source junction. To understand what effect VGS has
on a MOSFET Figure 3.8 illustrates a circuit that has little use outside of
this theoretical context. The source, drain, and bulk electrode are at ground,
and VGS has an electric potential applied to it. Applying a positive potential
to the gate electrode in this way will cause a build-up of positive charge on
the gate’s conductive plate above the silicon dioxide region. This build-up of
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positive charge will repel any majority carriers that may have been directly
beneath the silicon dioxide region of the gate. The region directly below
the silicon dioxide layer is known as the channel. As the majority carriers
of the channel region migrate away into the substrate their impurity atoms
become negatively charged. This uncovered negative charge in the channel
region is directly proportional to the quantity of repelled majority carriers.
In addition to the uncovered negative charge the majority carriers from the
two heavily doped neighbouring n-type regions will migrate into the channel
adding to the overall negative charge of the channel.
Having a layer of free-electrons flood the channel is why the channel is
sometimes referred to as the inversion layer. Now that the gate electrode is
positively charged and the inversion layer has become negatively charged by
the introduced free-electrons, the result is a type of parallel plate capacitor
where the silicon dioxide acts as the dielectric. Invisible electric field lines
pass from the gate electrode, through the silicon dioxide layer, to the inversion
layer. This electric field works to create a uniform distribution of the free-
electrons through the depletion region.
Until a sufficient density of free-electrons accumulate throughout the
channel there will not be a conductive link between the drain and the source
electrodes. Should the channel have the required density of free-electrons
throughout the entire channel region then a positive potential applied to the
drain electrode would cause a flow of current from the drain to the source.
When the MOSFET is conducting from the drain to source in this way it is
said to be on, and the potential on VGS to turn-on the MOSFET is referred
to as the threshold voltage, abbreviated to VTh.
MOSFET Drain Voltage
Figure 3.9 shows there are two types of VDS voltage to consider to best
understand the effect of VDS on the behaviour of the MOSFET, VDS at low
voltages and VDS at high voltages. In both examples the bulk and source are
at ground, and VGS = VTh (i.e. the transistor is on).
With VDS at low voltages the effects are depicted in Figure 3.9(a). The
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(a) VDS at low voltages.
(b) VDS at higher voltages.
Figure 3.9: The above two images illustrate how both a low, Figure 3.9(a),
and high, Figure 3.9(b), potential applied to VDS will effect the transistor
differently based on a fixed VGS. Notice at a high VDS the channel shape is
altered due to the lack of a uniform electric field from VGS.
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channel has sufficient free-electrons to move through the channel from the
source to the drain under the influence of the electric potential on VDS.
In Figure 3.9(a) iD is drawn in the direction of conventional current. The
magnitude of iD depends on the density of free-electrons in the channel which,
as explained before, is regulated by VDS. With VGS > VTh then iD > 0, and
as VGS increases iD increases for a fixed VDS.
With VDS at higher voltages the effects are depicted in Figure 3.9(b). The
channel still has sufficient free-electrons with VGS > VTh, however the shape
of the channel is no longer uniform. With an increase in VDS the electric
field in the channel has changed. Although VGS works to induce a uniform
distribution of free-electrons in the channel with a higher VDS voltage the
effect of the electric field from VDS tapers the channel. As such as VDS
increases with a fixed VGS then iD will increase to a point until iD reaches
a maximum value. Despite any additional increase to VDS the iD flow will
remain unchanged and the transistor is said to be in saturation.
iD =
1
2
µnCox
W
L
(VGS − VTh)2 (3.11)
From Equation 3.11 it is clear the simplest approach to configuring a
MOSFET is to set VGS to the required value to provide the desired iD value.
From Equation 3.11 iD is the current in the channel, Cox is the capacitance of
the silicon dioxide region, µn is the mobility of electrons in the channel, and
the W and L arguments are the width and length dimensions of the channel
region. VTh, Cox, and
W
L
vary widely among devices between manufactur-
ers. VTh and µn are dependent on temperature with the consequence that
when VGS is at a fixed value iD becomes dependent on temperature. This is
something worth considering when designing a MOSFET circuit.
MOSFET Applications
As a three terminal device the MOSFET, like all transistors, is able to control
the flow of current by the use of an electric potential. This behaviour has
two immediate practical functions, one in the analogue domain and the other
in the digital domain.
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Analogue applications of the MOSFET are much the same as they are
for any transistor. The MOSFET device can be used as a current source for
a circuit [75]. However the primary application for the MOSFET is as an
amplifier [76]. To configure a MOSFET as an amplifier first the operating
range must be identified. VGS is biased with a DC voltage chosen such that it
sits within the liner region of the iD-VDS plot whilst providing enough swing
for the input signal such that distortion is avoided. The same is true for the
biasing of VDS. In this set up the VGS is the input of the transistor and the
output is taken from the drain. The measure of amplification achievable with
a transistor is called the gain. In this mode of operation the MOSFET will
act between the state of low current flow and high current flow through the
channel.
The digital applications of the MOSFET are several. Should the flow of
current transition from high to low, caused by an appropriate voltage bias,
the MOSFET can act as a switch. If the high and low states of current flow
are mapped as logic states then the MOSFET can act as a digital switch in a
logic circuit [77]. Using the same characteristics of the MOSFET the device
can be used as a memory device. However, in this type of memory device
the memory is volatile and as such the transistor must always have a voltage
supply to preserve the memory’s state.
3.4.2 Floating-Gate MOSFET
The FGMOSFET is a transistor that is structurally similar to the MOSFET.
The difference between the MOSFET and the FGMOSFET is the FGMOS-
FET has a floating-gate embedded within the silicon dioxide region and the
MOSFET does not. Since the floating-gate is completely surrounded by a
highly resistive material any charge within the floating-gate is electrically
isolated and the charge within the floating-gate is said to be trapped. Whilst
the transistor is under normal operation the trapped charge has no means of
migrating away from the floating-gate.
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Electron and Hole Injection
The internal emission of carriers in insulators has achieved some importance
in the application of electron and hole injection in FGMOSFET devices. The
process can be used to charge or discharge traps in the silicon dioxide region
of the transistor, and provide a partial simulation of high-energy radiation
[78]. With the internal photoemission approach light is used to excite charge
carries [79], where electrons from the conduction band of the silicon migrate
from the SiO2 and travel through the oxide [80]. Alternatively an AC field
across the silicon can be used to induce the avalanche process, causing the
injection of hot-carriers [79]. By the avalanche approach, of the resulting
hot-electrons and hot-holes, some of the charge carries have sufficient energy
to cross the Si - SiO2 barrier and migrate through the transistor.
In order to trap charge in the floating-gate region of the transistor the
device needs to be programmed. Programming of the ALD1123E package,
the transistor package under test, would exploit the avalanche approach of
introducing hot-carriers from the SiO2 region. Typical mechanisms of pro-
gramming the FGMOSFET are to use the Fowler-Nordheim tunnelling [81]
and hot-carrier injection techniques. To load charge into the floating-gate a
specific voltage is applied to VGS in order to induce hot carriers that become
trapped in the floating-gate.
Trapped Charge on the Floating-Gate
The addition of trapped charge on the floating-gate alters the electrical char-
acteristics of the device. A FGMOSFET, as with any MOFSET transistor,
has an ‘on’ voltage that is required in order to induce an inversion layer un-
der the SiO2 region of the transistor. The ‘on’ voltage is referred to as the
threshold voltage, VTh, as it is voltage necessary before the transistor will
pass current from the drain to the source, the threshold before which the
transistor is ‘off’. The VTh voltage the MOSFET requires should be applied
to the VGS of the device.
By virtue of the trapped charge of the floating-gate the necessary VTh
changes for the transistor. For an n-p-n device, where the the inversion
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layer is made up from electrons that migrate away from the heavily doped
n+ regions and into the p-type substrate, the inversion layer is formed by
the influence of the electric potential applied to the gate junction of the
transistor. If the floating-gate of the n-p-n device if loaded with trapped
electrons then the required bias on VGS increases accordingly.
FGMOSFET Structure
Figure 3.10: The structure of the FGMOSFET device.
The first report of a FGMOSFET was made in 1967 [82]. The first inten-
ded applications for the transistor was to store digital data in an EEPROM,
EPROM, and FLASH memories. Alternative applications for the FGMOS-
FET started to crop up once electron tunnelling in a standard CMOS double
poly was introduced [83]. With its introduction a cost effective means of
building FGMOSFET devices was established and this allowed many re-
searchers to investigate FGMOSFET concepts without requiring access to
specialised fabrication processes.
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Applications of the FGMOSFET
The digital application of the FGMOSFET is to use the FGMOSFET as a
logic state device. If the gate of a p-type FGMOSFET is fully loaded with
electrons then the necessary VTh to turn on the transistor increases. This
could be indicative of a logic 0, or an off state. However, if the gate is
completely devoid of all trapped charge then the necessary VTh to turn-on
the transistor decreases. This could be indicative of a logic 1, or an on state.
The ability of the FGMOSFET to store charge within its floating-gate does
give it a powerful use as a logic state device. However, it is the ability of the
FGMOSFET to remember its state even after the power supply to the device
has been withdrawn that gives the FGMOSFET its real value as a digital
competent. The FGMOSFET is a non-volatile store of a logic state. The
common application of the FGMOSFET is within flash memory like that
found in a USB pen drive used for data storage.
The analogue application of the FGMOSFET device is the reason why
the FGMOSFET can potentially be used as a radiation measurement device.
The analogue application of the FGMOSFET device looks to manipulate
the stored charge trapped in the floating-gate by the influence of ionising
radiation.
The claim that the FGMOSFET can be used as a radiation measurement
component looks to exploit the linear relationship between exposure of ion-
ising radiation and the measurable VTh of the FGMOSFET. This linearity
is a fundamental requirement for the suitability of the FGMOSFET as a
radiation measuring electronic component.
3.4.3 Radiation Effect on Silicon
The broad effects of radiation on silicon are well documented elsewhere [84,
78, 85], however this selection will include a brief outline of radiation damage
on silicon to help put into context the potentially detrimental consequences
of silicon operating in a radiation heavy environment.
The radiation environment is a name used to categorise the expected
working conditions of silicon or an integrated circuit. There are several
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defined radiation environments each with their own characteristic types of
radiation. Knowing the typical radiation profile of a radiation environment
contextualises the application of the silicon and helps the engineer design
sufficient protection into the integrated circuit to minimise the harmful and
unwanted effects of the radiation. The radiation environment categories in-
clude:
• Space.
• High Energy Physics.
• Nuclear.
• Natural Environments.
• Processes Inducing Radiation.
The profile of a radiation environment can typically have either particle
or photon radiation, or both.
Radiation damage to silicon will vary based on the type, energy, and
intensity of the radiation itself. Generally speaking the higher the energy of
an interacting photon, or the greater the mass of the interacting particle, the
more destructive the effect will be to the structure of the silicon lattice. The
transfer of energy from the photon interacting with the silicon depends on the
energy of the photon, the trajectory of the photon, and the kinetic energy of
the photon. The type of damage caused to silicon by radiation roughly falls
into one of two categories: ionisation damage, and displacement damage.
Ionisation damage is damage typical of photons interacting with silicon.
For lower energy X-rays the photoelectric effect is the predominant resulting
effect. The photoelectric effect will cause electron-hole pair generation within
the lattice due to a transfer of energy between incoming photons and an
atom’s orbital electrons. In silicon an interacting photo requires an energy of
at least 1.1 eV at 302 K for a orbital electron to gain sufficient energy to move
from the valence band to the conduction band [86]. For SiO2 an interacting
photo requires at least 8.9 eV of energy to cause an orbital electrons to
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migrate from the valance band to the conduction band [87]. The significance
of the band gap property to silicon based compounds is reviewed elsewhere
[88].
For incoming X-ray radiation with higher energies the Compton effect is
observed. In this case the absorbed photon graduates an orbital electron from
the valance band to the conduction band and the residual energy from the
interaction is ejected as a secondary photon. Should the secondary photon
have sufficient energy it may graduate another orbital electron to the con-
duction band. This energy loss of incoming radiation is commonly referred to
as ionisation. Incoming ionising radiation will have one of two effects on the
FGMOSFET, either the cause of electron-hole pairs within the silicon dioxide
region, or encourage the migration of trapped charge out of the floating-gate.
When the Compton effect occurs within the SiO2 region of the FGMOSFET
electron-hole pair production occurs. This is where valence band electrons
obtain sufficient energy to graduate to the conduction band.
The electron-positron pair generation is the effect resulting from interact-
ing photons of energies greater than 1.02 MeV. In this type of pair production
the photon interacts with the nucleus of the atom. Using the relationship of
energy to mass, E = mc2, as defined by Albert Einstein [89], the energy of
the incoming photon must be sufficient to create the mass of both the elec-
tron and the positron. Any residual energy will be used as kinetic every for
both particles. The high energy pair generation is described as, γ → e−+e+.
If there is a strong electric field across the region where electron-hole
pair production occurs the graduated electron will move under the field’s
effect. Thus the doped silicon conducts at a level higher than is normal
whilst being irradiated. The positively charged holes that are also created as
part of the electron-hole pair production are also mobile, but to a different
degree. The production and subsequent trapping of holes in transistor cause
serious degradation in transistor performance. This trapped charge alters the
electrical properties of the device. To create an electron-hole pair in silicon
dioxide the incoming ionising radiation must be of at least 18 eV.
Displacement damage is the damage caused by energetic particles inter-
acting with the silicon’s lattice structure. Under an event causing displace-
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ment damage an incoming high energy particle will exchange energy through
an elastic or inelastic collision with an atom in the silicon lattice structure.
Should an incoming particle with sufficient energy collide with a silicon atom
then the atom can become displaced from within the silicon lattice struc-
ture. This type of defect to the lattice is referred to as a point defect. The
alteration to the silicon lattice structure caused by energetic particles is com-
prehensively discussed elsewhere [90]. However, it should be understood that
when enough displacement events occur within the silicon lattice the struc-
ture of the compound may become irreversibly destroyed. For a MOS device
extensive displacement damage will result in a compromise to the electrical
characteristics of the component itself.
The use of silicon based components to measure radiation has long been
practiced. Diodes, MOSFETs, and even FGMOSFET devices have all been
used as dosimeters. From particle physics to space application the hardening
of electronics to the harmful effects of radiation is a science onto itself. In
instances where components are to act as radiation sensitive instruments the
hardening of select regions of the component is necessary.
In radiotherapy the energy of the radiation beam associated with treat-
ment is measured in electron volts (eV). The energy of the beam is approx-
imately equal to the maximum electric potential multiplied by the charge
on an electron. Thus a 1 MV beam will produce photons of no more than
1 MeV.
The range of energies a dosimeter for radiotherapy will experience is de-
termined by the operating range of energies of the linac. To treat superficial
structures (i.e. skin cancers), kilovolt X-rays are typically used and for can-
cers deeper within the patient megavolt energy beams are used to achieve
the necessary beam penetration. The radiotherapy linac can typically oper-
ate from 100 keV to 25 MeV with beam energy seldom exceeding 1.5 MeV.
As such the radiation measurement component, the FGMOSFET, needs to
remain operational whilst exposed to radiation of energies from 100 keV to
25 MeV. An operational FGMOSFET used to measure the absorbed dose
of ionising radiation requires the device that maintains a linear response to
the uniform dose of radiation and remain sufficiently functional such that
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the measured absorbed dose can be communicated to whatever logic it feeds
into.
Figure 3.11: The effect of ionising radiation on trapped charge in the FG-
MOSFET will cause a change in charge density within the transistor’s em-
bedded floating-gate.
Assuming adequate radiation hardening is added in the custom design
FGMOSFET optimised for IVD it is the only the floating-gate of the FG-
MOSFET that requires maximum radiation sensitivity. Figure 3.11 demon-
strates how the FGMOSFET is expected to respond with exposure to ionising
radiation in the radiotherapy application. From this illustration it becomes
clear why it is the floating-gate of the transistor that should be the most
radiation sensitive region of the entire FGMOSFET structure.
Obviously for radiotherapy with X-ray and γ-ray treatment the FGMOS-
FET will only ever be subject to the ionising effect of radiation and not
the displacement effect caused by particle based radiation. With a well of
trapped charge sitting inside the floating-gate the exchange of energy from
incoming photons will energise the trapped charge such that is can escape out
of the floating-gate and move towards the control-gate under the influence of
the bias potential of the control-gate.
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This description of how the FGMOSFET acts as a dosimeter is a de-
scription of just one method to configuring the FGMOSFET as a dosimeter.
There are alternative methods [91], however the method described above is
favourable for the programmable type of transistor.
3.4.4 FGMOSFET for Radiation Measurement
This section is included to provide a short summary of the major reasons
why the FGMOSFET technology is prefer over other transistors for the de-
velopment of a implantable dosimeter.
• Fabrication size - smaller footprint than a RADFET.
• Can be integrated onto a single circuit.
• Low manufacturing cost.
• Programmable VTh - making the level of sensitivity selectable.
• Reprogrammable VTh - making the device reusable.
By comparison to the RADFET, although the RADFET is more sensitive
a component for the same incoming dose of ionising radiation the footprint on
silicon between the RADFET and the FGMOSFET makes the FGMOSFET
a favourable component. The sensitivity of the device refers to the mVGy−1
of the device.
Given that the FGMOSFET has a smaller physical footprint on silicon
the device lends itself to an integrated circuit more naturally. The intended
dosimeter for the application of radiotherapy will be designed as an implant-
able device, and there is an overall design goal that the entire dosimeter
should not exceed a 1 mm3 volume. As such, the smaller the radiation meas-
urement component the more easier it will fit within the proposed dosimeter
design.
With the FGMOSFET the charge density on the floating-gate can be
set before the device is irradiated. The charge density on the floating-gate
will determine the electric field strength the electron-hole pair are subject
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to with incoming ionising radiation. The grater the charge density on the
floating-gate the more probable the movement of change is at electron-hole
pair production.
Reprogramming the FGMOSFET after radiation exposure offers the pos-
sibility that the transistor can be reused multiple times. In the application of
an implantable dosimeter for radiotherapy it is extremely unlike the device
would be reused. However, the same device would also to have use in applic-
ations where radiation measurement is continually required, and not from
within a patient’s tumour.
3.5 Summary
Starting with a brief summary of semiconductor physics this theory chapter
has presented the necessary information to understand what effect ionising
radiation has on the silicon based structure of the FGMOSFET, and how
those effects from ionising radiation are measurable through changes in the
electrical characteristics of the FGMOSFET undergoing exposure. Thus
making the FGMOSFET a suitable electronic component to measure ab-
sorbed dose of radiation. Understanding the FGMOSFET can be used as
radiation measurement component this chapter also presented the design re-
quirements of an implantable dosimeter for radiotherapy to improve QA in
treatment procedure, where the FGMOSFET as a detector would be at the
centre of the design to that new device.
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Chapter 4
Micro Antenna Theory
4.1 Introduction
The work completed for this thesis is towards building a new implantable do-
simeter for IVD, an instrument that measures the dose of ionising radiation
a cancer patient is exposed to during radiotherapy and wirelessly commu-
nicates the measured result to the medical physicist overseeing treatment
delivery. To achieve this a component in the proposed dosimeter will need to
be a micro antenna, an integrated antenna capable of transmitting inform-
ation on a high frequency EM wave from the implanted dosimeter to the
readout electronics. This theory chapter will provide the necessary inform-
ation to understand the design choices made for the fabrication of a micro
antenna for an implantable medical electronic device.
By starting with an overview of Maxwell’s equations it can be under-
stood how the propagation of EM waves about a surface are mathematically
described. An expression for the efficiency of an antenna is presented next,
where the antenna’s efficiency is used as the relative performance indicator
between the different micro antenna designs. This leads into a section in-
troducing the Poynting vector, an equation that describes the direction of
propagation of an EM wave. In the subsequent section, given in a mathem-
atical form, is a general expression of the total power for all three iterations
of the micro antenna design. From this general form an expression for the
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radiated power, a constituent from the total power, is found. Using this
information it can best be understood which portion of a current moving
through a conductor is attributed to the radiated signal from the transmit-
ting micro antenna. With the use of software for mathematical computation,
Maxwell’s equations were used to provide an expression for the radiated sig-
nal from the transmitting micro antenna in terms of the dimensions of the
micro antenna’s design. Expressions for both the single-loop and multi-loop
antennas are presented in terms of the dimensions of their design and by
describing the micro antenna in this way the relative efficiency of any poten-
tial micro antenna design can be predicted. This description of approximate
antenna efficiency for the micro antenna leads into a section on the design
dimensions and limitations for each of the three fabricated micro antenna
designs. This theory chapter closes with a comparison between the predicted
performance of the single-loop and multi-loop micro antenna designs, and
presents their respective radiation patterns as determined through computer
simulation. The predicted radiation pattern was not measured through ex-
perimentation, only the relative antenna performance at fixed distances was
investigated.
All of this theory and simulation work includes the necessary steps re-
quired to obtain information about the predicted performance of the intended
micro antenna design. This work was accomplished ahead of the character-
isation and performance experiments completed with the fabricated micro
antennas. This chapter builds on the basics of electromagnetic theory and
therefore, for much of this chapter, its content is a summary of well estab-
lished theoretical principles of physics that have been extensively documented
elsewhere [92, 93, 94, 95].
4.2 Maxwell’s Equations
The design process for a new type of micro antenna for medical electronic
devices is a process completed in two stages; the first is to use a mathematical
model to describe the micro antenna and simulate its performance through
computer software, and the second stage is to abstract that computer model
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into a physical prototype antenna through a fabrication process and evaluate
the real performance of that micro antenna’s design. A comparison between
the results of the micro antenna’s mathematical model, obtained via simula-
tion, with the results measured from the practical characterisation is useful
information to determine areas for improvement in any subsequent evaluated
micro antenna designs.
It is the work completed by the 19th century Scottish physicist James
Clerk Maxwell that forms the basis of mathematical theory necessary to
implement a computer simulation that predicts the behaviour of the de-
signed micro antenna. In 1861 Maxwell published the first of a five paper
series entitled, “On Physical Lines of Force”, in the journal Philosophical
Magazine [96, 97, 98, 99, 100] where he outlined a revised understanding of
four mathematical equations that describe electric field and magnetic field
theory. These four equations include: Gauss’ law for an electric field, Gauss’
law for a magnetic field, Farady’s law, and the Ampe`re-Maxwell law.∮
S
~E · nˆ da = qenc
ε0
(4.1)
∮
S
~B · nˆ da = 0 (4.2)
∮
C
~E · dlˆ = − d
dt
∫
S
~B · nˆ da (4.3)
∮
C
~B · dlˆ = µ0
(
Ienc + ε0
d
dt
∫
S
~E · nˆ da
)
(4.4)
The permittivity of free space is given the term, ε0, where the permittivity
is a measure of a material’s ability to permit an electric field. The unit of
measurement for permittivity is farads per metre (Fm−1). ε0 = 8.8542 ×
10−12 Fm−1. The permeability of free space is given the term, µ0, where
permeability is a measure of a material’s ability to permit a magnetic field.
The unit of measurement for permeability is Henry per metre (Hm−1). µ0 =
1.2566× 10−6 Hm−1.
Gauss’ law for electric fields is described in the integral form in Equa-
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tion 4.1. The left side of the equation,
∮
S
~E · nˆ da, describes the number of
field lines passing through a closed surface (S), otherwise referred to as the
electric flux. The right side of the equation, qenc
ε0
, describes the total amount
of charge contained within S divided by the permittivity of free space, ε0.
Gauss’ law for electric fields describes the relationship between an electric
field and the electric charges that cause the electric field.
Gauss’ law for magnetic fields is described in the integral form in Equa-
tion 4.2. The left side of the equation,
∮
S
~B · nˆ da, describes the number of
field lines passing through a closed surface (S), otherwise referred to as the
magnetic flux. The right side of the equation is 0. Gauss’ law for magnetic
fields describes the magnetic field as it is generated by a magnetic dipole and
because there is no such thing as a magnetic monopole the total magnetic
flux passing through S is 0.
Farady’s law is described in the integral form in Equation 4.3. The left
side of the equation,
∮
C
~E · dlˆ, describes the circulation of the electric field
around the closed path, C. The right side of the equation, − d
dt
∫
S
~B · nˆ da,
describes the rate of change with time of the magnetic flux through any
surface bound by C. Faraday’s law shows how a changing magnetic field
creates an electric field.
The Ampe`re-Maxwell law is described in the integral form in Equa-
tion 4.4. The left side of the equation,
∮
C
~B · dlˆ, describes the circulation of
the magnetic field around the closed path, C. The right side of the equation,
µ0
(
Ienc + ε0
d
dt
∫
S
~E · nˆ da
)
, is the sum of two sources for the magnetic field:
Ienc, a steady conduction current, and
d
dt
∫
S
~E · nˆ da, the rate of change with
time of the electric flux through any surface bound by C. The right side
of the equation therefore describes the changing electric flux through any S
bound by C. The Ampe`re-Maxwell law shows how a magnetic field can be
created by either an electrical current or by a changing electric field.
∇2 ~E = µ0ε0∂
2 ~E
∂t2
(4.5)
∇2 ~B = µ0ε0∂
2 ~B
∂t2
(4.6)
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Collectively this set of equations, the four revised mathematical equations
that describe electric field and magnetic field theory (Equations: 4.1, 4.2,
4.3, and 4.4), are referred to as Maxwell’s equations and form the basis
of the branch of physics known as classical electromagnetism. Using these
equations Maxwell deduced the relationship between the electric field and the
magnetic field and eventually derived the EM wave equation as published in
the 1865 paper, “A Dynamical Theory of the Electromagnetic Field”, in
which Maxwell also became the first physicist to propose the idea of light as
an EM wave [101]. The EM wave equations are defined in Equation 4.5 for
the electric field and Equation 4.6 for the magnetic field, and both equations
are second order partial differential equations that describe the propagation
of EM waves through a vacuum. ∇2 is the vector Laplace operator, or a
differential operator defined over a vector field. ∇2 ~E and ∇2 ~B from the
left side of both equations describe, respectively, the second derivative of
the vector electric field over space and the second derivative of the vector
magnetic field over space. ∂
2 ~E
∂t2
and ∂
2 ~B
∂t2
from the right side of both equations
describe, respectively, the second derivative of the vector electric field and
the second derivative of the vector magnetic field.
4.3 Antenna Efficiency
An EM wave is a wave that takes place in the EM field. All EM waves consist
of both an electric and magnetic component. Both the electric and magnetic
field oscillate in-phase perpendicular to each other perpetuating the motion
of the wave, and perpendicular to the direction of the wave’s propagation.
EM waves travel at the speed of light, c ≈ 3× 108 ms−1.
η =
Rrad
Rrad +Rloss
(4.7)
The efficiency is given the symbol, η. For the design of a micro antenna
in the transmission of EM waves the efficiency is described by Equation 4.7.
The micro antenna efficiency is defined as the ratio between the radiation
resistance (Rrad) and the loss resistance (Rloss), where Rrad represents the
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portion of the signal that is transmitted from the micro antenna and Rloss
accounts for the remainder of signal that is dissipated through the resistance
of the conductor [102, 103]. Both Rrad and Rloss are a measure of resistance,
and therefore their SI unit is the Ohm (Ω).
In the design of a micro antenna for the application of implantable medical
electronic devices it is imperative to optimise the efficiency of the micro
antenna as a transmitting antenna by reducing the Rloss component of the
signal through the conductor.
4.4 The Poynting Vector
~S = ~E × ~B (4.8)
In 1884 the English physicist John Henry Poynting published a paper
that described how the direction and magnitude of an EM wave is based
on the conservation of electric and magnetic fields [104], and thus predicted
the existence of what are known as plane waves in classical physics. EM
waves are plane waves. The conservation of the energy for the EM wave is
mathematically described by Equation 4.8 and is referred to as the Poynting
vector. The SI unit for the Poynting vector is the power density (Wm−2)
thus making the Poynting vector an expression for the instantaneous flow of
power per unit area. ~S denotes the direction of power flow per unit area for
an EM wave, ~E is the electric field, and ~H is the magnetic field.
~S =
1
2
( ~E × ~B∗) (4.9)
An expression for the complex power density for the far field is math-
ematically described by Equation 4.9 [105], and is an amended form of the
Poynting vector to describe the radiated field by a magnetic dipole antenna.
The ∗ in the magnetic field expression, ~B∗, denotes the complex conjugate.
The complex conjugate of a complex number refers to the expression of that
complex number as having the same real component, but with an imaginary
component of equal magnitude and opposite sign. The loop antenna is a
magnetic dipole antenna. The total power radiated by the current carrying
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loop is found by integrating Equation 4.9 over a large spherical radius, from
distances r through to ∞, and is therefore a measure of the total radiated
power through the far field region of EM radiation.
Pf =
1
2
©
∫∫
s
( ~E × ~B∗) · d~s (4.10)
The complex power flow through a closed surface is expressed in Equa-
tion 4.10, where d~s = ds~ˆn and ~ˆn is the unit normal to the surface directed
out from the surface. The integral of the complex Poynting vector over a
closed surface, s, gives the total complex power flowing out through the sur-
face s. If the complex Poynting vector represents the complex power density
(Wm−2) at a point then the complex power through any surface s (not ne-
cessarily a closed surface) can be found by integrating the complex Poynting
vector over that surface [106].
4.5 Loop Antenna’s Radiated Power
Maxwell’s equations can be used to mathematically describe the propagation
of EM waves about a surface. In the case of micro antenna design Maxwell’s
equations were analytically solved to determine an expression for the corres-
ponding electric field, ~E, and the magnetic field, ~B, for a particular micro
antenna design. For each design of micro antenna the analytical solution
considered the micro antenna’s shape assuming EM radiation through free
space. Other relevant physical effects for micro antenna design were neglected
in this analysis, including: losses due to substrate coupling, eddy currents,
resistance, and influence of the contacts [107].
The Poynting vector defined in Equation 4.8 can be thought of as repres-
enting the energy flux which is the rate of flow of energy (Jm−2s−1) of the
EM field. The complex power density vector defined in Equation 4.9 is used
to determine the far field energy flux of the normal component (at 90◦) of
the Poynting vector over a surface at a radius r where the far field extends to
infinity. The total complex power, Ptotal, flowing through a spherical surface
at radius r was obtained by integrating the normal component of ~S over this
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surface.
Ptotal = A1 +
A2
r2
+ j
A3
r3
(4.11)
From the antenna layout an algebraic expression for the vector potential
( ~A) in space, as a function of the geometry and current, was obtained. Next,
from Maxwells equations, the corresponding expressions for ~E and ~B were
calculated. From these latter expressions a formula for the Poynting vector
as a function of the driving current through the micro antenna was obtained.
For the third antenna layout, the multi-loop micro antenna, the total expres-
sion of the Poynting vector was obtained by summing the Poyinting vectors
corresponding to each single nested loop. The angular dependency of the
far field was obtained from the normal component of the Poynting vector
over a surface of radius, r, in the limit to infinite distance. Carrying out
the integration for all three micro antenna designs, a general expression for
the total complex power for the micro antenna design is expressed in Equa-
tion 4.11. A1 and A2 from the right side of Equation 4.11 represent the
radiation resistance, Rrad, or the portion of the signal that is transmitted
from the micro antenna. A3 from the right side of Equation 4.11 represents
the stored energy in the near field, the reactive power. However, only the
A1 term from Equation 4.11 represents the radiated power from r to infinity
and is therefore the only term that can be used to approximate Rrad for the
micro antenna design. Rrad is found by equating the radiated power (Prad)
at infinity to the power dissipated by a resistor, assuming I0 = 1 A, as shown
in Equation 4.12 and Equation 4.13.
Prad = A1 =
1
2
RradI
2
0 (4.12)
Rrad = 2A1 (4.13)
In the following two subsections an expression for Rrad for both the single-
loop and multi-loop micro antenna is outlined based on the dimensions of
the micro antenna’s design. With a mathematical expression of Rrad for a
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micro antenna’s design the subsequent calculation of the micro antenna’s Prad
and η becomes straightforward. It is from this arrangement that only small
changes are required to the computer model of a micro antenna’s design to
predict the expected efficiency of that micro antenna.
It should be noted that for the following two subsections, Section 4.7.1
and Section 4.7.2, there is an expression for the single-loop, Equation 4.14,
and multi-loop, Equation 4.15, micro antenna. Each of these two equations
is based on a mathematical description of the wire trace the micro antenna
makes around the circuit. A straight line is the simplest trace upon which
to integrate to find the complex power flow through a surface of the micro
antenna’s wire trace. As such, both Equation 4.14 and Equation 4.15 are
described as the sum of their individual sides.
4.5.1 Single-Loop Design
From the mathematically deduced approximation of Rrad in Equation 4.12
the single-loop micro antenna radiation resistance is expressed as:
Rrad =
10
60
∆Lk3
piεω
[(
1 +
1
10
k2∆L2
)
B2
+
(
−2 + 3
10
k2∆L2
)
B +
(
1 +
6
10
k2∆L2
)] (4.14)
Where the terms in Equation 4.14 include: ∆L = L−W , the difference
between the antenna side length (L) and the track width (W ), k = 2pi
λ
, the
wave vector, and B = ∆L−G
∆L
, the size of the gap (G) between the contact
pads.
4.5.2 Multi-Loop Design
From the mathematically deduced approximation of Rrad in Equation 4.12
the multi-loop micro antenna radiation resistance is expressed as:
Rrad = M1N
5 +M2N
4 +M3N
3 +M4N
2 +M5N (4.15)
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The coefficients of the terms in Equation 4.15 include:
M1 =
8a4k5
15piωε
M2 =
a4k5
3piωε
(
7
2
+ 4a−1∆L
)
M3 =
a4k5
3piωε
(
53
30
+ 7a−1∆L+ 4a−2∆L2
)
M4 =
a4k5
3piωε
(
− 7
20
+
53
20
a−1∆L+
21
4
a−2∆L2 + 2a−3∆L3
)
M5 =
a4k5
3piωε
(
−13
60
− 7
20
a−1∆L+
53
40
a−2∆L2 +
7
4
a−3∆L3 +
1
3
a−2k−2
)
Where a is the gap between nested tracks (S) of the multi-loop antenna
design. The expression found in Equation 4.15 indicates that the Rrad in-
creases with the number of loops in the multi-loop design. However, as the
number of loops increase so too does Rloss due to the increase in track length,
thus causing an overall reduction in the efficiency of the micro antenna. The
optimum performance indicator of the efficiency of the micro antenna’s design
is where Rrad is larger compared to Rloss.
4.6 Micro Antenna Design
EM waves are produced by the acceleration of charge through a conductor.
The change of velocity by the moving charge will induce the propagation of
a magnetic field and that will, in turn, induce the propagation of an electric
field and so on. Thus EM radiation is created. That is to say a conductor
that has an alternating current passing through it will emit EM radiation
at the same frequency as the alternating current’s oscillations. It is under
this principle that the transmitting antenna can be used for communication.
The receiving antenna operates in the reverse of this principle, assuming the
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receiver antenna is orientated in the same direction as the polarised wave.
The incoming EM wave will encourage the movement of charge within the
antenna at the same frequency as the wave itself. By tuning a capacitor in
an LC tank circuit, an efficient transfer of energy will be achieved between
the incoming EM wave and the charges within the antenna’s conductor.
Presented in the sections that follow are the dimensions of all three types
of micro antenna design that were investigated. The practical character-
isation was completed for the current batch of fabricated micro antennas
before a subsequent batch of micro antennas was produced. It was due to
this sequential approach to antenna design that the results from the current
batch of micro antennas could be interpreted before the fabrication of any
subsequent antenna design. Thus the next batch of micro antennas included
favourable amendments to its design based on the data provided by the last
batch of micro antennas. The chosen dimensions for all three batches of fab-
ricated micro antennas was therefore based on the combination of simulation
results and practical characterisation results.
4.6.1 First Batch: Single-Loop
Figure 4.1 shows the chosen dimensions for the first batch of micro antennas
and is a single-loop design. The design and fabrication of this first micro
antenna was very much a learning process. The simulated results were com-
pared to the practically measured characteristics of the design. Using the
results obtained in the design, fabrication, and characterisation of this first
batch of micro antennas the assessment of each stage of the antenna design
evaluation process was recognised. Thus a better understanding of processes,
and errors to processes, for each stage of antenna evaluation was avoided in
subsequent evaluated batches of micro antennas. Notice in Figure 4.1 the
dimensions included are: the track width (W ), the length of one side (L),
and the gap between the contact pads (G). These were the major dimension
parameters that could be altered between fabrication batches.
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Figure 4.1: Batch 1 micro antenna dimensions.
4.6.2 Second Batch: Single-Loop
By the second batch of fabricated micro antennas, a couple of revisions were
made to the dimensions of the single-loop design over the design to the first
batch and those revisions are illustrated in Figure 4.2. The micro antenna’s
shape in the second batch was altered to help improve its performance over
the performance of the first batch of micro antennas. Those revisions to the
antenna’s dimensions included increasing both W and G. From the expres-
sion in Equation 4.14 the Rrad attribute of the micro antenna can be resolved
for both the W and G dimensions. The simulation data therefore sugges-
ted these revisions would produce an improvement to antenna performance
based on the calculated antenna efficiency.
4.6.3 Third Batch: Multi-Loop
The third batch of micro antennas was a multi-loop design and the dimen-
sions of this design are presented in Figure 4.3. Unlike the single-loop design
of the previous two fabricated batches it was the ambition of the work com-
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Figure 4.2: Batch 2 micro antenna dimensions.
Figure 4.3: Batch 3 micro antenna dimensions.
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pleted for the third batch of micro antennas to determine the performance of
the multi-loop design. With data on both the single-loop and the multi-loop
design a performance comparison between the two design approaches can be
made from the data gathered in the experiment.
4.6.4 Fabrication Limitations
In the design of the micro antenna, for both the single-loop and multi-loop
design, there were some dimensions to the micro antenna that could be ad-
justed to improve the predicted efficiency of the micro antenna. These di-
mensions included the track width (W ), the number of loops (N), the gap
between the contact pads (G), and the spacing between the loops (S). How-
ever, due to the technical characteristics of the available fabrication process
the depth (or thickness) of the track was fixed at 0.5 µm. Before the fab-
rication of any micro antennas began it was assumed that these dimensions
were the only adjustable parameters in the design of the micro antenna that
would improve the real-world performance of the micro antenna.
Due to the time constraints and costs involved in the fabrication of the
micro antennas a subsequent batch of micro antennas was only fabricated
after completing the performance analysis and characterisation of the cur-
rent batch of micro antennas. It was because of this iterative approach to the
fabrication of the micro antennas that it was discovered that the track expos-
ure was an additional adjustable dimension to the micro antenna design that
would alter the real-world performance of the micro antenna. Track exposure
refers to the upper surface of the track on a circuit being exposed to the nat-
ural surrounding environment. In this case the track exposure left the wire
trace of the micro antenna exposed to air. As such, for the second and third
batches of micro antennas, the micro antenna track was embedded within
a silicon dioxide layer to keep the track from oxidising and thus altering its
conductive properties and making the conductivity more predictable. This
is the difference between the theory and practical implementation of antenna
design and it was fortunate that the experiment proceeded in stages based
on the sequential fabrication of batch iterations, otherwise this study might
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never have accommodated the need to refine micro antenna design including
the track exposure.
4.7 Micro Antenna Simulations
Having an understanding of the mathematics for micro antenna simulation
for both single-loop and multi-loop antennas, and knowing the dimension of
the micro antenna being simulated, the performance of the micro antenna
as a transmitting antenna can be simulated by computer software. For the
calculation of Rrad and the plots presented in Figure 4.4 and Figure 4.5
the Maple 14 software simulation package was used. Maple 14 is a general
purpose commercial mathematics software. For the single-loop micro antenna
design Equation 4.14 formed the bases on the Maple 14 simulation, and for
the multi-loop micro antenna design Equation 4.15 was used in the Maple 14
simulation package. Figure 4.4 is the polar plot and radiation pattern for the
first batch of micro antennas. It is therefore the lesser refined design revision,
between the design of the first and second batches, of the single-loop micro
antenna. The second batch of single-loop micro antenna was predicted to
outperform the first batch of micro antennas. As Figure 4.5 is an illustration
of both the polar plot and radiation pattern of the multi-loop micro antenna
design, it is therefore the simulated behaviour of the micro antenna from the
third batch of fabricated micro antennas. The third batch of micro antennas
was predicted to out perform the first batch of micro antennas.
In this section the typical results from a micro antenna simulation are
presented for both the single-loop and multi-loop design. The dimensions for
each fabricated batch of micro antennas was, in part, chosen based on the
results of the micro antenna simulations.
For a transmitting antenna the energy radiated from the antenna forms
an EM field and for the loop antenna design the EM field is not equal in all
directions. The EM field a transmitting antenna forms can be described by
its radiation pattern and polar plot. The radiation pattern and polar plot
for both the single-loop and multi-loop antenna is found using simulation
software. The radiation pattern and polar plot describe the propagation of
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the antenna’s transmitting EM wave for the far field of operation, where
the boundary of both plots is from the micro antenna up to a distance at
infinity. The axis of measurement in both plots is therefore the power (W)
of the measured signal as a function of distance. r =∞, PRad = 1 pW.
4.7.1 Single-Loop Design
Simulating the single-loop micro antenna design produced the two plots,
presented in Figure 4.4, that describe the radiation pattern of the emitted
EM energy from the transmitting micro antenna. The dimensions used to
produce the plots in Figure 4.4 were taken from the second batch of micro
antennas.
4.7.2 Multi-Loop Design
Simulating the multi-loop micro antenna design produced the two plots
presented in Figure 4.5 which describes the radiation pattern of the emit-
ted EM energy from the transmitting micro antenna. The dimensions used
to produce the plots in Figure 4.5 were taken from the third batch of micro
antennas.
4.7.3 Antenna Efficiency
Batch No. G (µm) W (µm) N η
2 200 50 1 14.0× 10−6
3 200 35 2 9.40× 10−6
1 100 25 1 1.70× 10−6
Table 4.1: Predicted relative performance of micro antenna design.
Table 4.1 is a summary of the relative performance of all three micro
antenna designs. G, W , and N are physical dimensions to the micro an-
tenna design. As illustrated in Figure 4.1, Figure 4.2, and Figure 4.3 the G
dimension is the separation of the track pads, W is the track width, and N
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(a) Single-loop polar plot.
(b) Single-loop radiation pattern.
Figure 4.4: Understanding the EM wave energy as it radiates away from
the transmitting micro antenna. Figure 4.4(a) shows the polar plot. Fig-
ure 4.4(b) shows the radiation pattern for the single-loop micro antenna
design.
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(a) Multi-loop polar plot.
(b) Multi-loop radiation pattern.
Figure 4.5: Understanding the EM wave energy as it radiates away from
the transmitting micro antenna. Figure 4.5(a) shows the polar plot. Fig-
ure 4.5(b) shows the radiation pattern for the multi-loop micro antenna
design.
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is the number of loops in the antenna’s design. The oder of the three mi-
cro antenna designs in Table 4.1 is by the fourth characteristic of the micro
antenna, the predicted efficiency, η. It should be noted that the dimension
for the separation of tracks for concentric loops, S, has not been listed. This
dimension is only applicable to the design of batch number three, and listed
below.
The estimated efficiency for the first batch of micro antennas with G =
100 µm and W = 25 µm, was η = 1.70 × 10−6. With the revisions to
the dimensions of the second batch of micro antennas, G = 200 µm and
W = 50 µm, then the estimated efficiency was found to be η = 14.0× 10−6.
According to this simulation work the predicted efficiency of the single-loop
micro antenna design is improved by increasing the track width and increas-
ing the gap between the contact pads. The increase in antenna efficiency
caused by increasing the track width is due to a reduction in ohmic losses
through the track. The increase in antenna efficiency caused by increasing
the gap between the contact pads is thought to be a consequence of a reduc-
tion in phase cancellation of the EM waves generated by the parallel tracks
of the loop.
The estimated efficiency for the third batch of micro antennas was a more
involved calculation as it is based on a multi-loop micro antenna design. The
optimum efficiency for the multi-loop micro antenna was found by calculating
the estimated efficiency for an increasing number of loops (N), where an
increasing number of loops would improve the magnetic flux of the micro
antenna but also increase the ohmic losses through the track as the track
increased in overall length. It was found for N = 2, S = 125 µm, and
W = 35 µm that η = 9.40 × 10−6. It was therefore expected that the
order of relative performance between all three different designs of micro
antenna would be; the second batch of single-loop micro antennas as the
best performing, the third batch of multi-loop micro antennas as the second
best performing, and the poorest performing micro antenna would be the
first batch of micro antennas.
Referring back to Equation 4.7 it is clear that the efficiency, η, of a micro
antenna is characterised by the ratio between the radiation resistance (Rrad)
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and the loss resistance (Rloss of the micro antenna. As η is a ratio it is
without a unit. This measure of efficiency is comparable amongst the there
micro antenna designs only. The expected performance of the micro antenna
was measured experimentally, and the results of that work are presented
in Chapter 6. As the micro antenna efficiency is ratio the simulation work
completed to obtain η for each micro antenna design, and thus predict the
performance of the micro antenna, was only done to indicate an expected
performance improvement relative to each micro antenna design. To measure
the degree of performance improvement between each of the three micro
antenna designs experimental lab work was completed.
4.8 Summary
Starting with a brief summary of Maxwell’s equations it was quickly shown
in this chapter how, through Poynting vector analysis, the relative predicted
efficiency of the micro antenna design was calculate based on the dimensions
of the micro antenna’s design. Included in this chapter is the necessary theory
to understand the design choices made in the design of the micro antenna.
The work completed in this chapter was necessary to describe the predicted
performance of the intended micro antenna design, and was accomplished
ahead of the characterisation and performance experiments completed with
the fabricated micro antennas.
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Chapter 5
Transistor Experiment and
Results
5.1 Introduction
This is a results chapter and the data presented within this chapter make a
credible academic contribution to the field of IVD for radiotherapy. The res-
ults discussed in this chapter have undergone peer review and been published
in the Journal of Instrumentation [108].
This chapter will begin with a quick overview of the expected working
environment for a medical instrument operating during the course of a ra-
diotherapy treatment. An overview of this working environment will contex-
tualise the aims and objectives of this study. For an electronic dosimeter for
radiotherapy there will need to be an electronic component capable of meas-
uring radiation. This chapter presents the work and results of a study that
investigated the suitability of the FGMOSFET as the electronic component
capable of measuring the absorbed dose of ionising radiation as typically de-
livered to a patient in the field of medical radiotherapy. The chapter will
provide a detailed report on every stage to the FGMOSFET experiment
should there be a need to replicate the results found.
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5.2 The Operating Environment
The gray is the SI unit used to quantify the absorbed dose of ionising ra-
diation. The gray is defined as the absorption of one joule of ionising ra-
diation by one kilogram of matter, human tissue, where 1 eV is equivalent
to 1.602 × 10−19 J. The gray is given the symbol Gy. It is the unit used
in the context of radiotherapy to describe the quantity of intended dose of
ionising radiation a patient has been prescribed. The delivery of a patient’s
treatment is typically split up over several fractions and, depending on the
type and location of the cancer, the dose of ionising radiation is chosen. A
treatment dose seldom exceeds 80 Gy.
Figure 5.1: Profile of absorbed dose of ionising radiation in human tissue
[109].
Although the medical physicist will configure the linac beam energy, a pa-
tient’s treatment is still characterised by a unit of absorbed dose of ionising
radiation. To understand this point take a moment to study Figure 5.1 [109].
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Radiotherapy is the process of using ionising radiation to kill cells. Radio-
therapy is a treatment where the radiation source is outside the patient, and
brachytherapy is the name given to a treatment where the radiation source
is placed within the patient. The radiation beam of EBRT can be any-
thing from high energy photons including X-rays and γ-rays, to accelerated
particles including electrons, protons, and carbon ions.
Figure 5.1 shows how the absorbed dose changes as the radiation beam
passes through the patient’s body. The origin of the x-axis in Figure 5.1 is
the point where the patient tissue begins. Depending on the type of beam
the absorbed dose profile will vary. It is not the energy of the beam that will
determine the dose profile, and ultimately what portion of the beam’s dose
has reached the target volume, but it is the beam type that determines what
portion of the beam’s dose that has reached the target volume.
It is important to note that this absorbed dose profile does not de-
scribe the photons/particles as losing energy. On the contrary, only an en-
ergy exchange with interacting atoms will result in a loss of energy to the
photons/particles of the radiation beam. However, what the absorbed dose
profile does describe is how protons, photons, and carbon ions are delivered
to the tumour. The dose deposited by protons remains relatively constant
as they travel through the normal tissues towards the the target volume.
The kinetic energy of the protons is transferred to the tumour by electrons
knocked out of atoms. These electrons ionise DNA, and their biological ef-
fective resembles that of MV photons [110]. At the target volume there is a
sharp rise in the dose deposited by the proton particle. This peak in the plot
shown in Figure 5.1, and is referred to as the Bragg peak. Both protons and
carbon ions exhibit a Bragg peak. Thus, the biological effectiveness of the
particle based beam sharply increases at the target volume [110]. The Bragg
peak is a result of elastic scattering.
By contrast, for photon based dose profile, i.e. for X-ray based radio-
therapy, the dose profile in Figure 5.1 shows an exponential decrease in the
transmitted intensity with increasing depth is due to absorption. From a
photon beam the absorbed dose of radiation at the target volume is only a
fraction of the overall dose. It is because of this characteristic of the X-ray
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radiation beam that the treatment with X-ray radiation is delivered such
that the sum of the absorbed dose at the target volume meets the required
absorbed dose per fraction. That is why a modern gantry for X-ray based
treatment must move around the patient to deliver a portion of the treatment
dose from multiple directions.
By contrast the absorbed dose of high energy particles tend to peak at a
distances from the source. That is, the number of beam particles interacting
with atoms is greatest at a distance from the source. The linac producing the
beam of high energy particles can manipulate the beam such that the Bragg
peak of absorbed dose occurs at a predetermined distance from the source.
Despite this seemingly advantageous characteristic of the treatment, using a
particle based radiation beam the dose is still delivered with a rotating gantry.
A rotating gantry delivering partial dose from multiple angles will minimise
the collateral damage to healthy cells surrounding the target volume.
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Equation 5.1 is a mathematical expression for charged particles as they
move through matter, and how they interact with the electrons of atoms in
that material [111]. Equation 5.1 is the Bethe formula. v is the velocity
of a particle, c is the speed of light, β = v/c, E is the energy of a particle,
x is the distance travelled by a particle, z is the particle charge, e is the
charge of the electron, me is the rest mass of the electron, n is the electron
density of the target, I is the mean excitation potential of the target, and ε0
is the vacuum permittivity. The Bethe formula describes the energy loss per
distance travelled of charged particles travelling thorough matter.
5.3 Experiment Aims and Objectives
This study was to determine the suitability of the FGMOSFET as a radiation
measurement component that can be used in medical radiotherapy. The
intended instrument the FGMOSFET will be used with is an implantable
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dosimeter. A dosimeter providing a real-time measurement of the absorbed
dose during a patient’s treatment will improve the confidence of both doctors
and patients in a potentially lethal procedure. An implantable dosimeter
works to improve the QA of radiotherapy by measuring the absorbed dose
during treatment delivery for that fraction and any discrepancy between the
absorbed dose and the intended dose will alert the medical physicist of the
treatment error. In order for the FGMOSFET to work in this application it
should be a cost effective low power active component capable of accurately
measuring the absorbed dose of ionising radiation with energies typical of
cancer treatment.
5.3.1 Operational Experiment Objectives
Several factors determine the dose of radiation a patient will be prescribed,
including location and size of the tumour, but a considerate bias is also
given towards the radiosensitivity of the patient’s cancer. Radioresistance
is a measure of the relative resilience between cells, tissues, and organisms
to the harmful effects to radiation, and radiosensitivity describes the relat-
ive susceptibility to the lethal effect of radiation [112]. X-ray radiation is
most effective on cells that have a greater reproductive activity [113], for
example in bone marrow where the rate of cell division is high. The most
radioresistant cancers receive the heaviest doses of ionising radiation. For
the FGMOSFET to operate within medical radiotherapy it needs to be suf-
ficiently radioresistant to remain able to measure the dose of radiation it
has been exposed to whilst still being a functional component throughout a
patient’s treatment. As such the FGMOSFET should be exposed to 100 Gy
of ionising radiation, considerably more than 80 Gy typical for treatment of
highly radioresistant cancers, for confidence that the FGMOSFET is reliably
capable of performing as a radiation measurement component throughout a
patent’s entire course of treatment.
Medical use of ionising radiation to treat a cancer patient will operate
with energies from 10 KeV to 25 MeV. The FGMOSFET should be able
to operate within this range of radiation energy. X-rays generated in the
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10− 30 keV range are known as Grenz rays [114], whereas the energy range
for superficial-treatment lilacs is about 30 − 125 keV. Orthovoltage linacs
generate X-rays from 125− 500 keV. The MeV linac has been the standard
radiotherapy equipment for the past 30 years, and its production of X-rays
is identical to that of a low energy linac. However, the energy range of MeV
linac is quite broad by comparison, from 4− 24 MeV [110].
Treatment of a patient is typically completed over a number of frac-
tions delivered weekly. For the FGMOSFET to be successful as a radiation
measuring component in medical radiotherapy it should be able to accurately
measure radiation during each session and also retain its predictable response
to ionising radiation between treatment sessions. Configuring the dosimeter
to a known state before treatment is not outside the scope of acceptable op-
eration, but the response of the FGMOSFET must remain predictable week
on week for the entire course of the treatment.
5.3.2 Technical Experiment Objectives
In addition to these operation-related performance requirements there were
a few additional areas of technical interest this study was looking to satisfy
from FGMOSFET exposure to ionising radiation. Analogous to the response
of cell biology to ionising radiation when a silicon device is exposed to ionising
radiation there are both immediate and a latent effects caused by radiation
damage.
Also of interest, the discernible performance difference found in the abil-
ity of the FGMOSFET to act as a device measuring the absorbed dose of
ionising radiation when the density of charge on the floating-gate region of
the transistor is maximum, minimum, or in between. It is known that the
performance of the FGMOSFET as a dosimeter is the result of the movement
of charge within the transistor caused by the very radiation it is measuring,
and it is therefore pertinent to investigate the difference in shift of electrical
characteristics of the FGMOSFET with a different pre-charged density on
its floating-gate region when subject to ionising radiation.
Within the FGMOSFET the VTh of the device is determined by the stored
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charge of the floating-gate. In other words, the stored charge of the floating-
gate of the FGMOSFET is the pre-charge density of the device. In the
context of the conventional use of the FGMOSFET in digital electronics the
stored charge of the floating-gate is what defines the electrical bias needed
on the transistor’s gate in order to switch the device from an ‘on’ to an ‘off’
state, and vice versa. However, in the analogue context the stored charge
of the floating-gate is exploited in an alternative manner to determine the
absorbed dose of ionising radiation the device has been exposed to. Incoming
ionising radiation will cause a shift of stored charge through one of two
mechanism, electron-hole pair production, or migration of majority carriers.
In this analogue context the pre-change density will have a bearing on the
VTh of the device. As more ionising radition comes in the more VTh will
shift, either positively or negatively depending on the majority carriers of
the device. However, in addition to this effect, the pre-charge density will
determine the rate at which the VTh property of the transistor will vary
for a constant rate of incoming ionising radiation. The greater the density
of trapped charge within the FGMOSFET the greater the probability of
movement of charge due to exposure to ionising radiation. As such, observing
to what degree of difference the pre-charge density makes on the FGMOSFET
a measure of device sensitivity becomes possible. If at a high pre-charge
density the FGMOSFET exhibits a significant rate of change of VTh, by
comparison to the rate of change of VTh at a lower pre-charge density, then
the device would possibly be useful in low-dose high-precision applications.
However, equally as interesting is a transistor with a small or negligible rate
of change in VTh for the same radiation exposure and pre-charge density, as
such a device would have a greater region of linearity under which it exhibited
a response to incoming EM waves. In such a scenario that device would be
would possibly be useful in high-dose long delivery duration applications.
Consideration of the recoverability of the FGMOSFET after exposure
to ionising radiation is consideration of the immediate effects of ionising
radiation on the FGMOSFET. The principle method of operation by which
the FGMOSFET is capable of acting as a radiation measurement component
has to do with the displacement of stored charge within the device. This
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effect of ionising radiation on the FGMOSFET has been extensively studied
elsewhere [115]. Incoming ionising radiation will induce movement of stored
charge within the FGMOSFET. This induced movement of stored charge
has been credited to two phenomena, electron-hole pair generation within
the silicon dioxide region near either the floating-gate or the interface of
the transistor, and the displacement of stored charge from the floating-gate
region of the transistor [116]. However a closer look at the recoverability
of the FGMOSFET is thought to provide an insight into the predominant
cause of charge migration within the FGMOSFET during ionising radiation
exposure.
Recoverability of the FGMOSFET refers to the quantity of pre-charge
density the transistor can achieve after its exposure to ionising radiation. It
is know that the change in VTh is what is observed during, and after, radiation
exposure of the transistor, and that this change in VTh is caused by one of
two phenomena. However, if the majority effect causing this change in VTh of
the FGMOSFET undergoing radiation exposure is through the displacement
of stored charge from within the floating-gate region of the transistor then
the majority of the pre-charge density of the transistor can be restored after
irradiation. By contrast, if the majority effect causing the change in VTh
of the FGMOSFET undergoing radiation exposure is through electron-hole
pair generation within the silicon dioxide region then the majority of the pre-
charge density of the transistor can not be restored after irradiation. This
is because the pre-charge density of the FGMOSFET refers to the forced
trapping of majority carriers in the floating-gate region of the device.
Consideration of the annealing effects of ionising radiation is considera-
tion of the latent effects of ionising radiation on silicon. In the fabrication
of doped silicon, controlled annealing is used to introduce dopant impur-
ity atoms into the crystal structure of the lattice. This process alters the
electrical properties of the semiconductor.
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5.4 Experiment Overview
This experiment was to determine the radiation effects on sub-millimetre
FGMOSFET devices, specifically to determine if the FGMOSFET is suitable
to measure the absorbed dose of relatively low energies of ionising radiation
typically produced by an X-ray/γ-ray linac routinely used to treat a cancer
patient.
Figure 5.2: Experiment apparatus as set-up to irradiate an array of FGMOS-
FET devices with ionising radiation.
Figure 5.2 is a graphic to illustrate the experimental set-up necessary to
irradiate a sample of FGMOSFET devices with a low dose radiation source.
This experimental set-up was adopted to determine the suitability of the
FGMOSFET to measure the absorbed dose of ionising radiation typical of
medical radiotherpay. A printed circuit board (PCB) was designed and fab-
ricated specifically to house an array of FGMOSFET devices securely whilst
they were being irradiated. A 60Co source was used to provide a uniform field
of constant radiation that the FGMOSFET devices were exposed to while
the experiment was running. A tripod clamp was used to hold the PCB in a
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fixed position and at a fixed distance from the radiation source. The tripod
clamp used to hold the PCB was orientated so that the PCB was directly
facing the radiation source providing the most uniform possible field of ex-
posure to the transistors. The tripod clamp was placed at a predetermined
distance from the radiation source, a distance that would ultimately determ-
ine the duration of exposure. The distance between the radiation source and
the PCB is marked by x in Figure 5.2. A customised cable was assembled for
the experiment to provide reliable measurements as data moved to and from
the PCB and a computer. The process of recording measurements for the
duration of the experiment was automated by a computer programme. The
results from the experiment were stored on the computer for later analysis.
The objective of the study was to evaluate the change in the electrical
characteristics of the FGMOSFET based on its exposure to ionising radi-
ation. An observable shift in the electrical characteristics of the FGMOSFET
by exposure to ionising radiation is known to occur due to the movement of
charge within the FGMOSFET. By exposing the FGMOSFET to a controlled
source of ionising radiation whilst accurately recording, in real-time, any shift
in the electrical characteristics of the FGMOSFET a correlation can be made
between the rate of absorbed dose of ionising radiation and the observed shift
in electrical properties of the FGMOSFET.
5.4.1 The Radiation Bunker
With permission from Brunel University their low dose radiation bunker was
used to carry out this experiment. Figure 5.3 is a plan-view of the radiation
bunker at Brunel University that clearly marks the layout of the bunker.
The bunker has a swipe card and key lock on the main entrance. Anyone
entering the bunker will step into the observation post. The location of the
observation post is a safe place to stand while any experiment is underway.
The observation post has space for the experimental apparatus any user may
want to operate whilst their experiment is running. The bunker itself is built
around the radiation chamber. The radiation chamber is lined by concrete
walls on every side and it is where the 60Co source is kept. The 60Co source is
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Figure 5.3: A plan-view of the low dose radiation bunker at Brunel University.
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secured within a mechanised box that is operated from the observation post.
When the radiation source is opened the 60Co source will fill the radiation
chamber with a uniform radial field of γ radiation. Also in Figure 5.3 the
experimental apparatus set-up from Figure 5.2 is superimposed on the bunker
plan-view layout. This additional information has been added to help depict
how the experiment was implemented from within the bunker.
Working with materials as hazardous as 60Co necessitates strict adher-
ence to rigorous health, safety, and security protocols. These measures in-
clude swipe card and key access to the bunker, a log book to record users
present during sessions, thermoluminescent dosimeter badges to detect acci-
dental dose overexposure, and two steel security doors between the radiation
chamber and the observation post. The 60Co source is normally secured in a
closed state and the source is unrevealed. When the 60Co source is unrevealed
the radiation chamber can be unlocked, users can enter the radiation cham-
ber, and it is safe for the users to set-up the apparatus inside the radiation
chamber for the experiment. The 60Co source cannot be revealed whist the
two steel security doors granting access to the radiation chamber are open
and unlocked. The key required to reveal the 60Co source is the same key
used to unlock the steel security door adjacent to the observation post. The
key cannot be removed from this steel security door until the steel security
door has been pulled over to the closed position and its lock has been turned
to the locked position. To turn the lock to the locked position on the steel
security door the user must be standing on the observation post side of the
steel security door. Only when the key is used from inside the observation
post can the 60Co source be moved to the open state and the radiation source
be revealed. Once the 60Co source is revealed the flow of γ radiation begins.
It is imperative for user safety that this protocol is not compromised.
5.4.2 The Radiation Source
The radiation source of the low dose bunker at Brunel University is a 60Co
source, a radioisotope with a 5.27 year half-life. 60Co will decay, by beta
decay, to the stable isotope of nickel-60 (60Ni). The decay scheme for 60Co
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is shown in Figure 5.4. This decay scheme depicts the decay of 60Co. Note
there are two γ photons emitted as the unstable 60Co radioisotope decays
to the stable 60Ni isotope. The beta emission of the 60Co source results in
the emission of two γ-rays, one with 1.17 MeV and the other with 1.33 MeV
of energy. However the 1.17 MeV energy photons account for more than
99 % of the irradiated γ-rays produced by the decaying radioisotope. Using
a radiation source emitting photons of 1.17 MeV of energy is a suitable source
substitution to replicate the typical radiation energy a cancer patient would
receive from a radiotherapy linac to treat a cancer they have been diagnosed
with.
Figure 5.4: The decay scheme for a 60Co radioisotope.
Before the experiment could begin the 60Co source had to be calibrated.
Calibration before starting the experiment is done to determine the dose rate
of the 60Co source. The present operating dose rate for the source is needed
to determine the precise set-up of the equipment for the experiment. As the
60Co source is a radioisotope the number of beta decay events diminishes
with time, and it therefore follows that the rate of γ-rays produced by the
radioisotope also decreases with time. The present operating dose rate from
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the 60Co source is a critical calibration measurement for the experiment.
Typically the 60Co source is being used to irradiate a target with a precise
dose of radiation and the effect from this total dose exposure is what the
user is measuring. The experimental data the user is looking to obtain from
a 60Co based radiation experiment is defined by the total dose of radiation
the target has been exposed to. The total dose of radiation the user wants
the target to receive is determined by dividing the total intended dose by the
present operating dose rate of the 60Co source. The resulting number is the
duration of time the target needs to be exposed to the 60Co source. What
makes determining the present operating dose rate of the 60Co source more
complex is that the radial emission of ionising radiation coming from the 60Co
source obeys Newton’s inverse square law. The inverse square law can be used
to describe the propagation of EM waves when the photons are emitted from
a single source. It states, the dose rate from the radiation source is inversely
proportional to the square of the distance from the radiation source. This
means the dose rate at 2 m from the 60Co source is 1
r2
of the dose rate at
1 m. In other words the critical pre-experiment calibration measurement of
the present operating dose rate from the 60Co source is necessary to determine
both the duration of the experiment and the precise distance the target needs
to be from the source to ensure the total dose received by the target matches
the intended dose to be received by the target.
To calibrate the radiation source, and determine its present operating dose
rate, two steps are taken. First is to determine the expected operating dose
rate for the radiation source, and second is to confirm the present observed
dose rate for the radiation source. The expected operating dose rate for the
60Co source is found to be referring to the decay profile for the particular
source. The present observed dose rate for the 60Co source is made by using
a digital dose rate meter.
Table 5.1 shows the dose decay profile for the low dose 60Co radiation
bunker at Brunel University. Table 5.1 is only an extract from the full dose
decay profile for the working life for this particular 60Co sample at the Brunel
University bunker. Table 5.1 shows the dose decay profile for 2008, from
month 96 through to month 108 of the working life for the source, and as
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Activity Dose Rate @ 10 cm Dose Rate @ 40 cm
Date Half-Life Ci Gy/min mGy/sec Gy/min mGy/sec
Jan ’08 1.5180 10.44 0.1996 3.3273 0.0125 0.2080
Feb 1.5338 10.33 0.1975 3.2910 0.0123 0.2057
Mar 1.5497 10.22 0.1953 3.2551 0.0122 0.2034
Apr 1.5655 10.10 0.1932 3.2197 0.0121 0.2012
May 1.5813 9.99 0.1911 3.1846 0.0119 0.1990
Jun 1.5971 9.89 0.1890 3.1499 0.0118 0.1969
Jul 1.6129 9.78 0.1869 3.1155 0.0117 0.1947
Aug 1.6287 9.67 0.1849 3.0816 0.0116 0.1926
Sep 1.6445 9.57 0.1829 3.0480 0.0114 0.1905
Oct 1.6603 9.46 0.1809 3.0148 0.0113 0.1884
Nov 1.6762 9.36 0.1789 2.9819 0.0112 0.1864
Dec 1.6920 9.26 0.1770 2.9494 0.0111 0.1843
Jan ’09 1.7078 9.16 0.1750 2.9173 0.0109 0.1823
Table 5.1: The decay profile data of the 60Co source in the low dose radiation
bunker at Brunel University for the year of 2008, as expected by the provider
of the 60Co source.
the experiment was carried out in July 2008 it is the July record from the
table that is most relevant to the experiment’s set-up. The data presented
in Table 5.1 is taken from a compressive table provided with the 60Co, and,
as such, the data in this table was not measured or calculated as part of the
experimental process. This data is provided as a point of reference.
In order to confirm the expected dose rate of the radiation source a PTW
Farmer Air Ionisation Chamber is placed at 10 cm directly in front of the
radiation source, the radiation chamber in the bunker is sealed, and the dose
rate was measured using a Thermo Scientific NE2670 Farmer Dosemeter from
the observation post within the bunker.
On the 23rd of July 2008, with the ionisation chamber at 10 cm from
the 60Co source, the NE2670 recorded a dose rate of 3.3333 mGys−1. From
Table 5.1 the expected dose rate is 3.1155 mGys−1. That gives an operat-
ing error of ±6.99 %, an error that should be considered when estimating
the absorbed dose of radiation the experiment’s target has received. This
measurement completes the calibration of the radiation source, a necessary
calibration before the experiment begins in order to determine the distance
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the radiation source should be from the target, or x in Figure 5.2.
Figure 5.5: The absorbed dose as a function of distance for the 60Co source
in the low dose radiation bunker at Brunel University.
Knowing a dose rate at a fixed distance from the source is the only
necessary piece of information required to determine the dose rate at any
reasonable distance from the source. Using a single calibration point a
dose/distance profile can be drawn up. Working with the dose rate of
3.3333 mGys−1 at 10 cm from the 60Co source recorded on the 23rd of July,
2008 the dose/distance profile from Figure 5.5 is drawn up. The 23rd of July,
2008 is a significant date as this is the date that the transistors under test
were irradiated. This plot is characteristic of the inverse square law and it
depicts the relationship between dose rate and distance, that the dose rate
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is diminishing as one over the square of the distance from the source.
Table 5.2 is an extract from a more complete table describing the absorbed
dose of radiation as a function of distance from the radiation source. The
extract shown in Table 5.2 is presented to better understand the distance
chosen for the experiment, the distance between the radiation source and
the centre of the PCB. Table 5.2 has been included to justify the initial value
chosen for x in Figure 5.2.
Dose Rate Total Dose (Gy)
x (cm) 1⁄r2 mGys−1 Gys−1 185 min 186 min 187 min
8.5 0.01384 4.61315 0.00461 51.206 51.483 51.760
8.6 0.01352 4.50649 0.00451 50.022 50.292 50.563
8.7 0.01321 4.40349 0.00440 48.879 49.143 49.407
8.8 0.01291 4.30398 0.00430 47.774 48.032 48.291
8.9 0.01262 4.20780 0.00421 46.707 46.959 47.212
9.0 0.01235 4.11481 0.00411 45.674 45.921 46.168
9.1 0.01208 4.02488 0.00402 44.676 44.918 45.159
9.2 0.01181 3.93785 0.00394 43.710 43.946 44.183
Table 5.2: Data for the dose as a function of distance for the 60Co source in
the low dose radiation bunker at Brunel University for the year of 2008.
5.4.3 The FGMOSFET, ALD1123E
The MOSFET transistor is an electronic component fabricated from the ar-
rangement of three doped silicon regions. Silicon is known to be sensitive
to ionising radiation such that with sufficient exposure to ionising radiation
the silicon structure of the MOSFET transistor will degrade such that the
transistor may no longer functions with acceptable performance. This kind
of degradation is irreversible. This limitation of the MOSFET transistors,
its susceptibility to ionising radiation, extends to the FGMOSFET. If the
FGMOSFET is exposed to sufficiently energetic ionising radiation for a suf-
ficiently long period of time then the FGMOSFET component will become
irreversibly damaged beyond any practical use. However, despite the damage
caused by ionising radiation on silicon, the assumption that the FGMOSFET
will be a successful candidate as an electronic component capable of meas-
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uring the absorbed dose of radiation comes not from its commonality with
all MOS transistors in its response to ionising radiation, but instead its fa-
vour will be justified with the addition of a the floating-gate region to the
MOSFET’s structure. More specifically, optimising the shape and size of the
floating-gate region to the FGMOSFET can potentially lead to considerably
greater performance of the FGMOSFET as a radiation measuring component
for medical dosimetry over any alternative MOS transistor.
The use of RADFET devices as dosimeters for ionising radiation is well
established [117, 118, 119]. These devices are normally operated with a large
gate biases, 10 − 100 V, for optimum electron-hole pair generation caused
by radiation exposure [91]. RADFET devices can also be operated with
0 V on the VGS, but the sensitivity due to radiation exposure is generally
reduced by a factor of 5 − 10 [117]. Due to the fabrication limitations and
more demanding operation requirements the FGMOSFET is favoured over
the RADFET.
If the FGMOSFET has a floating-gate region that is significantly larger
in proportion to the rest of the component then, by virtue of the difference in
proportionate size of the adjacent regions, when the FGMOSFET is exposed
to ionising radiation the floating-gate region of the transistor will absorb con-
siderably more ionising radiation compared to the rest of the transistor. It
is this design advantage of the FGMOSFET that should prove the FGMOS-
FET to be sufficiently resilient to the damaging effects of ionising radiation,
yet still function after the most aggressive of radiotherapy regimes a patient
might be prescribed and also perform with the necessary sensitivity.
To validate the suitability the MOS transistor in the measurement of
the absorbed dose of ionising radiation during medical radiotherapy this ex-
periment used a FGMOSET component that is commercially available, the
ALD1123E from Advanced Linear Devices Inc. (ALD). Based in Sunnyvale,
California, ALD has been in the business of developing and manufacturing
CMOS linear integrated circuits since 1985.
The ALD1123E is a monolithic quad electronically programmable ana-
logue device consisting of four n-type FGMOSFET devices. The choice to
use a commercially available FGMOSFET component instead of designing a
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Figure 5.6: The pin diagram of the ALD1123E, a package enclosing four
FGMOSFET devices, each with an electrically adjustable VTh.
transistor from the ground up, such that it would be optimised to the partic-
ularly disagreeable operating conditions of medical dosimetry, is twofold. For
one, without having first completed some preliminary work to demonstrate
the theory behind the FGMOSFET as a radiation measurement compon-
ent for medical radiotherapy it is unlikely to secure the funding required to
pay for the fabrication of a custom design FGMOSFET optimised for the
intended application. However the second reason to go with a commercially
available FGMOSFET device instead of a custom design component, and
arguably a more valid reason for the decision to use the ALD1123E, is that
the four transistors on the ALD1123E chip have electrically adjustable VTh,
or turn-on voltage.
Using the E100 EPAD programmer in conjunction with the ALD1123E
IC devices the VTh of each transistor in the package can be programmed.
Programming a transistor on the ALD1123E using the E100 external pro-
grammer will result in the charge density on the floating-gate region of
the transistor being altered. The programmer works to add charge to the
floating-gate of the FGMOSGET device and thus increase the necessary VGS
to attract a sufficient number of charge carriers into the inversion region
of the transistor to enable a flow of current between the drain and source
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when a VDS potential is applied. The VTh of a transistor can be set between
1.000 V and 3.000 V with steps of 0.1 mV. Due to the electrical isolation
of the floating-gate in the transistor any charge added to this region has no
means to migrate out of this region provided the transistor is used under
conventional operating conditions. There is no limit to the number of times
a transistor in the ALD1123E package can be programmed.
Exposing the ALD1123E to ionising radiation constitutes unconventional
operating conditions and it is under the influence of ionising radiation that
the behaviour of the FGMOSFET was studied. The experiment was to
quantify a measurable shift in the electrical characteristics of the FGMOS-
FET by exposing it to ionising radiation, specifically addressing the shift
in the VTh based on its exposure to ionising radiation. By using ALD1123E
devices in conjunction with the E100 programmer an array of transistors was
used, each with their own programmed VTh, and this experimental config-
uration afforded two important characteristics of the FGMOSFET device to
be investigated. Firstly, programming the array of transistors to varying VTh
across the array meant the experiment could investigate the performance dif-
ference between transistors with different densities of charge in their floating-
gate region when exposed to the same dose of ionising radiation. Secondly,
to programme a ALD1123E device for a second time after its exposure to
ionising radiation meant the predominant effect of ionising radiation on the
FGMOSFET could be isolated. To programme the device after its exposure
to ionising radiation meant the cause of the movement of charge within the
FGMOSFET due to ionising radiation could be isolated to either the dis-
placement of stored charge from within the floating-gate region of the tran-
sistor or the electron-hole pair generation within the silicon dioxide region
near either the floating-gate or the interface of the transistor. The premise for
this assumption has to do with the processes involved when the FGMOSFET
is being programmed. The E100 programmer includes a specialist circuit to
safely apply an inordinate bias to VGS inducing the hot-carrier injection tech-
nique where free-electrons are encouraged into the floating-gate region by the
force of an electric field. Once charge is trapped in the floating-gate region,
and the transistor returned to a circuit of normal operation, the VTh for the
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transistor will become permanently altered. So should the FGMOSFET be
programmed to a maximum VTh initially and then when the transistor is irra-
diated by a controlled source of ionising radiation the VTh value will diminish.
After radiation exposure is complete the transistor can be programmed back
to VTh maximum, if obtainable. The question then becomes, by programming
the FGMOSFET after its been irradiated, can the electrical characteristics of
the device be recovered to pre-irradiation performance. This recoverability
of the transistor is a means to measure the portion of the ionising radiation
that is responsible for irreversible destructive damage to the FGMOSFET.
Should the irradiated transistor be programmed to the same pre-irradiation
maximum VTh, and the electrical characteristics of the transistor match its
pre-irradiation performance, then it becomes reasonable to approximate that
the majority of the absorbed dose of ionising radiation acted on the stored
charge within the floating-gate region of the FGMOSFET device and not
on any other part of the transistors. Or, at least to say, any absorbed ion-
ising radiation by parts of the transistor outside the floating-gate region left
negligible effects on the transistor such that its performance was persevered
between harsh radiation sessions.
This arrangement of the ALD1123E IC being used in conjunction with
the E100 programmer means both the recoverability of the FGMOSFET and
the radiation hardness of the device could be quantified.
5.4.4 Printed Circuit Board
From Figure 5.3 it is clear a PCB was used to hold the irradiated transistors
in place during the experiment. Considerable effort was spent calculating the
duration of the experiment based on the present operating dose rate of the
radiation source and the distance of the transistors from the source. As such
it was imperative that the position and orientation for the array of transistors
remained fixed and secure throughout the experiment. The solution used
was a PCB circuit to hold four ALD1123E devices in place, provide a bias
circuit to ensure a constant IDS, and provide a reliable cable connector for
continuous data to and from the PCB and the computer recording the results.
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The PCB was held in place by a clamp on a tripod. This made it easier to
position the PCB at a measured distance from the source.
(a) IC1 schematic (b) IC2 schematic
(c) IC3 schematic (d) IC4 schematic
Figure 5.7: Various edge detection algorithms
Before the PCB could be fabricated a schematic of the intended circuit
was required. From the circuit schematic the CAD work necessary to layout
the PCB could be accomplished. Figure 5.7 is a summary of the four IC
packages used on the PCB. For the four ALD1123E transistor IC packages
each circuit is presented through; Figure 5.7(a), Figure 5.7(b), Figure 5.7(c),
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and Figure 5.7(d). The current limiting resistor network for each IC is on
the VGS pin of each transistor. Note that each IC houses four transistors,
and so there is a current limiting resistor network at each VGS pin on each
of the four transistors. The resistor network for IC1 has a 0.5 MΩ bias on
VGS, for IC2 with 1 MΩ bias on VGS, for IC3 with 1.5 MΩ bias on VGS, and
IC4 with 2 MΩ bias on VGS. However, the schematic of the fabricated PCB
is captured through five figures in total. In addition to the four transistor
ICs, and their respective current limiting resistor networks, a connector was
required to bridge communication between the PCB and the PC recording
experimental measurements.
Figure 5.8: 25-way parallel port connector, from PCB to PC..
The fifth schematic required to build the PCB to house four ALD1123E
packages is presented in Figure 5.8, the 25-way parallel port connector. This
connector provided the interface between the PCB and the PC taking meas-
urements. Only 16 of the 25 lines on the 25-way connector were required.
But in order to work with an established form-factor a 25-way parallel port
adapter was used.
To understand the link between each of the individual schematic diagrams
consider each terminal with the same label to be hardwired on the PCB. For
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example, in Figure 5.7(a) the Vout used to measure the change in VTh for
the first transistor from the first IC throughout the experiment is labelled
with the terminal, “VTh IC1 (M1)”. This is pin 2 of IC1. From Figure 5.8
the terminal labelled, “VTh IC1 (M1)”, is connect to pin 11 of the 25-way
parallel port connector. Therefore, for the PCB CAD layout, pin 2 from IC1
is connected to pin 11 of the 25-way connector.
Figure 5.9: The CAD diagram of the PCB circuit containing four ALD1123E
devices.
The CAD of the circuit for the PCB is presented in Figure 5.9. This is a
simple circuit and highlights how only a limited number of components were
necessary for the successful operation of the circuit. The circuit contained
four ALD1123E chips, and each ALD1123E chip contains four FGMOSFET
devices. The experiment was designed to measure any change in VTh due to
ionising radiation and so the VGS pin of each of the four transistors from each
of the ALD1123E chips had to run from the PCB to the computer recording
the results from the experiment. That is a total of 16 data lines from the
PCB to the computer. It is worth noting that there was no power supply
included as part of the electronic circuit on the PCB. In addition to the 16
datalines the PCB also had a 3 V power line and a ground line running to
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the PCB from the computer recording the experiment’s result.
To meet the experimental objectives the four ALD1123E packages were
programmed before the experiment began. To make it easier to determine
which transistor was programmed to what initial VTh all four transistors on
a single ALD1123E package were programmed to the same VTh. However in
order to investigate by how much, if at all, the magnitude of the programmed
VTh makes to the rate of change of VTh due to ionising radiation, each of the
four ALD1123E packages was programmed to a different initial VTh. So for
all four transistors the approximate initial threshold voltages were as follows:
VTh1 = 1 V, VTh2 = 2 V, and VTh3 = 3 V. For VTh4 the package was pro-
grammed beyond the recommended operating VTh, and instead programmed
to the maximum possible VTh. This was a necessary measure to investigate
which region of the FGMOSFET responds most to ionising radiation. As
such, VTh4 = 3.5 V.
The other requirement of the PCB circuit was to ensure IDS = 1 µA
across all transistors. The circuit for each transistor is kept in saturation
with the gate and drain shorted together. The source is pulled to ground,
and the ground is common to all devices. Depending on the initial VTh a
specific arrangement of resistors biased the drain pin of the transistor. For
example, a transistor from IC2 was programmed with a VTh = 2 V, and with
the need for IDS = 1 µA a resistance of 1 MΩ between the supply rail and
the gate was chosen.
To the left of the diagram is the footprint of a standard 25-way parallel
port connector. Although the total number of lines running from the PCB
was 18 it was thought that a standard parallel port connector would provide
a secure connection between the PCB and computer recording the results.
5.4.5 Electrical Noise Issues
From Figure 5.3 it is clear a cable was needed to run from the PCB holding
the array of transistors inside the radiation chamber to the computer in the
observation post recording the experiment results. Although only 18 lines
were needed the cable chosen was an adapted 25-way cable. Using a standard
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25-way parallel cable that was adapted to the experiment meant a reliable
signal could be transported from the radiation target to the computer.
Figure 5.10: This image is a screen capture from an oscilloscope used to meas-
ure the relative difference in signal quality of the customised cable assembled
for this experiment.
The screening of the 15 m cable assembled was found to be crucial as the
noise levels measured without proper screening were around 10 times higher.
The Figure 5.10 is a screen shot from the oscilloscope used to measure the
signal VGS from the first IC. The signal to the top of the figure is from
the cable without screening, and the signal below that is of the cable with
screening. Testing the quality of the customised cable improved the reliability
of the data the experiment produced.
5.4.6 LabVIEW Automation
Referring to Figure 5.3 the layout of the experimental apparatus within the
bunker is reviewed. Included is a computer positioned at the observation
post. This computer was used to observe the progress of the experiment
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while the experiment was running, as well as to record the data gathered
from the experiment.
The computer was running an instance of LabVIEW, a popular tool for
the automation of the experimental process and typically used in conjunc-
tion with National Instruments’ data acquisition (DAQ) hardware. Lab-
VIEW boasts a user-friendly interface and its graphical programming lan-
guage makes experiment automation intuitive to set-up.
For the experiment completed the LabVIEW programme recorded data
from all 16 transistors across all four ALD1123E devices. The LabVIEW
programme was set so that every second it would record the VGS value for
each of the transistors.
The data points captured from the LabVIEW programme wrote directly
to an Excel spreadsheet. An Excel spreadsheet is a useful starting point
for the manipulation of experimental data. An Excel spreadsheet can be
quickly manipulated to produce a plot depicting the relationship observed in
the experiment. However for the experiment completed with the ALD1123E
devices the number of data points gathered in total rendered Excel an inef-
fective means of working with that data.
Having the experiment automated by using LabVIEW had the distinct
advantage that the VGS values for each of the transistors could be captured
simultaneously as well as removing the chance of human error if the data was
instead recorded by hand. The other beneficial feature to using LabVIEW
to automate the experiment was the data could be plotted in real time. In
other words while the experiment was running. This meant that when the
experiment was running for the first time the expected decrease of VTh was
observed while the measured VGS was being recorded. This gave confidence
that the experiment had been set-up correctly.
5.4.7 Data Acquisition Interface
Although it was a cable commonly used for a parallel port interface that
was customised to carry the 16 analogue VGS lines, one 3 V line, and one
ground line from the PCB to the computer running LabVIEW, this standard
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parallel port cable was unsuitable as the interconnect between the PCB and
the LabVIEW software. For the LabVIEW software to be able to record an
analogue measurement of VGS per transistor per second it required a Data
Acquisition (DAQ) interface.
For the experiment a PCI-6259 from National Instruments was fitted to
the computer. The PCI-6259 is a high speed multifunction DAQ PCI board
that was connected to a SCB-68 I/O connector block. The PCI-6259 has 32
analog inputs working at 1×106 samples per second per channel with a 16-bit
analog to digital converter. The PCI-6259 was more than capable of making
the required accurate measurements of the VGS at one sample per channel
per second. The 18 lines from the adapted 25-way cable connected to the
SCB-68 block, and from there the PCI-6259 DAQ board was addressable by
the LabVIEW software.
5.5 Experiment Procedure
The experimental set-up is illustrated in Figure 5.3 and it shows that the
PCB is positioned at a predetermined distance from the radiation source
denoted by an x. For the experimental procedure that was carried out to
determine the suitability of the FGMOSFET as an electronic component
capable of measuring the absorbed dose of ionising radiation the PCB was
positioned 8.7 cm from the 60Co radiation source. At that distance the dose
rate is 4.40 mGys−1 as described in Table 5.2.
Before any of the transistors were exposed to a single dose of ionising
radiation all 16 transistors were programmed to have their initial VTh set
to a predetermined value. To make it easier to keep track of the initial
VTh for each transistor all four transistors on a single ALD1123E device
were programmed to the same level. Sharing the initial VTh on more than
one transistor improved the reliability of the data found in the experiment.
The transistors were programmed as such: VTh1 = 1 V, VTh2 = 2 V, and
VTh3 = 3 V. To satisfy the experimental objectives VTh4 was programmed to
the maximum possible value such that VTh4 = 3.5 V.
The experiment intended to deliver a dose as close as possible to 100 Gy
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of ionising radiation, with the energy of the ionising radiation remaining un-
changed at 1.17 MeV throughout the experiment. The delivery of the dose
of radiation was broken into 4 phases. The phases were either radiation-on,
where the 60Co source is exposed, or radiation-off, where the 60Co source is
closed. The first phase was a long radiation-on phase. The second phase
was a short radiation-off phase. The third phase was a long radiation-on
phase. The fourth and final phase was a long radiation-off phase. Breaking
up the dose exposure received by the FGMOSFET devices was an initiative
to satisfy the complete list of experimental objectives specified at the outset.
Having a first phase as a long radiation-on phase ensured there was an oppor-
tunity to observe the expected effect of a decrease in VGS before carrying out
the entire experiment. If this initial phase failed to produce the predicted re-
sponse then the experiment was either at fault or the known effects of ionising
radiation to silicon have been incorrect. With a pause between the two major
doses of radiation as a short radiation-off phase, and with all transistors still
biased, there was an opportunity to; first, observe an immediate halt in the
decrease of VGS thus confirming that it was the incoming ionising radiation
causing the change in electrical characteristics of the transistor and, second,
to observe any immediate annealing effects in the transistor once the incom-
ing radiation was suspended. The advantage to making the third phase a
long radiation-on phase was to bring symmetry to the first long radiation-on
phase and add reliability to transistor performance as a component measur-
ably sensitive to the effects of ionising radiation. If the measurable response
of the shift in electrical characteristics of the transistors exposed to ionising
radiation is reproducible then its occurrence is not an anomaly. The fourth
and final phase of the experiment was a long radiation-off phase where all
the transistors were still biased but with no exposure to radiation. This was
to observe what long term annealing effects can occur within the transistors.
The first phase ran for 3.1 hours. The second phase ran for 1 hour. The
third phase ran for 3.1 hours. The fourth phase ran for 16.5 hours. At a dose
rate of 4.40 mGys−1 at 8.7 cm from the 60Co radiation source both the long
radiation-on phases were exposed to TotalDose = 2× (3.1× 60× 60× 4.4×
10−3) Gy. That works out at a dose of 49.1 Gy for both the first and third
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phases of the experiment, or 98.2 Gy total.
5.6 Experiment Results
In an effort to assess the suitability of the FGMOSFET as a dose meas-
urement electronic component for the application of medical science this
experiment ran for 7.2 hours automatically gathering a single value for VGS
of each of the 16 transistors at a rate of one data point per second. Thus
totalling 26, 170 data points per transistor and more than 420 k data points
over all. Analysis of this data was achieved by working with the C++ pro-
gramming language using the object orientated principles of C++, direct
access to memory, and the ROOT framework, to manage this large dataset.
The ROOT framework, developed at CERN for the purpose of data analysis
in particle physics, includes a sophisticated library of tools to translate large
datasets into meaningful information.
The first calculation made after the experiment was complete was to de-
termine more precisely the dose of ionising radiation the array of transistors
was exposed to. The PCB was position 8.7 cm from the 60Co radiation source,
but that 8.7 cm was measured from the midpoint between all four ALD1123E
devices of the PCB. On closer inspection, after the experiment was complete,
it was found that each of the ALD1123E devices was 2.7 cm from the mid-
point where the measurement between the PCB and the radiation source
was taken. A simple pythagorean calculation corrects the distance from the
60Co radiation source to the midpoint of each ALD1123E device from 8.7 cm
to 9.1 cm. Referring to Table 5.2 the dose rate of ionising radiation for the
60Co source that the transistors were exposed to changes from 4.40 mGys−1
at 8.7 cm to 4.03 mGys−1 at 9.1 cm. As the first and third phases of the ex-
periment were both long radiation-on phases totalling 6.2 hours in duration,
the corrected total dose of ionising radiation the FGMOSET devices were
exposed to is 89.95 Gy for 6.2 hours.
In an effort to provide clarity to the initial outcome of the experiment
Figure 5.11 shows the data from just one transistor from the four separate
ALD1123E devices. As each ALD1123E chip was programmed to different
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Figure 5.11: A plot expressing VGS against time from the third transistor
from each of the four ALD1123E devices.
VTh values before the experiment began, this plot provides a snapshot of what
was precisely experienced by each transistor whilst they were irradiated by
the 60Co radiation source for 6.2 hours at a radiation energy level of 1.17 MeV
throughout the experiment. The first observation to make from this plot is
how the plot is clearly divided into three distinct phases. The first phase
is characterised by the first downward slope in each of the four transistors
presented in Figure 5.11. The second phase is characterised as a flat line,
VGS is no longer decreasing though the second phase. The third phase is
characterised by the same downward slope found in the first phase. It is
also worth mentioning that the transition between the three phases occurs
at the same point in time for all four transistors and because Figure 5.11
shows data from each to the ALD1123E devices being irradiated it can be
said that the cause for transition between the phases must be the same for
all four ALD1123E devices. The second observation to make from the plot
presented in Figure 5.11 is the distinct difference in gradient between the
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four transistors. The gradient of the decaying VGS is symmetric about the
first and third phase of the experiment for each transistor suggesting the
slope is responding to the same stimulus in both the first and third phases
of the experiment, while the difference in slope between the four transistors
correlates to their different initial programmed VTh values.
Figure 5.12: This plot shows the data from all four transistors on the
ALD1123E device programmed with VTh = 2 V before the experiment began.
On closer inspection of the data another interesting result is discovered.
Figure 5.12 presents the measured VGS as a function of time from four tran-
sistors again but, unlike Figure 5.11, the data in this plot is for four tran-
sistors all from the same ALD1123E device. That means all four transistors
started the experiment with the same programmed value, VTh = 2 V. If the
four separate transistors are hard to distinguish in Figure 5.12 it is due to
the high quality matching achieved within the fabrication process, a testa-
ment to the quality of engineering from ALD. To highlight the fact there are
in indeed four transistors in this plot a snippet of the plot is scaled up to
illustrate just what is going on with the VGS characteristic of the FGMOS-
FET while the experiment is running. This snippet is taken only 20 minutes
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into the experiment highlighting that there is no delay to the response of
the FGMOSFET to ionising radiation. The snippet is a detailed view over
a period of approximately 30 minutes. The most noteworthy observation to
be made from the data presented as a snippet compared to the data being
presented as a whole, although on the scale of the entire experiment it may
appear unclear, is that there is indeed a marginal discrepancy between each
of the four transistors from a single programmed ALD1123E device. For a
more precise and quantified measure of the sensitivity of the FGMOSFET to
ionising radiation a statistical analysis is needed.
The sensitivity of the FGMOSFET is measured as the change in VGS as
a function of time. With the way the experiment was set-up the total dose
for each transistor is known to be 89.95 Gy at 9.1 cm from the 60Co radi-
ation source. At this distance the dose rate is measured at 4.03 mGys−1.
Therefore to determine the sensitivity of the FGMOSFET as a radiation
measuring electronic component the rate of change of VGS was calculated.
An approximation of the sensitivity to dose of the FGMOSFET was stat-
istically determined by calculating the gradient of a least square linear fit
using all the measured VGS data during both the long radiation-on phases
of the experiment. The sensitivity of the FGMOSFET to the dose of ion-
ising radiation was calculated from the data points measured during the
long radiation-on phases of the experiment, a total of 10, 878 from a possible
26, 170 data points for each transistor.
First Phase Sensitivity Third Phase Sensitivity
Transistor VGy−1 σ VGy−1 σ
1 6.52× 10−3 0.196× 10−6 6.54× 10−3 0.300× 10−6
2 6.55× 10−3 0.118× 10−6 6.57× 10−3 0.207× 10−6
3 6.67× 10−3 0.155× 10−6 6.65× 10−3 0.390× 10−6
4 6.61× 10−3 0.157× 10−6 6.64× 10−3 0.210× 10−6
Table 5.3: Approximate sensitivity of the ALD1123E device programmed to
VTh = 2 V and calculated by taking a least square linear fit of the data from
the two irradiation phases.
Table 5.3 provides a summary of the approximated sensitivity for the
ALD1123E device programmed to VTh = 2 V. This table highlights the mar-
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ginal discrepancy shown in the scaled up snippet from Figure 5.12. Notice
how close each approximate sensitivity is between the four devices and the
symmetry found between the two phases of radiation exposure. The data
presented in Table 5.3 shows the amplitude of the approximate sensitiv-
ity calculated for the transistors in the ALD1123E device programmed to
VTh = 2 V. Of course, looking at Figure 5.12 the direction of sensitivity
could be expressed as a negative number highlighting it was a decaying shift
in VGS the experiment observed. In addition to this, from the data presented
in Table 5.3, σ is the error for the data collected on each transistor measured,
where each transistor was programmed with a threshold voltage, VTh = 2 V.
Each σ value in Table 5.3 is for one of the four transistors in the VTh = 2 V
sample. σ is an indicator of how tight the data is about a line of best fit for
the dataset presented. The smaller the value for σ the lower the measure of
erroneous data points off the line of best fit, thus giving more confidence in
the data itself.
Initial VTh First Phase Sensitivity Third Phase Sensitivity
Chip V VGy−1 σ VGy−1 σ
1 1.0 3.1× 10−3 13.5× 10−6 3.2× 10−3 12.3× 10−6
2 2.0 6.5× 10−3 66.5× 10−6 6.6× 10−3 53.5× 10−6
3 3.0 7.2× 10−3 20.6× 10−6 7.5× 10−3 43.5× 10−6
4 3.5 8.9× 10−3 230× 10−6 9.3× 10−3 310× 10−6
Table 5.4: Approximate sensitivity of all ALD1123E devices calculated by
taking a least square linear fit of the data from two irradiation phases.
Table 5.4 provides a summary of the approximated sensitivity for all four
of the ALD1123E devices. Each of the ALD1123E devices had all four tran-
sistors on that device programmed to the same initial VTh. The sensitivity of
each ALD1123E device was statistically determined by calculating the gradi-
ent of a least square linear fit using all the measured VGS data during both
the long radiation-on phases of the experiment. Notice again in Table 5.4,
as observed in Table 5.3, there is symmetry about the two long radiation-on
phases of the experiment and that the symmetry was found to change when
the initial VTh for the chip was higher. Notice also that the sensitivity of
each ALD1123E device was found to increase when the initial VTh for the
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chip was higher. This observed trend of an exaggerated response to ionising
radiation with a higher initial VTh for the ALD1123E device is summarised
in Figure 5.13.
A possible explanation as to why this phenomenon was observed sug-
gests it is the presence of a greater electric field in a transistor that gives a
transistor with a higher initial VTh a greater probability of encouraging the
movement of charge. The magnitude of the electric field majorities carriers,
and charge in the silicon dioxide region, are subject to is dependent on the
pre-charge density of the floating-gate region. For a FGMOSFET with free
electrons trapped within its floating-gate region an electric field between the
p-type substrate and the floating-gate’s trapped charge will form. Consider
the instance where incoming ionising radiation causes electron-hole pair gen-
eration through the Compton effect, if the electron of the electron-hole pair
is subject to a strong electric field it will have a tendency to migrate away
from its parent atom before it drops back to an energy state of an orbital
electron. The stronger the electric field the more likely this effect is to occur.
Figure 5.13: A plot to highlight the relationship between the calculated ap-
proximate sensitivity and the initial programmed VTh.
The fourth and final phase of the experiment was a long radiation-off
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phase where all the transistors were still biased but had no additional expos-
ure to ionising radiation. During the fourth phase the experiment continued
running, the computer continued gathering data at one data point per second,
and data was gathered for a 16.5 hour duration. It was in this stage of the
experiment that critical data for the annealing effects of the transistors was
gathered.
y = A− (B × e−
√
t
T0 ) (5.2)
Data from the fourth stage of the experiment shows the transistors to
slowly recover some of their lost VGS. Using a modified exponential equation
a fit was found for the data from the 16.5 hour observation period. The
adapted exponential equation is described in Equation 5.2. This equation is
simply an expression to fit the data based on the shape of the curve, and the
significance of the equation holds no value beyond this point. y = 1 − e−x
gives the general shape of the curve. The term, A, is a y-axis offset shifting
the y-axis intercept and defining the point at which the curve will asymptote.
The term, B, is an x-axis offset.
To help illustrate the measured annealing effects Figure 5.14 is a plot from
just a single transistor programmed to VTh = 1 V during the fourth phase
of the experiment. Figure 5.14 is a plot including 60 k data points with
each data point being measured a second apart. This plot shows an overall
voltage recovery in the fourth phase of the experiment. In addition to un-
derstanding the direction the annealing effect experienced by the transistor’s
post irradiation the plot presented in Figure 5.14 highlights the chosen fit-
ting curve for the modified exponential equation presented in Equation 5.2.
A complete presentation of the observed annealing characteristics across all
16 transistors for the 16.5 hour period is presented in Table 5.5.
Apart from the voltage recovery the other interesting feature of the plot
in Figure 5.14 is the ‘ripple’ on the gradually increasing curve. The rate at
which the curve increases in VGS is marginal by comparison to the decay of
VGS based on radiation exposure. However, no explanation for the noise on
the data was determined. This shape could be the result of errors within the
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Figure 5.14: This plot shows the typical annealing effects as experiences by
just one transistor programmed to VTh = 1 V.
measurement process. Further research would be required to understand the
precise cause of this effect. As no further work was completed to explore the
cause of the noise on the data there is no expected behaviour to this noise.
Initial VTh Coefficient B
Chip V V σ
1 1.0 7.6× 10−3 1.0× 10−3
2 2.0 9.0× 10−3 0.9× 10−3
3 3.0 7.0× 10−3 0.9× 10−3
4 3.5 8.0× 10−3 0.9× 10−3
Table 5.5: The data presented in the above table provides coefficient values
for each initial VTh a transistor may have been programmed with. The data
in this table supports the proposed modified exponential fit to characterise
the annealing effects observed in the fourth phase of the experiment.
The annealing effect, presented by data in Table 5.5, was an important
effect to measure as part of the experimental process. Annealing within the
FGMOSFET is the recovery of the VTh characteristic of FGMOSFET. If the
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alteration to the VTh characteristic of the FGMOSFET is, in part, caused by
the Compton effect of electron-hole pair generation within the silicon diox-
ide region of the transistor then the recovery of the VTh characteristic is the
electron-hole recombination occurring after radiation exposure. Now, most
normally the FGMOSFET is used as a digital component, and the profil-
ing of the effect of radiation exposure on the device is used to determine its
suitability in space application. As such the annealing effect would routinely
be considered negligible as a digital component works within discrete logic
states, where these states have a wide tolerance for voltage differences. How-
ever, in the application of the device as a radiation measurement component
the device is being used in an analogue context. Due to the continue nature
of analogue electronics any small differential in electrical characteristics of
the transistor will produce a margin of uncertainty into its operation.
The last result to report from this experiment concerns an observation
after the radiation-on fourth phase. After the forth phase of the experiment
was complete all four ALD1123E devices were removed from the PCB and
stored, unbiased, at room temperature for three days. All four ALD1123E
were effectively switched off. After the three day period the four ALD1123E
devices were programmed for a second time to their initial VTh using the E100
EPAD programmer. A breakdown of the average percentage recoverability
measured is presented in Table 5.6. From this table it is worth noting that
the recoverability of the FGMOSFET seems to degrade as the initial VTh of
the transistor is higher. The measured results include a limit of accuracy
about the programmer capable of voltage adjustments of 0.1 mV between a
1.000 V and 3.000 V range.
Table 5.6 presents the average recoverability found for programming each
of the four ALD1123E devices after the fourth phase of the experiment was
complete. Recoverability is considered the measure of how much of the ini-
tial pre-programmed threshold voltage the device can achieve after radiation
exposure. If radiation exposure is primarily causing a change in the electrical
characteristics of the transistor, but also causing irreparable degradation of
the device, then it is reasonable to assume that after radiation exposure
the transistor is no longer capable of performing to the level it was origin-
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Initial VTh Programmed VTh
Chip V % σ
1 1.0 98.5 0.7
2 2.0 100.1 0.2
3 3.0 89.9 15
4 3.5 73.1 6.5
Table 5.6: This table presents the average recoverability found for program-
ming each of the four ALD1123E devices after the fourth phase of the exper-
iment was complete.
ally calibrated to. As such the recoverability of the device is measured as
a percentage, highlighting the degree of performance loss due to radiation
exposure.
5.7 Experiment Conclusion
The results presented in this chapter are based on the investigated effects of
γ radiation from a 60Co source on the electrical characteristics of a commer-
cially available programmable floating-gate NMOS transistor. As illustrated
in Figure 5.11 there was a measurable change in the VTh across all transist-
ors, irrespective of their initial programmed VTh, with excellent linearity and
little sensitivity spread being observed.
All 16 transistors in the experiment were initially thought to be exposed
to a dose of 98.2 Gy of ionising radiation, but this measurement was later
corrected to a more accurate value where the total dose received by the
transistors was 89.95 Gy. Although 89.95 Gy is less than the 100 Gy dose
intended for the experiment it is still a dose that exceeds the most aggressive
of radiotherapy treatment plans a patient could be prescribed. Thus making
the results presented in this chapter still within the context of the application
of medical radiotherapy.
During radiation exposure the absorbed dose of ionising radiation was
measured in real-time as a shift in the measured VGS. The approximate
sensitivity across all devices was calculated with the maximum sensitivity of
9 mVGy−1 found for the transistors programmed with the initial VTh = 3.5 V.
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The sensitivity saturation at higher biases is consistent with the floating-gate
transistor approaching the limit of its charge storage capacity, i.e. the greater
the initial VTh of the device the stronger an electric field the electron-hole
pairs produced will be subject to.
Figure 5.11 also highlights the difference in the response of a FGMOSFET
depending on its initial VTh. The gradient to all four plots in Figure 5.11
shows that the rate of change of measured VGS is greater for transistors with
a higher initial VTh compared to transistors with a lower initial VTh.
At room temperature the annealing effect that was measured during the
fourth phase of the experiment found a maximum recovery of 8 mV over a
16.5 hour period.
The final stage of the experiment investigated the recoverability of the
transistors, what portion of ionising radiation exposure caused permanent
irreversible damage to the transistors. It was found that for the devices
programmed to the highest initial VTh that their recoverability, post irradi-
ation, was poorest with only an approximate 73% of their initial VTh being
recoverable.
A closer look at the recoverability of the FGMOSFET is thought to
provide an insight into the predominant cause of charge migration within
the FGMOSFET during ionising radiation exposure. The two possibilities
include; electron-hole pair generation within the silicon dioxide region near
either the floating-gate or the interface of the transistor, and the displacement
of stored charge from the floating-gate region of the transistor. Whatever
charge cannot be recovered once the transistor has been programmed after
exposure to ionising radiation is due to the electron-hole pair generation
within the silicon dioxide region of the FGMOSFET.
The major physics points of the FGMOSGET include; electron-hole pair
generation within the silicon dioxide region of the transistor, the induced
electric field caused by the pre-charged floating-gate region of the transistor,
and the movement of change based on the Compton effect.
With the experiment investigating the response of the FGMOSFET across
all programmed initial VTh values the radioresistance of the transistors in the
ALD1123E package was investigated. As all the devices continued to respond
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to the total dose of radiation throughout the duration of the experiment
the FGMOSFET was found to be sufficiently radioresistant to the harmful
effects of ionising radiation whilst still remaining functional as a component
measuring the received dose of ionising radiation.
A scanning electron microscope was used to capture an image of the integ-
rated circuit beneath the protective packaging surrounding the ALD1123E
device and it was estimated the footprint to a single transistor is approxim-
ately 75× 200 µm2. At this size footprint it proves promising that a custom-
ised device could be used in a more final implementation of a dosimeter that
would be small enough for an implantable medical application.
It has been recognised that the medical application of ionising radiation
in the treatment of cancer is with an operating range of energies from 50 KeV
to 25 MeV for an X-ray/γ-ray radiation beam. This experiment used a 60Co
radiation source capable of producing 1.17 MeV γ radiation only. This exper-
iment did not investigate the performance of the FGMOSFET through the
range of operating energies for radiotherapy but it did observe the response of
the FGMOSFET by measuring its change in electrical characteristics during
its exposure to ionising radiation of an energy within the range of operating
energies for radiotherapy.
The structure of this experiment was broken into phases with the dose
of radiation being delivered during two long radiation-on phases separated
by a short radiation-off phase. The response of the transistors exposed to
ionising radiation was consistent between the two long radiation-on phases.
This symmetry about the first and third phase of the experiment shows a
performance consistency between the dose exposure sessions, and is com-
parable to the expected operating conditions of the practical dosimeter in
radiotherapy being used while the patient returns week on week for their
followup radiotherapy appointment.
The second phase of the experiment was a short radiation-off phase that
clearly shows an immediate halt in the decay of the measured VGS when the
radiation source has been closed. This response from all 16 FGMOSFET
devices supports the idea that it is the ionising radiation that is responsible
for the change in electrical characteristics of the transistor.
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The size, sensitivity, and programming characteristics of these devices
suggest that this type of floating-gate technology would be suitable as an
electronic component capable of measuring the absorbed dose of ionising
radiation for the application of medical dosimetry for radiotherapy.
5.8 Further Work
The work completed to achieve the results presented in this chapter was
substantial, however more can be done to improve this study to assess more
completely the suitability of the FGMOSFET as an electronic component for
the measurement of absorbed dose of radiation.
Testing the FGMOSFET with a 100 Gy dose of ionising radiation would
determine if the FGMOSFET is sufficiently resilient to retain performance
in the harshest of cancer treatments.
Although the results presented demonstrate the suitability of the FG-
MOSFET as a radiation dosimeter for medical radiotherapy, the FGMOS-
FET has been demonstrated to operate at one specific energy of X-rays only.
Testing the FGMOSFET against the spectrum of energies a patient may be
prescribed would be a prudent calculation to ensure the FGMOSFET is op-
erational across the full energy spectrum for radiotherapy. The 60Co source
is a strong 1.17 MeV energy source, and although the data gathered from
experimenting with this radioisotope forms a good bases of knowledge about
the performance of the FGMOSFET, and that modelling of the effect of vary-
ing energies could be simulated, the range of energies practical radiotherapy
extends to far exceeds the mid-level 1.17 MeV photons used here.
The X-ray/γ-ray based radiation source represents the treatment techno-
logy of the vast majority of oncology clinics in the UK. However high energy
photons only make up one type of radiation that can be used in the treat-
ment of cancer. Testing the FGMOSFET as a dosimeter in treatments using
a proton or heavier ion beam would be to assess the suitability of the FG-
MOSFET for the next generation of technologies to be adopted more widely
in the treatment of cancer.
The most important next step for this project would be to repeat the
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experiment after the development of a custom designed FGMOSFET for the
intended application of medical radiotherapy. The results in this chapter
clearly demonstrate the FGMOSFET can be used as an electronic compon-
ent to measure the absorbed dose of radiation but the FGMOSFET in the
form presented by the ALD1123E package is not suitable for an implantable
dosimeter. A custom design FGMOSFET is needed to confirm it can be
integrated with the other necessary electronics to form an integrated system
and act as a functional implantable dosimeter.
This chapter has presented the results from a study to investigate the
performance of a commercially available programmable FGMOSFET as a
radiation measurement component. It has been presented in this chapter that
measuring the VGS of a FGMOSFET while it is exposed to ionising radiation
will provide a real-time measurement of the absorbed dose of radiation the
transistor has been exposed to. It has been shown that the response of the
FGMOSFET when exposed to ionising radiation produces excellent linearity
between the measured VGS and the dose it has been exposed to, with a
sensitivity of up to 9 mVGy−1 recorded.
5.9 Summary
This chapter has presented an experiment to characterise the suitability of the
FGMOSFET as an electronic component for radiation measurement. This
chapter has presented the experimental method where the FGMOSFET was
exposed to a 60Co radiation source producing 1.17 MeV γ radiation at a dose
rate of approximately 4.03 mGys−1 at 9.1 cm from the source. This chapter
has presented the results of the experiment using the ALD1123E, a com-
mercially available chip containing four separate FGMOSFET devices each
with a programmable initial VTh. The best sensitivity found was 9 mVGy
−1
and the worst recoverability was 73% of their initial threshold voltage for
the transistors programmable to the highest VTh = 3.5 V. This chapter has
presented the conclusions of the experiment stating the ALD1123E provides
strong evidence of the suitability of the FGMOSFET as a radiation measure-
ment device for medical dosimetry, but that further work should be carried
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out to characterise a custom built transistor optimised for the application of
IVD.
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Chapter 6
Micro Antenna Experiment
and Results
6.1 Introduction
This is a results chapter and the data presented within this chapter make
up a credible academic contribution to the field of in-vivo dosimetry for
radiotherapy. The results discussed in this chapter have undergone peer
review and been published in the journal of Radiation Measurements Journal
[120].
This chapter will begin with a quick overview of the expected working
environment for a medical instrument operating during the course of a radio-
therapy treatment. An overview of this working environment will contextu-
alise the aims and objectives of this study. For an implantable electronic do-
simeter for radiotherapy there will need to be an antenna to provide wireless
communication between the device and the medical physicist. This chapter
presents the work and results of a study that characterised three alternative
micro antenna designs to determine which design is best suited for IVD. The
chapter will provide a detailed report on every stage to the micro antenna
experiment should there be a need to replicate the results found.
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6.2 The Operating Environment
Radiotherapy is the use of an external source of ionising radiation to target
a predetermined volume of a patient within which lies a cancerous growth.
Ionising radiation is lethal to all cells, healthy and malignant, and radiother-
apy is indiscriminate in dose delivery. All exposed cells within the target
volume, and along the axis of propagation the radiation beam is aligned
with, are subject to the same harmful effects of radiation exposure. The
need for continual improvements to QA in radiotherapy is paramount to en-
sure confidence in patient safety. Dosimetry, the measurement of absorbed
dose of radiation, is a popular choice for QA technology in radiotherapy
where verification of the intended dose can be made by comparing it with
the measured dose during treatment. Up until very recently, despite the lit-
eral meaning of IVD, dosimetry during treatment has been completed using
external dosimeters. The delivered dose is then estimated using a mathem-
atical calculation of the absorbed dose at the target volume. The reason
for this crude approach to QA in radiotherapy is mainly due to a lack of
available cost effective implantable dosimeters for radiotherapy. One recent
study using an internal dosimeter during patient treatment has highlighted
the previously unknown and undetected inaccuracies of conventional EBRT
in the treatment of cancer, finding a > 5 % variance in 40 % of breast cancer
patients, and a > 5 % variance in 36 % of prostate cancer patients, across
1,600 fractions [121]. The results from this study demonstrate the advant-
ages of having the treatment dosimeter implanted within the patient. Not
only will an implantable dosimeter improve QA in radiotherapy by accur-
ately measuring the absorbed dose but it will also accurately measure the
absorbed dose at the target volume and inform the medical physicist of what
portion of the intended dose was delivered to the cancer.
As an implantable dosimeter is intended to be internalised during radio-
therapy treatment a natural consideration is the risk to a patient undergoing
treatment. Implantable medical devices monitor and treat physiological con-
ditions within the body, and these devices, including; pacemakers, implant-
able cardiac defibrillators, drug delivery systems, and neuro-stimulators, can
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help manage a broad range of medical issues, such as cardiac arrhythmia,
diabetes, and Parkinson’s disease [122]. More than 25 million patients in
America alone have one type of implantable medical device or another [123].
Due to the possible dangers of such medical devices, and their prevalence
within modern medical treatment, regular review of risks and recommenda-
tions on the routine use of implantable deceives is discussed [124].
Fabricating such an implantable medical dosimeter, capable of running
over several treatment fractions, and maintaining reliability throughout the
patient’s treatment programme, is not without its challenges. It has been
recognised that should an implantable dosimeter for IVD be made from semi-
conductor materials it is possible to overcome some of the fabrication and
design challenges by integrating a silicon based dose measurement component
with the control electronics in a single integrated circuit [125]. Of course any
implanted medical device taking real-time measurements would require wire-
less communication to connect the medical physicist with the device before
the measurement could be read out. Although previous attempts to build
an implantable dosimeter for IVD have been successful [126] the advantage
of an integrated circuit design, where both the control electronics and dose
measurement electronics are are sub-millimetre, is lost when the antenna for
such a dosimeter is anything larger than sub-millimetre. It was therefore
the ambition of this experiment to design and characterise a sub-millimetre
antenna that could be added to the integrated circuit, including the control
electronics and dose measurement electronics, of a new enhanced dosimeter
to keep the overall design of the dosimeter sub-millimetre.
Radiotherapy is a treatment of cancer delivered at a specialist oncology
clinic, a clicic that is usually apart of a hospital. The sensitive nature of
electronic equipment in a hospital’s operating environment has led the Medi-
cines and Healthcare products Regulatory Agency (MHRA) to recognise that
electromagnetic radiation can interfere with some medical devices [127]. Par-
ticularly if used within 2 m of such devices. As such the MHRA has advised
on an NHS hospital-wide ban of mobile phones where necessary. It is such
sensitivities over the potential risks associated with unrestrained use of wire-
less electronic devices within a hospitals that has led to some governments
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allocating a dedicated band of frequencies for their explicit use within the
medical context. This includes the 1999 introduction of the Medical Implant
Communication Service (MICS) specification by the US Federal Communic-
ations Commission (FCC) [128].
The MICS specification is an unlicensed range of frequencies that can
only be used by medical electronics including the pacemaker and the cam-
era pill amongst other examples [129, 130, 131]. It has been determined
that the MICS range of frequencies, from the available range of frequencies
at the time the FCC was making a decision, best meet the technical re-
quirements for medical devices. The technical requirements for the assessed
MICS frequencies determined how conducive the tested frequencies were to
the propagation of EM waves within the human body.
It is therefore prudent in the design of a new enhanced implantable do-
simeter that requires a wireless channel for communication to adhere to the
MICS specification. Thus ensuring its compatibility within the operating
environment of a hospital. This chapter presents the work and results of a
study that characterised three alternative micro antenna designs to determ-
ine which of these design is best suited for IVD while accommodating the
MICS specification where possible.
6.3 Experiment Aims and Objectives
An implantable dosimeter for routine use to improve QA in radiotherapy
has an operation related performance requirement of wireless communica-
tion. An implantable dosimeter for IVD is a dosimeter that is placed inside
the target volume of the patient before radiotherapy treatment begins and
remains inside the target volume throughout the course the of treatment
until all treatment fractions are complete. It is therefore necessary for the
implanted dosimeter to have a wireless channel of communication for the
medical physicist to be able to interrogate the device and determine the ab-
sorbed dose of ionising radiation the dosimeter has recorded. This study
was to determine the best micro antenna for wireless communication for an
implantable dosimeter for radiotherapy.
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(a) Single-loop design. (b) Multi-loop design.
Figure 6.1: The two design types of micro antenna characterised for dosi-
metry application. Figure 6.1(a) the single-loop design. Figure 6.1(b) the
multi-loop design.
Figure 6.1 illustrates the difference between the two types of design of mi-
cro antenna this study characterised for IVD. The multi-loop antenna design
for Figure 6.1(b) differs from the single-loop antenna design of Figure 6.1(a)
by containing more than one loop of antenna trace about itself. It was the
ambition of the experiment presented in this chapter to complete a perform-
ance comparison between the single-loop and multi-loop design approach of
the micro antenna for wireless medical devices.
The MICS specification, defined by the FCC, states that electronic devices
used within a hospital environment for the wireless communication of bi-
otelemetry between a patient’s medical sensors and a doctor’s corresponding
readout equipment can safely operate within an unlicensed band of frequen-
cies dedicated to this application provided the electronic device operates
within the specification. The MICS specification declares the 401 MHz to
406 MHz range of frequencies as reserved for the wireless communication of
medical devices, provided the maximum transmit power is low. Low power
means an equivalent isotropic radiated power that is no greater than 25 µW
and a maximum bandwidth does not exceed 100 kHz at any one time. Thus
the MICS specification obliges a low data rate system. Using the estab-
lished FCC specification for RF operation in wireless medical electronics as a
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guideline on performance requirements of a micro antenna for an implantable
dosimeter it was the ambition of this experiment to characterise the response
of both the single-loop and multi-loop antenna design using no more than
100 kHz of bandwidth close to the allocated 401 MHz to 406 MHz range of
frequencies.
Given that an implantable dosimeter will measure the absorbed dose of
ionising radiation within the target volume during radiotherapy treatment,
and that radiotherapy treatment will be delivered within the hospital envir-
onment of an oncology clinic, the expected operational requirements for IVD
are uniquely low power and short range. That means, for any integrated
micro antenna sharing the same circuit as a silicon based dosimeter compon-
ent and control electronics, the received signal communicating the measured
absorbed dose of ionising radiation need only be a discernible signal above
the background noise and at no more than 2 m from the patient.
6.4 Experiment Overview
The aim of this experiment was to investigate the RF performance achievable
by a custom built integrated micro antenna fabricated on an integrated piece
of silicon, and to determine the best micro antenna between the single-loop
and multi-loop design for the application of medical dosimetry to improve
QA in radiotherapy as part of a cost effective implantable dosimeter for IVD.
Fabrication of the micro antennas was completed by the Micro and Na-
notechnology Centre (MNTC), a group based at RAL. Funding for the fab-
rication of the micro antennas was provided by the Innovations Ltd. group,
also based at RAL. The Innovations Ltd. group granted a £20, 000 sum to
pay for the work completed by MNTC. The funding from Innovations Ltd.
covered the cost of micro antenna fabrication only, and came with a man-
datory requirement. The experimental objective was for the results obtained
from characterising the micro antennas fabricated by the MNTC to further
support the innovation of a new enhanced dosimeter design. That design
should eventually include the micro antenna as part of an integrated circuit
where the shared silicon would also include a dose measurement component
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and control electronics. The Innovations Ltd. funding was therefore a funding
provided to carry out a feasibility study working towards a proof in concept
of the proposed dosimeter. The funding from Innovations Ltd. covered the
cost of the MNTC fabricating three batches of micro antennas only. The
micro antenna design could be altered between each batch and each antenna
in a batch was be identical. It was therefore imperative that the design for
each batch of micro antennas was optimised, without mistakes, and sufficient
to meet the experimental objectives. A sample of three micro antennas from
a fabrication batch was used for the experimental procedure.
(a) Single-loop antenna. (b) Multi-loop antenna.
Figure 6.2: The wire bond interconnect between the micro antenna and
PCB for, the single-loop design in Figure 6.2(a), and the multi-loop design
in Figure 6.2(b).
Figure 6.2 shows the technique of wire bonding being used as an inter-
connect is made between the PCB and the IC containing the antenna. In
total three batches of micro antennas were fabricated by the MNTC. The
first and second batches were of the single-loop micro antenna design, and
the third batch was of the multi-loop micro antenna design. The sample of
three micro antennas characterised each were mounted to their individual
PCB before being characterised by the complete experiment procedure. The
process of characterising a sample of micro antennas from each fabricated
batch was to build a performance profile as a function of distance of the
micro antennas by measuring a revived signal that the micro antenna was
transmitting. The information gained from characterising a batch of micro
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antennas was used to optimise the design of the subsequent batch of micro
antennas the MNTC produced.
6.4.1 Antenna Fabrication Process
Before the fabrication of a particular micro antenna design an estimate of the
expected performance of the micro antenna design was predicted based on a
derivation of the micro antenna’s layout using Maxwells equations and the
Maple mathematical package. Once the shape and size of the micro antenna
had been determined the micro antenna design was modelled using Synopsis
TCAD, a computer simulation software that helps to optimise semiconductor
device design. Based on the TCAD schematic the MNTC produced a batch
of micro antennas.
In total three batches of micro antennas were fabricated by the MNTC.
Each subsequent batch of micro antennas was only fabricated after the char-
acterisation of the pervious batch was complete. In this way the data gathered
on a batch of micro antennas could be used to make improvements to a sub-
sequent batch before it was fabricated by the MNTC.
Before the design of any micro antenna was started a couple of necessary
design rules were observed. The design of the micro antenna should not
exceed 1 mm in length on any side to ensure its compatibility with the
overall design requirements of a new enhanced dosimeter for IVD. In addition,
the design of the micro antenna should observe a void in the centre of the
antenna loop to improve the quality of the magnetic flux produced by the
micro antenna, thus improving the overall efficiency of the loop based micro
antenna. The magnetic permeability, µ, depends on the medium within
which the field exists, and within a vacuum the magnetic permeability is,
µ0 = 4pi × 10−7 Hm−1 [132]. The permeability of a material characterises
the response of that material to a magnetic field. In a simplified model
the permeability of a material is often regarded a constant for that given
material. All micro antennas were fabricated on a double polished 520 µm
silicon n-type with a resistivity between 1 Ωcm−1 and 10 Ωcm−1.
From Figure 6.3 the size and dimensions of the fabrication process for
141
(a) Schematic for first batch. (b) Schematic for second batch.
(c) Schematic for third batch.
Figure 6.3: Above are the schematics of the three batches of micro antenna
fabricated by the MNTC. Figure 6.3(a) schematic for the first batch. Fig-
ure 6.3(b) schematic for the second batch. Figure 6.3(c) schematic for the
third batch.
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all three batches of micro antenna, as completed by the MNTC, can be
appreciated. For the fabrication of the first batch of micro antennas, as
shown in Figure 6.3(a), a 200 nm layer of aluminium was deposited onto the
reverse side of the polished silicon 520 µm thick substrate using a sputter
coating technique. From the front face of the silicon wafer a 0.5 µm thick
insulation layerof SiO2 was deposited using the plasma-enhanced chemical
vapour deposition (PECVD) technique. Electron beam lithography was then
used, with a 0.9 µm thick positive tone resist to form the device template,
and a 0.5 µm thick aluminium layer was deposited using a thermal heating
technique, and finally the lift off process was used to clear the resist. For
the second and third batch of micro antennas, as shown in Figure 6.3(b) and
Figure 6.3(c), the fabrication process was adapted slightly to instead leave the
micro antenna trace embedded within the SiO2 layer of insulation. To achieve
this an additional 0.8 µm layer of SiO2 was deposited using PECVD and the
embedded micro antenna was added using the photolithography technique.
The need to introduce an additional 0.8 µm layer of SiO2 to embed the top
surface of the micro antenna trace was only considered after the first batch
of micro antennas was fabricated and tested. In the lab the performance
of the first batch of micro antennas was lower than expected. A theorised
explanation of this underperformance was to do with the exposure of the top
surface of the micro antenna trace. As the top surface of the micro antenna
trace was exposed to air it was subject to the possible effect of interacting
with oxygen in the air, and partially oxidising. With the introduction of the
this impurity to the top surface of the micro antenna trace the conductivity of
the trace itself would become compromised. So, for the subsequent fabricated
batches of micro antenna the top surface of the micro antenna trace was
buried under a 0.8 µm layer of SiO2 to keep the electrical properties of the
traces from becoming altered.
6.4.2 Printed Circuit Board
Each batch of fabricated micro antennas from the MNTC at RAL came on
a single slice of silicon. The individual micro antennas were diced to fit a
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2.54 mm2 area and separated from the rest of the silicon wafer. Each mi-
cro antenna was subject to a rigours experimental procedure consisting of
two experiments over several stages. Given the fragility of each separated
micro antenna the handling of the micro antenna in each stage of the exper-
iment had to be done with great care. To help make the handling of each
individual micro antenna safe a PCB was fabricated to house each micro
antenna throughout each stage of the experimental procedure.
Figure 6.4: A schematic of the PCB to mount a micro antenna.
Figure 6.4 shows the CAD layout of the PCB used to house a single micro
antenna from a batch produced by the the MNTC at RAL. There are three
sections to the PCB. On the right of the PCB is a 2.54 mm2 area where the
separated micro antenna was mounted to the PCB using a strong adhesive.
On the left of the PCB is a space to fit a BNC connector to interface the
micro antenna with experimental apparatus. The middle section of the PCB
adds the impedance matching network of inductors and capacitors between
the micro antenna and the source of the incoming signal.
The impedance matching network includes two parallel capacitors, C1
and C2, and a single series inductor, L. For an efficient power transfer of
the signal from the source, coming form the BNC connector, to the micro
antenna, transmitting the high frequency signal, there needs to be a matched
impedance between the source and micro antenna. If the BNC connector is
attached to a standard bench-top function generator then the output im-
pedance of that device would be 50Ω. In order for an efficient transfer of
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the signal from the function generator into the micro antenna the impedance
matching network of components needs to match the impedance of the micro
antenna to 50Ω. The impedance analyser, presented in Section 6.4.5 is a
standard piece of bench-top lab equipment capable of performing an imped-
ance analysis of an attached component, and provides a recommended set of
components for a impedance matching network to shift the tested component
to match a 50Ω interface. The data presented in Figure 6.9 illustrates this
point.
After the micro antenna was mounted to the PCB an electrical connection
between the PCB and the micro antenna’s IC was made using a wire bond
technique. The wire bonds between the PCB and the mounted micro antenna
were even more fragile than the micro antenna occupying a diced 2.54 mm2
area of silicon.
Including a BNC connector in the PCB was a way to interface the moun-
ted micro antenna with alternative experimental apparatus. The character-
isation process of a micro antenna was completed in multiple stages using
two experiment. By having a BNC connector to interface the mounted micro
antenna with different experimental apparatus made switching between the
different stages and experiments of the experimental processes safe.
Figure 6.5: The full PCB with, mounted micro antenna to the right, imped-
ance matching network in the centre, and the BNC connector to the left.
Figure 6.5 is a photo of the micro antenna as it was used throughout the
experimental process mounted to a PCB. Note that the micro antenna in
Figure 6.5 is located to the right of the PCB. This convenient configuration
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made handling the delicate micro antenna safe whilst completing the multiple
stages of the micro antenna characterisation process.
The following subsections will provide an introduction to some of the more
sophisticated lab equipment used to complete this experiment including; a
function generator, a spectrum analyser, and an impedance analyser. These
instruments were used across two separate experiments to complete a charac-
terisation of the performance of each antenna design under the requirements
of the MICS specifications.
6.4.3 Function Generator
Figure 6.6: The HM8134-3 function generator.
The HM8134-3 function generator from HAMEG Instruments GmbH,
presented in Figure 6.6, was used to generate a high frequency signal for
the micro antenna being characterised. The function generator is capable of
producing an output signal between 1 Hz and 1.2 GHz at a power between
−127 dBm and 13 dBm. For the purposes of this experiment, to characterise
the performance of the fabricated micro antennas for the use with the MICS
specification, this piece of lab equipment was adequate.
In addition to the HM8134-3 function generator producing the necessary
output signal required for the experiment, this particular piece of hardware
was also controllable via a software using an RS-232 interface.
6.4.4 Spectrum Analyser
The HMS3000 spectrum analyser from HAMEG Instruments GmbH, presen-
ted in Figure 6.7, was used to measure the received signal transmitted by
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Figure 6.7: The HMS3000 spectrum analyser.
the micro antenna being characterised. This spectrum analyser is capable
of measuring the spectrum between 100 kHz and 3 GHz of a signal with
an amplitude between −114 dBm and 20 dBm. Thus making this piece of
equipment suitable in the characterisation of the fabricated micro antennas.
In addition to the HMS3000 spectrum analyser accurately measuring the
received signal transmitted by the micro antenna, this particular piece of
hardware was also controllable via a software using a USB interface.
The spectrum analyser has a signal input on the front face. This signal
input enabled a BNC connector to attached to the device. Any attached
component to the BNC connector of the spectrum analyser was the interface
for the source of the high frequency signal under test. For the sake of the
experiment where the performance of the custom designed micro antenna
was being assessed it was a large free-standing tripod based RF antenna that
was used to provide the incoming signal. The large antenna was connected
to the spectrum analyser via the BNC connecter, and the measured signal
was received via the large antenna.
6.4.5 Impedance Analyser
The E4991A impedance analyser from Agilent Technologies, presented in
Figure 6.8, was used to perform a frequency response analysis of the micro
antenna being characterised. This impedance analyser is capable of perform-
ing a frequency sweep between 1 MHz and 3 GHz. For the purposes of this
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Figure 6.8: The E4991A impedance analyser.
experiment, to characterise the performance of the fabricated micro anten-
nas for the use with the MICS specification by testing the micro antennas
between 401 MHz and 406 MHz, this piece of lab equipment was suitable.
In addition to the E4991A impedance analyser accurately profiling the
frequency responses of the micro antenna, this particular piece of hardware
was also controllable via a software using a LAN interface.
6.4.6 Computer Automation
The scientific work necessary to characterise the fabricated micro antennas
was slow, time consuming, and methodical work. The experimental process
was completed in multiple stages and needed two experiment to accurately
measure the performance difference between the three different fabricated
antenna designs. As such, to minimise human error in the results record-
ing process of the experiment, computer automation of the lab apparatus
was implemented. Wherever possible a single computer running the Linux
operating system communicated with the lab apparatus via a number of
protocols including; USB, RS-232, and LAN. Communication with the indi-
vidual apparatus was accomplished using the C programming language and
the POSIX API to communicate directly with the hardware devices attached
to the computer’s operating system. The computer program would either set
the input stimulus to the experiment, the signal on the function generator
driving the micro antenna under testing, and record the experiment output,
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capture the peak amplitude measured by the spectrum analyser operating
over a particular range of frequencies. The recorded results were written to a
text file and saved for analysis after the experiment was complete. Capturing
data in this way minimised the possibility of human error in transcribing a
record of the measurements whilst saving the results into a favourable format
for later analysis.
6.5 Experiment Procedure
The characterisation of each fabricated micro antenna was a task completed
in several stages. The stages towards micro antenna characterisation was
achieved with the repeat use of two devised experiments. The first experi-
ment was to assess the impedance matching between the source of the high
frequency signal and the micro antenna itself. The second experiment was
to assess the performance of the micro antenna in transmitting the high fre-
quency signal over a distance. In this way, from the results found in this
process, a comparison could be made between the different designed micro
antennas in each fabrication batch.
6.5.1 Experiment 1: Impedance Characterisation
This experiment was completed using the E4991A impedance analyser. The
micro antenna was fixed to the front of the E4991A using the BNC connector
on the PCB. The impedance analyser was set to sweep between 1 MHz and
700 MHz taking a measurement of the micro antenna’s impedance and phase
at 1 MHz intervals across the range. The output from the experiment was
to produce a plot of the entire range of frequencies as shown in Figure 6.9.
Recall from Figure 6.4 the components L, C1, and C2 combine to form
the impedance matching network of the micro antenna’s PCB. Before the
performance analysis of the micro antenna as a transmitter can be started
the impedance matching network of PCB must be populated to ensure a
maximum transfer of power between the function generator producing the
high frequency test signal and the micro antenna transmitting that signal.
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(a) Unmatched antenna plot.
(b) Matched antenna plot.
Figure 6.9: The output from the impedance analysis. Figure 6.9(a) is the
impedance profile of the unmatched micro antenna. Figure 6.9(b) is the
impedance profile of the matched micro antenna.
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Using the E4991A impedance analyser with the unmatched micro antenna
an impedance plot was found, as shown in Figure 6.9(a). From this imped-
ance plot an equivalent circuit model was obtained. Using the values of the
equivalent circuit model in the PCB’s impedance matching network and re-
peating the same impedance characterisation experiment a new impedance
plot was found, as shown in Figure 6.9(b). What is significant about the
new impedance plot with the optimised impedance matching components is
the shift of the measured impedance amplitude at 400 MHz, from 210.200 Ω
in the unmatched configuration to 47.4458 Ω in the matched configuration.
Now that the micro antenna has an impedance that is matched to the signal
source it is used in the second experiment, the power/distance characterisa-
tion, to more reliably characterise the antenna’s performance.
Figure 6.10: The populated impedance matching network with the recom-
mended values of the equivalent circuit.
Figure 6.10 is included for completeness, and it shows a closeup of the
PCB with its mounted micro antenna and the recommended components for
impedance matching based on the first run of the impedance characterisation
experiment.
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6.5.2 Experiment 2 - Power/Distance Characterisation
In this experiment a characterisation of the micro antenna’s power as a func-
tion of distance was completed. Figure 6.11 provides an illustration of the
experiment’s layout. For this experiment both the HM8134-3 function gen-
erator and HMS3000 spectrum analyser were used in conjunction with auto-
mation from a Linux computer. The objective was to measure, by feeding
a fixed signal produced by the function generator into the micro antenna,
at what distance from the micro antenna could a measurable received signal
be detected. The spectrum analyser displayed any measurable transmitted
signal received by the large antenna.
Figure 6.11: Experimental apparatus layout for experiment 2 - RF analysis
of the micro antenna.
The measured received signal was taken at four distances from the trans-
mitting micro antenna; 0.5 m, 1.0 m, 1.5 m, and 2.0 m. The received signal
was measured at each distance through three axes of orientation for the large
antenna and through three aces of orientation for the micro antenna. During
the experiment set up, to ensure the received signal was the intended signal,
generated in the function generator and transmitted by the micro antenna,
the function generator first sends a 400 MHz signal and it is observed as
a narrow spike on the spectrum displayed by the spectrum analyser. The
function generator is then turned off and the spike on the spectrum analyser
drops off to the noise level. This is repeated, with the transmitting signal
being adjusted through a number of frequencies. This gives confidence the
received signal is the signal being generated by the function generator.
The received signal was measured for the fully shielded, partially shiel-
ded, and unshielded micro antenna. Shielding of the micro antenna refers to
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concealing part, or all, of the micro antenna using a conductive copper tape
in order to determine what portion of the received signal was transmitted
through the micro antenna itself and not through wiring or apparatus junc-
tions. This experiment was completed for each micro antenna tested using
an input signal of 0 dBm at 400 MHz.
6.5.3 Stages of the Experiment
For this experiment to characterise the micro antennas the experiment had
to be completed in a number of stages. The stages included within the
characterisation process repeated the use of the two different experiments.
Based on the results of the characterisation process for the three tested micro
antenna designs a performance comparison between the three designs was
used to determine which of the three designs is best suited as the micro
antenna for a wireless implantable dosimeter.
The first stage of the experiment was to determine a baseline performance
of the fabricated micro antenna. After mounting to a PCB each micro an-
tenna from a fabrication sample a wire bond link between the micro antenna
and the PCB was made. For the first stage of the experiment a temporary
0 Ω link was made across the L component of the PCB’s impedance match-
ing networking. Without any further changes to the impedance matching
networking of the PCB a baseline performance could be established. The
PCB housing the micro antenna was fixed to the function generator of the
second experiment, the power/distance characterisation experiment. The
power/distance characterisation of an antenna was achieved by measuring
the amplitude of the received signal at a fixed distances between the trans-
mitting micro antenna and the receiver antenna. The amplitude of the re-
ceived signal was measured at four distances between the transmitting micro
antenna and the receiving large antenna. At each of those four distances
the power amplitude of the received signal was measured through the three
axes of orientations for the receiver antenna, and through the three axes of
orientations for the micro antenna. At each of the four distances the power
amplitude of the received signal was measured with the micro antenna being
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fully shielded, partially shielded, and unshielded, using a conductive copper
tape. This experimental process is illustrated in Figure 6.11. These measure-
ments of the received signal’s power combine to form a performance snapshot
as a function of distance for the individual micro antenna.
After a baseline of micro antenna performance was established the next
stage of the experiment was completed. The impedance matching config-
uration of the micro antenna was approached. Using the first experiment,
the impedance characterisation experiment, an equivalent circuit model was
obtained for the unmatched micro antenna. Using the information from the
equivalent circuit model the impedance matching network of the PCB was
altered and the first experiment was run for a second time on the micro
antenna. By repeating the impedance characterisation experiment after the
impedance matching network of the PCB was updated the effectiveness of
the matching network was recorded. The first experiment performs an ana-
lysis of the micro antenna’s response to an applied signal between 1 MHz and
700 MHz at 1 MHz intervals. Now that the micro antenna has an improved
matching network the response of the micro antenna at the 400 MHz target
frequency should be much closer to the ideal 50 Ω.
Replacing the first experiment for the second experiment the RF per-
formance for the the micro antenna is completed for a second time. This was
the final stage of the experiment to characterise the micro antenna with the
optimum components added to the matching network of the PCB. Again the
measured amplitude of the power of the received signal was completed for all
four distances through each of the three axes of orientations of the receiver
antenna and micro antenna, and for the fully shielded, partially shielded, and
unshielded micro antenna setup.
6.6 Experiment Results
This experiment was to determine, between three custom designed micro
antennas, the best performing micro antenna operating to the requirements
of a medical wireless implantable dosimeter for IVD. To determine which
of the three micro antenna designs was best suited for implantable medical
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electronics a batch of each micro antenna design was fabricated and tested
using a series of rigours and methodical experimental stages incorporating
two individual experiments. The results of this experimental procedure are
presented here.
Receiver Antenna Micro Antenna dBm at dBm at dBm at dBm at
Orientation Orientation 0.50 m 1.00 m 1.50 m 2.0 m
Straight Horizontal Straight -56.97 -59.90 -67.39 -68.26
Straight Horizontal Straight 90◦ -57.02 -61.53 -67.23 -67.48
Straight Horizontal Upright -57.41 -59.29 -67.62 -68.34
Straight Vertical Straight -55.48 -61.91 -58.60 -71.69
Straight Vertical Straight 90◦ -55.11 -61.55 -59.25 -70.72
Straight Vertical Upright -56.48 -61.19 -58.77 -70.96
Rotated Horizontal Straight -57.18 -59.60 -67.62 -62.09
Rotated Horizontal Straight 90◦ -57.02 -59.38 -67.64 -61.98
Rotated Horizontal Upright -57.10 -59.80 -67.85 -62.46
Table 6.1: A results sample from the power/distance characterisation ex-
periment for one of the micro antennas from the second batch of fabricated
antennas.
Table 6.1 is a sample of measurements taken as part of the power/distance
characterisation experiment for one of the micro antennas under test from
the second batch of fabricated antennas. This small snapshot of data col-
lected is for the partially shielded antenna configuration only, and includes
36 data points in total. Three times as many data points were measured
to also include the same antenna under fully shielded and unshielded condi-
tions. So the total number of data points for the matched micro antenna in
the power/distance characterisation experiment is 108. This measurement
process was repeated for all three micro antennas that make a sample from
a batch of fabricated micro antennas. Therefore an entire sample of micro
antennas includes 324 data points for the power/distance characterisation ex-
periment. Including all three fabricated iterations of the micro antenna, and
knowing that the power/distance characterisation experiment was completed
twice, once before the optimised impedance matching network and once after,
in total this experiment accumulated 1, 944 data points to characterise the
performance of all tested micro antennas.
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A comprehensive summary of the data acquired by testing the perform-
ance of the three batches of micro antenna is presented in, Table 6.2, Table 6.3,
Table 6.4, Table 6.5, Table 6.6, and Table 6.7. For each of the three batches
of micro antennas that were tested the data presented gives the measured
values for both the unshielded and partially shielded configuration in each
orientation of both the micro antenna and the large antenna. This data takes
a single data point for each distance and orientation. There is scope for error
within the measurement as more data points at each distance and orientation
wasn’t taken. However, the data dose provide a guideline on the profile of
transmitted signal by the micro antenna.
To make better sense of the data recorded a statistical approximations was
used across the entire set of results for the power/distance characterisation
experiment. The performance of each sample of micro antennas was averaged
across all orientations of the experiment’s data to produce a result that is a
sample equivalent micro antenna dataset.
dBm at dBm at dBm at dBm at dBm at dBm at
0.25 m 0.50 m 0.75 m 1.00 m 1.50 m 2.00 m
Batch #1 -76.41 -75.32 -79.63 -80.02
Batch #2 -57.14 -60.00 -65.00 -67.14
Batch #3 -65.65 -66.47 -69.63 -75.02
σbatch#1 0.98 0.44 0.73 1.20
σbatch#2 0.57 0.34 0.17 0.05
σbatch#3 0.98 4.21 2.21 1.76
Table 6.8: This dataset is the statistically approximated fabrication sample
equivalent dataset for the micro antennas tested using the power/distance
characterisation experiment.
Table 6.8 shows the sample equivalent micro antenna dataset used to
quantify the relative performance between all three micro antenna designs.
It is worth noting that only after the characterisation of the first batch of
micro antennas was it decided the range of tested distances for the micro
antenna should change from up to 1 m to a range up to 2 m. At 2 m it is a
more realistic distance an implantable dosimeter would operate from when a
medical physicist is interrogating the patient’s dosimeter. As such the dataset
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in Table 6.8 measures the performance of the first batch of micro antennas
up to 1 m distance only. Note also the lower half of Table 6.8 includes
the calculated standard deviation (σ) for each fabrication sample equivalent
micro antenna, where σ are the included ± error bars in the illustration of
the micro antennas’ relative performance in Figure 6.12.
Figure 6.12 highlights the performance difference between all three micro
antennas designed and fabricated. The data used to produced Figure 6.12
is take from the fabrication sample equivalent micro antenna dataset in
Table 6.8. Notice that for the first batch of micro antennas the plot in
Figure 6.12 is up to a range of 1 m only. The change to characterise the
performance of the fabricated micro antennas up to 1 m came after the first
batch of micro antennas was fabricated. The y-axis of the plot in Figure 6.12
increments on the negative scale so the strongest measured signal, in dBm,
moves up the y-axis. The error bars on each data point are taken as the
standard deviation from the average of three micro antennas in a fabrica-
tion’s sample. The larger the standard deviation the greater the variance in
the data of that batch of antennas. The noise floor of the testing environment
produced a fixed amplitude static at −90 dBm across all distances.
From Figure 6.12 the equation for the line of best fit for the three batches
is given as:
y = −2.592x− 51.304 (6.1)
y = −2.192x− 59.878 (6.2)
y = −1514x− 74.060 (6.3)
These equations are given in order. Equation 6.1 is for the line of best
fit for batch 2 of micro antennas, Equation 6.2 is for the line of best fit
for third batch of micro antennas tested, and Equation 6.3 is for the line
of best fit for the first batch of characterised micro antenna design. This
is the expected order of performance based on the predicted outcome given
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Figure 6.12: This plots illustrates the relative performance difference between
all three fabricated micro antenna design types.
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through the simulation work completed before the experiment was carried
out. Setting x = 1 for each of the three equations an estimate for the dBm,
y, can be found. A comparison between the three vales of y when x = 1
will give a rough guide as to the actual performance difference between the
three mire antenna designs. For the second batch of micro antennas, with
x = 1, y = −53.90 dBm, for the third batch of micro antennas, with x = 1,
y = −62.07 dBm, and for the second batch of micro antennas, with x = 1,
y = −75.57 dBm. From this data it is clear that the second batch of micro
antennas has outperformed all other micro antenna designs.
6.7 Experiment Conclusion
This experiment was to measure the performance difference between three
alternative micro antenna designs, and their suitability for wireless commu-
nication in medical electronic devices, specifically as an integrated micro
antenna to be used with an implantable dosimeter for IVD. In this section
the experimental conclusions are presented.
The broad aim of the experiment was to determine the performance dif-
ference between the single-loop and multi-loop design approach for the micro
antenna. Rigours testing of all fabricated micro antennas was completed us-
ing a multiple stage dual experiment procedure. The results from testing
two different types of micro antenna, two single-loop and one multi-loop,
found the refined single-loop micro antenna from the second batch of fabric-
ated micro antennas to be the best performing micro antenna from all three
fabricated micro antenna designs.
The process of characterising the design of each micro antenna was ac-
complished by implementing an experiment that determined the performance
profile of each micro antenna by meticulously recording the measured signal
at fixed distances and with all possible micro antenna and receiver antenna
orientations. Recording a performance profile over distance through all major
antenna axes of orientation was an important experiment objective.
A spectrum analyser is a remarkably sensitive and expensive piece of
equipment. It is designed for lab use, and can locally perform a variety
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of sophisticated mathematical operations on received spectrum. It also has
a plethora of I/O to enable data acquisition. However, for the sake of a
bespoke solution in the application of a medical dosimetry, a custom analyser
could be used in place of the E4991A from Agilent Technologies. In this
study a custom analyser was not investigated. Further work would be needed
to design and build a signal analyser for the use as a rudimentary signal
analyser. Any such customer signal analyser would be built as a cost effective
alternative to an expensive spectrum analyser.
From the function generator the signal driving all micro antennas under
test was a 0 dBm high frequency signal at 400 MHz. The results from this
experiment found the second batch of single-loop micro antennas to be the
best performing micro antenna design. At the maximum tested distance
of 2 m the estimated signal for the statistically calculated equivalent micro
antenna was almost −67 dBm. At 0 dBm the signal’s power is 1 mW, and at
−60 dBm the signal’s power is 1 nW. Therefore the best performing micro
antenna design produced a signal at the furthest distance of 2 m at three
orders of magnitude less than the signal driving the micro antenna. By any
conventional antenna design this level of efficiency would be unacceptable.
However the micro antenna application of implantable medical electronics
means the experiment was only aiming to prove the micro antenna design
could transmit a measurable signal, above the noise floor, at the maximum
experimental range. The noise floor of the experimental environment was at
−90 dBm where the power of the signal at this range is 1 pW. Thus, despite
the seemingly poor performance of the micro antenna’s design, the measured
signal at the maximum 2 m distance was still three orders of magnitude
greater than the noise floor. Therefore the design of the micro antenna from
the second batch of fabricated micro antennas can perform as a transmitting
antenna for the application of a new enhanced implantable wireless dosimeter
for IVD.
For this experiment the MICS specification provided a rough guideline
on a suitable performance requirement that should be used to characterise
the design of the fabricated micro antennas. The MICS specification defines
the 401 MHz to 406 MHz frequency range as the reserved range for medical
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devices, and states the maximum transmit power should be low with an
equivalent radiated power of ≤ 25 µW, and states the maximum bandwidth
used at any one time should not exceed 100 kHz. This experiment did not
directly implement the MICS specification with a high frequency signal at
400 MHz driving the micro antenna.
6.8 Further Work
Despite the promising findings of this early work into antenna design for an
implantable dosimeter it is understood that the results of this study may
have greater implications should the study be repeated to more strictly ad-
here to the MICS specification. Given the level of interest around wireless
medical devices passively providing extensive biotelemetry on patient health
the value of a functional micro antenna that can be directly integrated into
the electronic circuit of any medical device is important.
In addition, to compliment the findings in this initial study, the experi-
mental method should be revised to include an integrated circuit where an
improved micro antenna is coupled directly to a high frequency oscillator with
the necessary impedance matching network. In this way the measured signal
from the micro antenna under test can more reliably be explained by the
transmission from the micro antenna itself, instead of any signal potentially
leaking from the experiment’s apparatus.
As with any experiment where the technology being characterised is the
result of a mathematical model abstracted into a physical prototype there is
a latency between a change in the model and the implemented prototype due
to the fabrication process. The smaller and more sophisticated the integrated
circuit needed the more expensive the fabrication process becomes. As such
a field of research like micro antenna design is an iterative process towards
progress. In this sense the results presented here are promising, but only a
step towards a more refined solution.
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6.9 Summary
This chapter has presented an experiment to evaluate the performance dif-
ference between three custom designed micro antennas where the best per-
forming micro antenna would be used as part of an integrated circuited that
requires wireless communication.
This chapter has presented the experimental method where a sample of
three micro antennas from each batch of fabricated micro antennas was char-
acterised to determine their performance where the amplitude of a received
signal transmitted by the micro antenna was measured as a function of dis-
tance.
This chapter has presented the results of the experiment that charac-
terised the performance of the designed micro antennas including a strong
consideration of the MICS specification as a baseline for necessary operating
requirements. As such each of the micro antennas designed were tested up
to a distance of 2 m and looking to record a received signal above the noise
floor with the micro antenna being driven with a low power 0 dBm signal at
400 MHz produced by the function generator.
This chapter has presented the conclusions of the experiment stating the
best performing micro antenna design can be recommended for use in an
integrated circuit forming part of a new enhanced implantable dosimeter for
IVD.
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Chapter 7
Conclusion
This chapter summarises the main findings of the two studies carried out
for this thesis, includes a general discussion to consider these results in the
wider context of existing knowledge, and closes with an outline of further
work currently underway to push this project forward.
7.1 Achievements
The objective of the project is to design and build a new type of dosimeter,
an implantable wireless dosimeter to provide real-time measurement of the
absorbed dose of ionising radiation. The dosimeter would be built from a
single integrated circuit containing each of the four expected technology com-
ponents necessary for a new enhanced dosimeter design, including; a silicon
based dose measurement component, control electronics, an antenna for wire-
less communication, and a power source. This new enhanced dosimeter will
act as an improved quality assurance technology for radiotherapy, providing
confirmation of the absorbed dose of ionising radiation at the target volume
of a patient receiving treatment. This thesis presents the results of work
completed to address two of the four expected technology components of
this new enhanced dosimeter, including; an experiment to assess the suit-
ability of the floating gate metal oxide field effective transistor as a silicon
based electronic component capable of measuring exposure to ionising radi-
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ation, and an experiment to determine the best performing micro antenna
design for an implantable medical electronic device.
7.1.1 Transistor Experiment
In the transistor experiment the electrical response to exposure of the float-
ing gate metal oxide field effective transistor to a source of ionising radiation
was recorded and analysed. It was found that the response of this type of
transistor when exposed to ionising radiation is predictable, accurately meas-
urable, and repeatable. The charge stored on the floating-gate of the device
under test was programmable and it was found that the greater the density
of stored charge on the transistor’s float-gate the more sensitive the device
was to radiation exposure. The source of ionising radiation used for this
experiment produced γ radiation with energy typical of the electromagnetic
waves used in radiotherapy. As such it is inferred the floating gate metal
oxide field effective transistor is a suitable electronic component to measure
the dosage of ionising radiation and could be used as part of a new enhanced
implantable dosimeter for in-vivo dosimetry.
7.1.2 Micro Antenna Experiment
For the micro antenna experiment the performance difference between three
alternative micro antenna designs was assessed to determine which micro
antenna design is most suitable for the application of implantable medical
electronics. The unique operating environment of medical electronics requires
a low power solution to operate over a short distance and with low bandwidth.
Therefore, in the assessment of the three different micro antenna designs, it
was not the antenna’s transmission efficiency being characterised but instead
the clarity of the received signal through all test distances. This experiment
found the refined single-loop micro antenna design from the second fabricated
batch to be the best performing of the three micro antenna designs, and that
this antenna could be used as part of a new enhanced implantable dosimeter
for in-vivo dosimetry.
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7.2 General Discussion
This section is a general discussion, it draws together the results from the
two results chapters, and discusses the results in the wider context of existing
knowledge.
The transistor and micro antenna work combine to form two of the four
blocks necessary to build an implantable dosimeter. Simply including as
little as a VCO, and thin film micro-batteries, would be enough to build a
complete integrated dosimeter.
From the results presented in Chapter 5, and Chapter 6, both the micro
antenna and FGMOSFET have been found to be suitable components for
the application of in-vivo dosimetry. The completed transistor work is a
compliment to the published work of Tarr et al. [91], and the micro antenna
work is a compliment to the work of Kim et al. [130]. The suggested union of
these two elements of research as part of an integrated implacable dosimeter
are a compliment to the work of Shamim et al. [133].
7.3 Further Work
In April 2011 the success of a grant proposal was confirmed and the award of
£250, 000 form the Challenge Led Applied Systems Programme, funded by
the Science and Technology Facilities Council, had been allocated to take this
project onto the next stage. The grant includes funding for the design and
fabrication of a custom floating-gate transistor optimised for the application
of in-vivo dosimetry. This device has since been fabricated by the Tower-
Jazz group of Tower Semiconductor Ltd., a specialist silicon foundry based
in Migdal HaEmek, Israel. Application for this research grant was made in
conjunction with the The Oxford Cancer Centre of Churchill Hospital, Ox-
ford, and in collaboration with this specialist oncology clinic the new custom
transistors will be characterised using an NHS radiotherapy linac. It is there-
fore an aspiration of this project to improve on the results of the transistor
characterisation presented within this thesis as a stepping stone towards a
complete integrated implantable dosimeter for in-vivo dosimetry.
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7.3.1 Transistor Technology
The size of an optimised floating gate metal oxide field effective transistor
is a critical design consideration in future iterations of transistor technology
for in-vivo dosimetry. To ensure the best use of the available silicon in the
proposed dosimeter a sub-millimetre transistor with a proportionately large
floating-gate surface area will improve the resolution of the device as a dose
measurement component. Any further testing of the performance of the
floating-gate transistor as a dose measurement component should test the
dosimeter up to a 100 Gy dose, thus ensuring the transistor is a robust and
predictable device under the most aggressive of radiotherapy treatments.
In addition, the floating-gate transistor should be characterised across the
spectrum of ionising radiation practically used in radiotherapy, from 50 KeV
to 25 MeV. However the future of radiotherapy may not be in X-ray/γ-
ray based treatment, but instead with accelerated particles as the source of
ionising radiation. It would therefore be prudent to explore the response of
the floating-gate transistor under proton and heavier ion exposure.
7.3.2 Micro Antenna Technology
The next stage of research for the micro antenna is to integrate the micro
antenna on the same piece of silicon as the control electronics where a high
frequency carrier, meeting the MICS specification, could be produced. Only
by repeating the power/distance experiment to characterise the performance
of the micro antenna where, integrated on the same circuit, it is being driven
directly by a high frequency carrier can it be confirmed that the measured
received signal is being transmitted by the prototype wireless solution.
7.3.3 Control Electronics Technology
For the proposed dosimeter, a first step solution for the control electronics
technology is to characterise the performance of a voltage-controlled oscil-
lator. A voltage-controlled oscillator is a device that has a high frequency
analogue output, and the oscillating frequency of the output relates to the
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applied signal to its low frequency analogue input. In addition to this the
voltage-controlled oscillator can be built as part of an integrated circuit.
Therefore the voltage-controlled oscillator could potentially be designed such
that it forms part of the integrated circuit for the proposed dosimeter. The
high frequency output oscillation drives the carrier frequency feeding the
micro antenna and the low frequency input signal is taken directly from the
shifting VTh bias of the floating-gate transistor. This simple three stage solu-
tion could implement a rudimentary dosimeter where the ionising radiation
that causes a VTh shift on the floating-gate transistor would alter the output
frequency of the voltage-controlled oscillator, thus altering the transmitting
frequency of the micro antenna.
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